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Abstract 
Recent emphasis on using biomass as raw materials for the production of fuels and chemicals 
instead of non-renewable sources such as petroleum has accelerated the development of catalysts 
able to convert inedible plant and crop materials to value added compounds. Biocatalysis would 
seem to be an excellent choice for the process since organisms have evolved to convert sugars 
and other biomass materials to a variety of different compounds. Therefore, technologies that use 
biocatalysts have emerged as a promising foundation to build a green, sustainable bioeconomy. 
However, to derive value-added compounds from biomass, significant engineering work has to 
be performed to optimize naturally occurring organisms with better catalytic properties. The 
rapid advancement in understanding of molecular mechanisms of biological functions as well as 
development of novel molecular biological tools has now enabled this type of engineering work. 
 
Recently, two distinct fields have emerged to develop these self-renewing catalysts – protein 
engineering and genome/metabolic engineering – with the focus at the protein and organism 
level, respectively. While both techniques have had great success in developing biocatalysts, 
there has been little work in combining the two strategies to develop superior biocatalysts. 
Therefore, the main thrust of this work has been to combine protein and genome engineering 
efforts in order to exploit possible synergies between the two techniques.  
 
The first section describes the development of a selective biocatalyst for the production of the 
sugar substitute, xylitol, from a mixture of hemicellulosic hydrolysate sugars. First, a xylose-
specific xylose reductase enzyme was engineered for higher substrate specificity. However, after 
significant loss in enzymatic activity, genome engineering was targeted as an orthogonal strategy 
to increase substrate specificity further. The combined effort yielded a biocatalyst able to 
produce xylitol to ~100% purity. Next, this strategy of combined synergy was explored for the 
production of n-butanol, a promising biofuel, using recombinant yeast. Using directed evolution, 
one of the six butanol biosynthetic enzymes was engineered for soluble, functional expression in 
yeast. This enabled the production of butanol from galactose, but not glucose. In order to divert 
carbon flux from glucose to butanol, genome engineering was performed, which finally allowed 
production of butanol from glucose. These two demonstrate that protein and genome engineering 
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strategies can indeed be synergistic and that they can be used to develop properties in 
biocatalysts that can be beyond the capability of either one. 
 
Finally, two tools were developed to engineer the genomes of yeast, and E. coli. In yeast, 
MIRAGE (mutagenic inverted repeat assisted genome engineering) consists of a mutagenesis 
cassette comprising inverted repeat of selection markers. After introduction into the chromosome 
along with the desired mutations, the inverted repeat is excised due to its inherent instability in 
the chromosome, leaving behind no unnecessary elements in the chromosome. In E. coli, 
TRIIAGE (terminal repeat initiated illegitimate recombination assisted genome engineering) was 
been shown to be a powerful tool for creating precise mutations in the chromosome. The method 
relies on the ability of 16 bp direct repeats at the termini of linear DNA to enable circularization, 
and allow plasmid type pop-in/pop-out mutagenesis. 
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Chapter 1. Introduction 
1.1. Industrial/White Biotechnology 
White biotechnology refers to that with application to industrial processes, which along with red 
and green biotechnologies comprise the trinity encompassing all commercial biotechnologies. 
The latter two encompass medical/pharmaceutical, and agricultural biotechnologies respectively. 
Although possibly the first type of biotechnology ever to be put into practice – in brewing 
alcohol, curdling milk, and baking, etc. – predating the very notion of the words, in the last few 
decades, white biotechnology has been kept at bay by the low cost of raw materials from fossil 
fuel sources. Thus it has been relegated to producing chemicals for a niche, high-value, albeit 
small-volume market of specialty compounds such as high purity chiral chemicals. Resultantly, 
white biotechnology has been meeting the needs of only those markets where it is the only 
option. Now, the millennia-long latency period of white biotechnology is finally ending. Like a 
giant awaking from a long slumber, white biotechnology is stretching its limbs and has started 
dipping its fingers in every pie previously exclusive to synthetic chemistry [1-8]. The advantages 
of using fossil fuel-based carbon-sources are swiftly dwindling with lowering costs of 
biotechnological processes and increasing costs of fossil fuels and their aftereffect in 
environmental despoiling. Additionally, unlike fossil fuels, whose supply is destined to deplete, 
the raw materials for white biotechnology are rooted in natural and renewable sources. Already, 
several governments and private companies are looking forward and investing in white 
biotechnology so as to make the transition from using fossil fuels to more sustainable sources 
smoother. 
 
In spite of its benefits, white biotechnology currently continues to attract only a small share of 
total capital invested into biotechnology. The large majority of share is attracted by red 
biotechnology, followed distantly by green, and finally white. For example, in 2005 Germany’s 
red biotechnology enticed 88% of the € 326 million venture capital, whereas green and white 
split the remainder at 7%, and 5% respectively [9]. Similarly, in the USA, the majority of the $ 
35 billion invested into biotechnology in 2005 was in biopharmaceuticals [10]. The crucial 
factors fueling red biotechnology’s success is its proven track record in sustaining an astounding 
annual growth rate of ~18%, optimistic pipeline potential, and the inefficacy of traditional 
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therapies in treating diseases such as cancer, diabetes, and Alzheimer’s disease [9]. Green 
biotechnology has also presented a success story in the Americas and Asia; although Europeans 
have been far more hesitant in adopting it. Genetically Modified Organisms (GMOs) now 
comprise a significant portion of the cultivated crop with 48% of all soy, and 19% of all corn 
worldwide. 
 
The growth opportunities for white biotechnology are however significant, since the driving 
forces behind it are sustainability and its affability to ecological and environmental preservation. 
Of the forerunners of white biotechnological products are bioethanol and biodiesel, which are 
viable alternatives to gasoline and diesel. In his State of Union Address in January 2006, 
President George Bush stated, “We'll also fund additional research in cutting-edge methods of 
producing ethanol, not just from corn, but from wood chips and stalks, or switch grass. Our goal 
is to make this new kind of ethanol practical and competitive within six years.” And the goal set 
by the Department of Energy is to replace 30% of the liquid transportation fuels with biofuels 
and 25% of industrial organic chemicals with biomass derived chemicals by the year 2025 [9]. In 
Europe, the EU Biomass Action Plan has pledged to double the use of bio-energy by 2010, 
which in part requires substitution of a portion of gasoline with bioethanol [9]. However, these 
goals are just the initial baby steps and white biotechnology can offer more than just the answer 
to energy crises. Once a foundation has been laid, its implementation can provide easy access to 
a large repertoire of chemicals. And while it may not replace chemical processes entirely, it has 
the potential to absorb a fairly large share of the market. 
 
1.2. Engineering Biological Systems 
Interest in engineering biological systems stems from the fact that they can be highly efficient 
micro-factories able to metabolize and produce a variety of natural and unnatural compounds and 
their use in everyday life even predates the notion of quantized, cellular life. While uses of 
biological systems in fermentation, baking, and composting are commonplace, their value in 
chemical and therapeutic industries spurred extensive research in new ways to harness their 
power. 
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One of the major issues with biocatalysis is that the naturally occurring activity may not be ideal 
for an industrial application. Although it is possible to screen organisms for one with the desired 
activity, this approach can be very time-consuming and labor-intensive. With the advancement in 
understanding of molecular mechanisms of biological systems and tools available to manipulate 
them, engineering biological systems for a desired industrial application has become a reality. 
Compared to screening for industrially-relevant biocatalysts, engineering them has a higher 
chance of success. 
 
There are two general approaches to engineering biological systems – (1) protein engineering, 
and (2) genome/metabolic engineering. Although both aim to engineer biocatalysts, their focuses 
are at different scales. Protein engineering, as the title implies, concentrates on a single protein or 
collection of associated proteins with the aim of introducing or altering specific physical or 
chemical properties. Apart from a few exceptions like complex, multi-domain proteins such as 
polyketide synthases or non-ribosomal peptide synthases, most protein engineering approaches 
concentrate on developing better catalysts for a single type of reaction. Properties that are now 
routinely modified include, but are not limited to stability [11-14], activity [15, 16], solubility 
[17, 18], substrate specificity [19-22], or product selectivity [23, 24]. Genome/metabolic 
engineering generally aim to alter functions that are more complex and effect properties of an 
entire organism. These could be related to engineering a multi-reaction system or the general 
robustness and productivity of the biocatalyst. Examples of properties that are modified include 
ability to produce [25-27], or degrade novel compounds through multi-step reactions [28, 29], or 
increasing tolerance to inhibitors [30, 31]. The following sections describe the two approaches in 
more detail, with particular emphasis on delineating the differences between the two and the 
possible synergy realizable by combining the two approaches. 
 
1.3. Protein Engineering  
1.3.1. Rational design 
The obvious technique to engineering proteins and enzymes is to apply the tried and true 
techniques that have been successful in developing other forms of organic and inorganic 
catalysts. This Edisonian approach involves thorough study of the system to be engineered, 
followed by rational modification of the system. Although a successful strategy in many cases 
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[32-36], the complexity of biological systems precludes thorough study in most situations. 
Crystallographic structural data and mechanistic information are available for a select few 
enzymes and reactions, making it difficult to rationally design proteins for desired function. In 
spite of the limited understanding, rational design of protein function has been relatively 
successful. In fact, de novo design of new protein function has recently had success in designing 
enzymes around desired reactions [33, 35]. An alternative strategy, called directive evolution has 
had significantly more success in engineering enzymes for industrial applications. 
 
1.3.2. Directed evolution 
Directed evolution, or perhaps more aptly “premeditated synthetic evolution”, mimics natural 
Darwinian evolution in the laboratory at a highly accelerated pace. This, perhaps more than 
anything else, differentiates contemporary directed evolution from natural evolution. Synthetic 
evolution is usually undertaken at the level of a single gene, which is primarily due to current 
technological limitations rather than constraints of its definition; although several successes have 
already emerged in the synthetic evolution of complete pathways and organisms [37, 38]. 
Application of directed evolution promises to answer various industrial, medicinal, and perhaps 
even anthropological evolutionary questions.  
 
Conceptually, directed evolution is as simple as it is ingenious. Its advantage is that very little 
knowledge of the system to be improved is required a priori. Crystal structures and mechanistic 
data – vital for the traditional, rational design of proteins – are unnecessary. In spite of recent 
advances enabling rational design with relatively rapid elucidation of crystal structures by NMR, 
X-ray crystallography, or homology modeling, the initial investment of time is significant. Even 
empowered with such data, our limited understanding of factors determining tertiary protein 
structure and protein dynamics and the inability to accurately predict critical molecular 
interactions do not allow us to find distant allosterically linked residues for rational design. 
However, random mutagenesis has been shown to identify and target such sites with remarkable 
success [39-44]. 
 
One of the first uses of in vitro evolution technology can be attributed to Mills et al. [45] as early 
as 1967, but it did not gain widespread acceptance as a bona fide field until the 1990s when 
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molecular biology techniques had matured to allow for its commercial applications. Directed 
evolution starts by prudently picking a target - a single or multiple genes - and a desired goal.  
An iterative process of creating mutant libraries and choosing desired phenotypes over a 
synthetic fitness landscape is then begun until the goal is achieved or the desired property cannot 
be further improved (Figure 1.1). Various tools are currently available for each step in this 
process including mutant library creation and high-throughput screening strategies. 
 
Target Gene
Library of Mutants
Incrementally Improved Mutants
Highly Improved Mutant
 
      
 
 
 
Figure 1.1 Directed evolution 
starts by choosing appropriate 
target gene and a desired 
property for improvement. An 
iterative process of mutagenesis 
and screening is performed till an 
evolved mutant with the desired 
properties has been identified. 
Since methods that create mutations are near-blind processes that provide an overwhelming 
number of possibilities, they require an additional influence to guide them to the desired goal. 
This influence is crucial, and while in Nature, there is really only one primary pressure – survival 
– the goals of directed evolution experiments are often not easily aligned with such a goal. Thus, 
two additional strategies available are enrichments and high-throughput screens, the latter of 
which is akin to the oft-stated “looking for a needle in a haystack” analogy. 
 
In the absence of a selection scheme or an enrichment strategy, the primary bottleneck in most 
directed evolution experiments remains the library screening. Several improvements have been 
made to make this step quicker and less labor-intensive, yet it remains the weakest link in 
directed evolution. In spite of this limitation, directed evolution is a powerful approach and has 
numerous successes in engineering a vast variety of proteins for desired properties. 
 
1.4. Genome/Metabolic Engineering 
Engineered organisms can be treated as self-renewing catalysts that have the ability to carry out 
multi-step reactions in a highly controlled manner. In many cases, this property, along with the 
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ability to regenerate cofactors that may be required for enzymatic activity, makes whole-cell 
catalysis far more cost-effective than purified enzymes in most cases. However, there are entirely 
new sets of issues that get introduced when whole cells are used instead of enzymes. Mass-
transfer limitations due to the compartmentalization of enzymes within the cell membrane can 
decrease the overall rates of reactions, and is one of the most significant disadvantages to using 
whole cells.   
 
The process of exploiting the complexities of a cell with the aim of increasing the productivity 
and yield of a desired product by introducing user-defined pathways and metabolic fluxes is the 
hallmark of genome/metabolic engineering. Techniques exploited generally rely on introduction 
or deletion of biosynthetic pathways leading to, and away from the desired product. Successes of 
metabolic engineering have had significant impact on developing novel bioactive compounds 
[46-48], and better renewable fuels and chemicals [27, 49-54]. 
 
Several strategies have been employed to engineer microbes for improved biosynthesis. One of 
the most successful strategies have used in silico metabolic modeling to guide mutagenesis work 
(reviewed in [55, 56]). However, more recent efforts have taken into consideration cellular 
regulation as part of metabolic engineering. This allows control over more complex aspects and 
responses than those involved in direct chemical transformations. Global transcriptional 
machinery engineering [30], inhibitor tolerance [30, 31], substrate channeling [57], etc. have 
been explored to improve various aspects of biocatalysts for industrial use. 
 
For the most part, metabolic and protein engineering approaches have not been combined for the 
purposes of developing better catalysts, however there have been a few recent examples with the 
goal of producing biofuels [58-60].  
 
1.5. Scope & Goals of This Thesis 
Since protein and genome engineering introduce significant perturbations into their respective 
systems, inefficiencies are to be expected. Indeed such pleiotropic effects are well documented in 
protein and genome engineering studies [61-64]. To prevent accumulation of deleterious side-
effects it would be desirable to minimize the number of alterations. However, this in turn limits 
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the extent to which a desired property can be engineered. It may be possible to minimize such 
pleiotropic effects by using a two-pronged approach to biocatalyst engineering – one that 
combines protein engineering and genome engineering, such that the number of alterations in 
each case is kept to a minimum, but the combination of the two leads to a biocatalyst with 
desirable properties. 
 
While both protein and metabolic engineering have had significant successes in developing 
effective, industrially relevant catalysts, little effort has been put into combining the two 
strategies and exploiting the potential benefits of both. The two have generally been kept at arms 
length, and it has been unclear whether the combination of protein and metabolic engineering 
would be epistatic, additive, antagonistic, or synergistic. The main thrust of this thesis is to 
independently engineer proteins and genomes and then combine the two efforts to observe the 
possibility to finding synergy between the two with the aim of creating better biocatalysts. 
Results indicate that the two efforts tend to be synergistic, rather than epistatic or additive and set 
precedence for a new paradigm for developing better biocatalysts. 
 
1.5.1. Overview of chapter 2: xylitol 
The goal of this project was to develop a selective biocatalyst that is able to differentiate between 
two epimeric sugar substrates (D-xylose and L-arabinose) and reduce one to a desired product 
(xylitol) while not reducing the other to an undesired byproduct (L-arabinitol). Using directed 
evolution, a selective enzyme was engineered that increased the selectivity of the conversion 
when compared to the parent enzyme. However, the increased selectivity came at the cost of loss 
in affinity toward the desired substrate. In order to avoid further loss in catalytic efficiency, an 
orthogonal strategy was implemented that increased the selectivity of the process by altering the 
L-arabinose metabolism of the host E. coli strain. When the engineered enzyme was expressed in 
the genome engineered host, the selectivity of the conversion increased synergistically (Figure 
1.2).  
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1.5.2. Overview of chapter 3: butanol 
In order to produce butanol in a heterologous host (S. cerevisiae), genome engineering was 
performed to introduce a bacterial n-butanol biosynthetic pathway into this yeast. However not 
all enzymes were functionally expressed in this yeast, and protein engineering was performed to 
enable the expression of functional proteins in this heterologous host. While the protein 
engineering effort enabled the creation of a functional biosynthetic pathway, n-butanol could not 
be produced from glucose. Genome engineering to divert carbon flux to n-butanol instead of 
dead-end side-products enabled the production of n-butanol from glucose (Figure 1.3). Again, 
this demonstrates that a combination of protein and genome engineering efforts can be combined 
to create superior biocatalysts. 
2:1
8:1
21:1
1:0
Protein
Engineering
Metabolic/Genome
Engineering
Combined
SynergyXylitol:Arabinitol
 
 
 
 
Figure 1.2 Protein and genome 
engineering individually increased 
the selectivity of a bioprocess for the 
production of xylitol from a mixture 
of sugars. However, when combined, 
the two increased the selectivity 
synergistically, producing near-pure 
xylitol. 
Butyraldehyde
n-Butanol
Glucose
Ethanol
Glyceraldehyde-3-Phosphate
Butyryl-CoA
Genome 
Engineering
Protein 
Engineering
 
 
 
 
Figure 1.3 Protein engineering enabled the 
development of a soluble enzyme able to catalyze 
a key reaction in n-butanol biosynthesis. Genome 
engineering diverted metabolic flux to butanol 
away from the undesired product ethanol. The 
combination of the two efforts finally realized a 
yeast strain capable of producing n-butanol from 
glucose. 
1.5.3. Overview of chapters 4 & 5: tools for genome engineering 
Since metabolic engineering involves altering the genome of the organisms quite extensively, it 
requires tools that enable the creation of precise, site-specific alterations. Although tools exist to 
alter the genomes of E. coli and S. cerevisiae, they suffer from limitations that prevent quick, 
efficient chromosomal mutagenesis. These chapters describe novel techniques to create 
mutations in the chromosome without the need for any helper plasmids or heterologous proteins. 
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MIRAGE (mutagenic inverted repeat assisted genome engineering) is a method that utilizes the 
innate instability of inverted repeats/palindromes to introduce desired mutations and then remove 
the unnecessary elements such that no undesirable elements are retained in the chromosome 
(Figure 1.4A). Long inverted repeats are lethal to E. coli [65-67], and therefore MIRAGE cannot 
be adapted for it. However, the discovery of a unique non-recombinogenic pathway that 
circularizes linear DNA into a circular molecule enables plasmid-based pop-in/pop-out 
mutagenesis with linear DNA. The high efficiency of this method makes it ideal for introducing 
precise mutations in the E. coli genome more conveniently than previously possible (Figure 
1.4B). 
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Figure 1.4 Genome engine-
eering tools developed. (A) 
MIRAGE (mutagenic inve-
rted repeat assisted genome 
engineering) exploits the 
instability of inverted repeats 
in the chromosome. (B) 
TRIIAGE (terminal repeat 
initiated illegitimate recomb-
ination assisted genome engi-
neering) relies on the ability 
of linear DNA to circularize 
inside cells. Both methods are 
convenient tools to perform 
highly precise genome mut-
agenesis in S. cerevisiae and 
E. coli respectively. 
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Chapter 2. Highly Selective Production of Xylitol from a Mixture of 
Hemicellulosic Sugars 
 
2.1. Introduction 
Xylitol is a pentitol (5-carbon sugar alcohol) currently used as a natural sweetener in foods, 
pharmaceuticals, and confectionary industries. Studies have shown that among sugar substitutes, 
xylitol is one of the most promising candidates for application in a wide range of products due to 
several favorable properties. Its primary advantage over other sugar substitutes is that it has anti-
cariogenic properties since it cannot be metabolized by Streptococci, Lactobacilli and other 
microbes commonly found in the mouth [1-5]. Additionally, its metabolism has minimal effect 
on blood-sugar level making it suitable for use by diabetic patients. Recent studies have also 
shown that xylitol may help in preventing osteoporosis [6-8] and ear infections [9-11]. The 
gastrointestinal tolerance of xylitol and its naturally cooling effect, due to a negative heat of 
solvation, are among other properties favoring its use in products such as chewing gums, 
toothpastes, and mints. In spite of its advantages, the use of xylitol is currently limited and falls 
well short of another, cheaper sugar alternative sorbitol in the billion dollar polyol market 
(Figure 2.1). Other than its use as a sweetener, xylitol is also an industrially important chemical, 
and the US Department of Energy (DOE) has named it among one of their top 12 platform 
chemicals from agricultural sources (Figure 2.2) [12]. 
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Figure 2.1 Share of different polyols in a billion dollar 
market (data from zuChem, Inc.). 
 
Figure 2.2 DOE's TOP12 sugar-based platform 
chemicals [12].
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Xylitol is found naturally in fruits and vegetables, although its fraction is too small for 
commercial purposes. Therefore, commercially available xylitol is obtained by processing its 
oxidized form, D-xylose. Second only to glucose, D-xylose is the most common sugar in nature, 
and is the primary component of plant hemicellulose. Unlike cellulose (Figure 2.3) which is a 
homogenous glucose polymer, hemicelluloses (Figure 2.4) are complex polymers of several 
pentoses (primarily D-xylose and L-arabinose), hexoses (mainly glucose, mannose, and 
galactose) and organic acids. Exact composition of hemicellulose also differs depending on the 
source (Table 2.1). While several pre-treatment techniques to fractionate and hydrolyze 
hemicellulose to its monomers currently exist in industry, acid hydrolysis followed by enzymatic 
degradation is the preferred method. Thereafter, the hydrolysate is chemically reduced, and the 
xylitol is purified from the mixture of reduction products. The hydrogenation is carried at high 
pressure (40 atm), high temperature (135 ºC) with elemental hydrogen over Raney-Nickel 
catalyst (Figure 2.5). Recent studies have tried to formulate several safer and environmentally 
friendlier techniques based on biotechnology to produce xylitol using a D-xylose reductase 
enzyme (XR; aldose reductase family EC 1.1.1.21). These include recombinant bacterial [13, 14] 
and yeast fermentation [15, 16], non-recombinant yeast fermentation [17, 18], in vitro enzymatic 
reduction using in situ co-factor regeneration [19], electrochemistry-coupled fermentation [20], 
and fluidized-bed based reaction [21]. However, the maximum yield of xylitol in any of these 
processes is limited by the steps involved in purifying D-xylose from other hemicellulosic 
hydrolysate components, which is generally 50-60 % of the maximum attainable amount [22]. 
This issue remains as yet unaddressed in all reported xylitol production techniques as the broad 
substrate specificity of XRs would result in the production of unwanted side products such as L-
arabinitol, sorbitol, and galactitol. The byproduct L-arabinitol is of primary concern to techniques 
using XRs since they can reduce L-arabinose almost as efficiently as D-xylose.  
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Figure 2.3 Structure of cellulose. 
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Figure 2.4 Structure of hemicellulose. 
 
Figure 2.5 Current industrial process for xylitol 
production from hemicellulosic sugars. 
 
Table 2.1 Composition of hemicellulosic fraction from various agricultural sources [23]. 
  D-xylose L-arabinose D-glucose D-galactose other 
Birch wood 89% 1% 1% - 8% 
Rice bran 46% 45% 2% 6% 1% 
Wheat straw 66% 34% 0.3% 0.1% 0.1% 
Corn fiber 48-54% 33-35% - 5-11% 3-6% 
 
The primary goal of this project was therefore to develop a process that will produce xylitol 
efficiently and simultaneously minimize L-arabinitol production starting from a mixture of major 
hemicellulosic sugars – D-xylose, L-arabinose and D-glucose (Figure 2.6). The first part of this 
chapter will concentrate on the development of a D-xylose-specific xylose reductase via directed 
evolution so that contaminating sugars such as L-arabinose and D-glucose will be minimally 
reduced to their respective alcohol. In the second part, a rational, orthogonal strategy involving 
genome/metabolic engineering will be described to create a selective whole-cell catalyst. Finally, 
in the last section, the effect of combining both, the protein and genome engineering strategies 
will be described. It was observed that the two strategies were synergistic in their ability to 
increase the selectivity of the bioprocess, rather than simply being additive. 
xylose
arabinose
glucose
xylose xylitol
XR
xylitol
arabinose
glucose
H+ + H-
(NADPH)
arabinitol
biomass
 
Figure 2.6 The strategy for a selective bioprocess that will produce xylitol from 
a mixture of hemicellulosic sugars. 
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2.2. Results & Discussion 
2.2.1. Choice of template XR 
Paramount to the success of such an undertaking is identifying an appropriate template. The XR 
from the filamentous fungus Neurospora crassa (NcXR) has previously been identified as the 
most active XR to date (Table 2.2) [24]. In addition, the protein has several other favorable 
properties such as high level of heterologous soluble expression in E. coli and over twofold 
preference of D-xylose when compared to L-arabinose (Table 2.3). Several groups have 
attempted at changing the substrate specificity of various enzymes, but in most cases, results 
have lead to the production of even more relaxed substrate specificity [25-27], which may be 
desirable in some cases. Other groups have completely shifted the substrate specificity of 
proteins with narrow specificities [28, 29], yet examples of narrowing specificities of 
promiscuous enzymes are few, and a relatively challenging undertaking, particularly where 
substrates are epimeric (Figure 2.5). Enzymes involved in sugar metabolism have evolved to 
accept a broad range of substrates to provide organisms a competitive advantage in various 
environments where nutrition is limited. To create a substrate-specific enzyme, a combined 
rational design and directed evolution strategy was implemented. This strategy includes 
sequential rounds of saturation mutagenesis of targeted residues and screening for decreased L-
arabinose to D-xylose activity, as well as random point mutagenesis and selection for desired 
substrate specificity. 
Table 2.2 Catalytic parameters of XRs from various organisms. Adapted from [24]. 
Organism 
kcat 
(min-1) 
KM, xylose 
(mM) 
kcat/KM, xylose       
(mM-1min-1) 
KM, NADPH 
(mM) 
kcat/KM, NADPH          
(mM-1min-1) 
N. crassa 3600 34 106 1.8 2000 
C. intermedia 900 50 18 56 16 
C. parapsilosis 3100 32 98 37 84 
C. tropicalis ND 30-37 ND  9-18 ND 
C. tenuis 1300 72 18 4.8 271 
P. tannophilus 600 162 4 59 10 
P. stipitis 1500 42 36 9 167 
S. cerevisiae 860 13.6 63 7.6 113 
 
Table 2.3 Substrate specificity of N. crassa XR. Adapted from [24]. 
Substrate kcat (min-1) KM (mM) 
kcat/KM  
(mM-1min-1) Efficiency 
D-xylose 3600 ± 200 34 ± 4 110 100% 
D-ribose 3120 ± 100 70 ± 10 45 41% 
L-arabinose 1800 ± 100 40 ± 10 45 41% 
D-galactose 1800 ± 100 180 ± 30 10 9% 
D-glucose 1320 ± 100 360 ± 60 3.6 3% 
18 
 
2.2.2. Heterologous, tunable expression of NcXR in E. coli (Book1 pg36-99, Book2 pg2) 
Woodyer et al [24] have shown that high levels of soluble expression for NcXR can be achieved 
in E. coli BL21(DE3) under a strong and inducible T7 promoter. However, in order to develop a 
selection strain to engineer a D-xylose-specific XR, a vector providing a lower, more 
physiological-level expression is desirable. Thus plasmids pTrc99A, pKK223-3, pQE-80L, and 
pMAL-c2x (under trc, tac, T5, and tac promoters, respectively) were tested as expression 
vectors. The ~1,000 bp gene ncxr PCR amplified from pET15b-ncxr [24] was cloned into these 
vectors at various restriction sites within the multiple cloning site (MCS), however, no soluble or 
insoluble expression in hosts WM1788, XL1-Blue, or JM109 was observed by SDS-PAGE 
analysis (Figure 2.7). The gene was finally expressed only under a T7 promoter of pACYCDuet-
1 and pET20b and expressed in BL21(DE3). Expression using pACYC-ncxr was also tested 
using the strain WM1788(DE3) with positive results. The use of WM1788(DE3) in conjunction 
with pACYCDuet-1 expression vector, which while using a T7 promoter, resulted in acceptable 
expression levels due to a low plasmid copy number. Crude lysate activity assays and sequencing 
data confirmed active expression and that no incidental mutations had been introduced during 
cloning steps. The inclusion of a His6-tag for purification, and tunable expression level based on 
inducer (IPTG) concentration, as well as a compatible origin of replication with several other 
vectors made pACYC-ncxr (Figure 2.8) an ideal construct for all further engineering studies. 
 
321 654 87 9 10
 
Figure 2.7 SDS-PAGE analysis to check NcXR 
expression using pTrc99A (lanes 1, 2, 3), pKK223-3 
(lanes 4, 5, 6), both in WM1788, and pET15b in 
BL21(DE3) (lane 7, 8). Negative control (lane 9), and 
purified NcXR (lane 10). 
ncxr 119...1087
His-Tag 83...100
CAT 2171...1512p15A ori 2533...3445
lacI 4651...3569
T7p 4775...4791
pACYC-ncxr
4791 bp T7t 1245...1292
 
Figure 2.8 Vector map of pACYC-ncxr. 
 
2.2.3. Developing a high-throughput selection method 
The adage of any directed evolution study is that “you get what you screen for” [30]. An efficient 
high throughput selection method is therefore of cardinal importance to the success of any 
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directed evolution undertaking. In order to pre-select mutants with promising phenotype among 
those without, a selection strain was developed that directly correlates substrate specificity of 
mutant NcXR with survival of the host expressing it. Such a strategy was initially developed by 
Nate Wymer (zuChem, Inc., Peroria, IL). However, it did not work well with NcXR, thus a 
revised strategy was developed. 
 
A positive selection requires linking XR activity to cell survival. To implement this, it was first 
required to engineer a shunt in the pathway for D-xylose metabolism to link the activity of XR 
with the ability of the cells to survive on D-xylose as a sole carbon source. This would provide a 
positive selection selecting only those cells with active NcXR mutants on minimal D-xylose 
medium. Negative selection would require linking XR activity of L-arabinose to growth 
inhibition. This selection relies on two known facts about carbohydrates related cell toxicity in 
bacteria. The first is that the aforementioned toxicity is due to the synthesis of a lethal 
phosphorylated sugar intermediate [31]. Second, sugar-specific phosphotransferases in E. coli 
are known to lack strict substrate specificities [32-38], and can therefore be used to generate a 
toxic phosphorylated sugar-derivative. This required generation of a phosphorylated intermediate 
from L-arabinitol, L-arabinitol-5-phosphate. To create a strain capable of both positive and 
negative selection based on the above activities, the endogenous D-xylose isomerase (XylA) was 
inactivated and carbon flow was forced through the XR mutant encoded on a plasmid. 
Inactivation was performed using the method developed by Datsenko et al [39], with a few 
variations. Replacement of xylA in WM1788(DE3) by FRT flanked kan or cat selectable marker 
and subsequent deletion of said markers was established using colony PCR. This strain was 
renamed HZ348. Inactivation of L-arabinose metabolism pathway was unnecessary since the 
parental strain WM1788(DE3) had ∆araBAD genotype. This genotype was instrumental in 
choosing WM1788(DE3) as an expression host and not BL21(DE3), which has an intact L-
arabinose metabolism pathway. The final steps involved completing the D-xylose metabolism 
pathway and introducing a sugar-specific phosphotransferase enzyme with poor substrate 
recognition. Since XR converts D-xylose into xylitol, a compound that cannot be metabolized by 
E. coli, a second enzyme xylitol dehydrogenase (XDH) was required to oxidize xylitol into D-
xylulose, a ketose that can be easily assimilated into the pentose phosphate pathway. The XDH 
from Gluconobacter oxydans is a well-characterized enzyme [40], and was therefore chosen for 
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this purpose. L-Ribulokinase encoded by E. coli araB is a phosphotransferase whose natural 
substrate is L-ribulose, however due to its promiscuity is able to accept L-arabinitol. These two 
genes were cloned into a constitutive expression vector pTKXb and introduced into HZ348 to 
yield HZ349. A summary of pathway engineering including enzymes and intermediates involved 
are illustrated in Figure 2.9. 
 
Growth of HZ353 (HZ349 with pACYC-ncxr) was confirmed on minimal medium with D-xylose 
as the only carbon source. Neither HZ348, nor HZ349 grew on xylose medium, confirming that 
active NcXR is essential for growth. Presence of L-arabinose in the medium decreased the rate of 
colony formation significantly, but did not completely prevent growth of HZ353 even at high 
concentrations. The optimum conditions for cell growth and selection were determining by 
varying several parameters individually and are summarized in Table 2.4. 
 
 
D-xylose
D-xylulose-5-phosphate
xylitol
D-xylulose
NADPH
NADP NAD
NADH
ATP
ADP
NcXR XDH XylB
L-arabinose
L-ribulose L-ribulose-5-phosphate
L-arabinitol L-arabinitol-5-phosphate
(TOXIC)
PPP
AraA
AraB
AraB
AraD
NADPH
NADP
NcXR
ATP ADP
XylA
 
Figure 2.9 Recombinant (red) and endogenous (blue) 
pathways in HZ353 catalyzed by various enzymes 
(green).  Bold arrows indicate pathways, and black texts 
indicate metabolites in HZ353. PPP, pentose phosphate 
pathway. 
Table 2.4 Optimum growth conditions for HZ353.  
L-Arabinose was used only when applying selective 
pressure. 
 
Variable Optimum 
Temperature 30 °C 
IPTG 10 µM 
Thiamine-HCl 0.001 % 
M9 salts 1 x 
MgSO4 2 mM 
CaCl2 0.1 mM 
D-Xylose 0.50 % 
L-Arabinose 0.50 % 
Kanamycin (Kan) 5 µg/mL 
Chloramphenicol (Cm) 5 µg/mL 
 
2.2.4. Developing an assay for NcXR activity & selectivity (Book2 pg49, Book4 pg2-10) 
The reduction of substrates by XR is accompanied by a concomitant stoichiometric oxidation of 
NADPH (nicotinamide adenine dinucleotide phosphate, reduced form) cofactor, which has a 
characteristic absorbance at 340 nm. Therefore, the rate of reaction can be directly monitored as 
the slope of decreasing absorbance of reaction mixture by a UV/Vis spectrophotometer. This can 
be performed for purified proteins, and even crude cell lysates with overexpressed XR allowing 
for adaptation into a higher throughput screening when used in conjunction with a plate-reader. 
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Such a screen was developed in a 96-well plate format to determine activity of NcXR and 
mutants in a more quantitative manner, in presence of D-xylose or L-arabinose. Colonies formed 
by individual transformants were picked from an agar plate, grown, and induced to express 
mutant NcXRs. Cell-free lysates were individually tested for activity toward D-xylose and L-
arabinose with the reaction rate monitored by a spectrophotometric plate-reader. Initial slopes 
were a measure of activity toward each substrate and a ratio between the reaction rate of L-
arabinose and that of D-xylose was used as a measure of selectivity. The overall “fitness” 
(Equation 2.1) of a mutant was defined as the ratio between its activity (Equation 2.2) and 
selectivity (Equation 2.3). 
 
Excessive variations in readings would result in false positives or negative results, and therefore 
it was important to determine conditions under which the coefficient of variance (CV, Equation 
2.4), or deviation from the mean remained under 20 %. These conditions were finalized for 
BL21(DE3) harboring pACYC-ncxr as well as for HZ353. Cells were picked into 96-well plates 
and grown till late log-phase at 37 ºC and thereafter induced at 30 ºC with a high concentration 
of IPTG for 16-20 hrs. The long induction time allowed the cell density in all wells to reach 
approximately the same value. Constant shaking was imperative to prevent cells from settling to 
the bottom and for proper aeration. Microtiter plates were incubated in a humid environment to 
minimize evaporative losses. Incomplete cell lysis is a possible variation which was avoided by 
using plate sealers to cover plates and served a dual purpose of enabling high speed vortexing 
without spillage or inter-well contamination. It was noticed that variation was minimized when 
high reaction rates were measured over a short period of time (1 min), thus also providing a 
better resolution of relative activities. Substrate concentrations used were near KM values, also to 
provide the highest resolution for changes in affinity toward either substrate. 
 
Equation 2.1 
 Fitness = A
S
 =
relative Activity toward xylose
relative Selectivity toward arabinose
=
mutant
parent
arabinose
xylose
xylose
rate
rate
rate
rate
 
  
 
 
  
 
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Equation 2.2 
arabinose
xylose
Relative Selectivity toward arabinose
rate
rate
=    
Equation 2.3 
mutant
parent
Relative Activity toward xylose = 
xylose
rate
rate
 
 
 
 
Equation 2.4 
CV 100%x
x
σ
= ×
< >
 
 
2.2.5. Determination of substrate interacting residues (Book2 pg39-40) 
To determine residues interacting directly with the substrates, D-xylose was first docked into the 
substrate binding pocket of a NcXR homology model [24] and was subjected to energy 
minimization. Due to the promiscuous nature of NcXR, it has a large pocket for binding 
substrates. Therefore residues with atoms within 8 Å were considered as substrate interacting, 
instead of 4.5 Å, which is generally considered within van der Waals interaction distance. 
Thirteen residues were found to be within this distance, and are listed in Table 2.5. A similar 
docking process was repeated for L-arabinose, to determine key residue interactions that may 
discriminate between the two substrates. Functional classification based on docking analysis and 
published data was performed to identify the minimal subset of residues that can be mutated 
without significantly inhibiting activity. Other than the residues known to be imperative for 
catalysis (Tyr49 and Lys78) all residues were considered for mutagenesis. The three residues 
identified as most important for discriminating between C4-epimers D-xylose and L-arabinose 
were Asp48, Phe112 and Asn307 based on their apparent proximity to the fourth carbon (C4). 
 
Table 2.5 List of substrate contacting residues identified by 
docking analysis. Hypothesized function listed. 
Residue Hypothesized Function 
Trp21 Catalytic Activity 
Asp44 Catalytic Activity 
Asp48 Discrimination between D-xylose and L-arabinose 
Tyr49 Known Catalytic Residue 
Lys78 Known Catalytic Residue 
Trp80 Substrate Discrimination 
His111 Substrate Discrimination 
Phe112 Discrimination between D-xylose and L-arabinose 
Trp129 Substrate Discrimination 
Phe222 Substrate Discrimination 
Phe225 Substrate Discrimination 
Asn307 Discrimination between D-xylose and L-arabinose 
Pro309 Substrate Discrimination 
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2.2.6. Creating and screening mutant libraries (Book2 pg50-99, Book4, Book5, Book7 pg2-69) 
Several rounds of screening were used to scrutinize the mutants to minimize the number of false 
positives from the library. After selection on solid media, colonies were picked into 96-well 
plates and induced cell lysates were used to screen for activity against both D-xylose and L-
arabinose substrates as described previously. Mutants (usually < 150) with highest fitness 
(Equation 2.1) were streaked on chloramphenicol supplemented LB plates and then re-screened 
as before, but in triplicate, i.e., three colonies were picked and screened per mutant. This round 
of screening was able to eliminate a large number of false positives since outliers would easily be 
identified by large deviations from average readings for the mutant. Thereafter, a third round of 
screening was performed using 1-5 mL cultures grown in tubes instead of 96-well plates. From 
here on screening was performed individually on each lysate with either of the substrates using 
the Cary UV/Vis spectrophotometer. The number of promising mutants was usually narrowed 
from ~15 to one or two after this round of screening. Finally, a fourth round of screening was 
performed using purified protein and the best mutant was further characterized to determine its 
kinetic parameters. 
 
Two different approaches were used to achieve the goal of creating a more D-xylose specific XR. 
The first involved saturation mutagenesis of targeted residues identified as important for 
substrate specificity based on structural analysis of the homology model. The second involved 
random mutagenesis throughout the gene. Due to the nature of the goal, it was decided to 
initially concentrate on mutating residues that directly interact with the substrate. Eleven 
independent libraries were created each with a single position randomized using NNS primers to 
maximize all sense codon representation. Since the sites were mutated individually, the overall 
diversity was limited to 20 per library. Such a library was therefore small enough to be manually 
screened using the 96-well plate assay, providing a quantitative assessment of the mutants’ 
selectivity. To ensure a reasonable assurance of complete coverage of all mutants, about 150 
mutants were screened per library. Mutant S with the mutation Phe112Ser was identified as the 
mutant with the highest (~5.5-fold) increase in selectivity as determined by a ratio of catalytic 
efficiency between D-xylose and L-arabinose. The location of the mutation on residue Phe112 
was not surprising since it had been previously identified as a possible discriminator between D-
xylose and L-arabinose. However, the mutation also affected the activity toward D-xylose, 
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dropping the catalytic efficiency almost 14-fold. Nevertheless, since selectivity is of greater 
importance, the loss in activity was acceptable. A second round of mutagenesis was performed 
on the remaining ten residues over the S template. However, even after screening ~200 colonies 
per library, no mutant with any improved selectivity was identified. It was then decided to use 
random mutagenesis to identify mutations outside the substrate interacting region that may 
contribute to improved selectivity toward D-xylose. Random mutations were introduced on the S 
template by error-prone polymerase chain reaction (epPCR) to create a library of >105 individual 
mutants. After selection solid medium, ~1,500 of the largest colonies were picked into 96-well-
plates for quantitative analysis. However, no mutant with improved selectivity was detected 
among them. The experiment was repeated, with another independent library, albeit with similar 
results. It seems the S mutant was resistant to further improvement, and it was thus decided to 
concentrate mutagenesis on the wild-type template. 
 
To achieve the desired diversity in the mutant library on the wild-type NcXR template, it was 
necessary to optimize the level of mutagenesis, or more exactly, the average number of 
mutations per gene. EpPCR is the standard method for introducing random point mutations, the 
frequency of which can be easily controlled. By adjusting the concentration of Mn2+ ion in the 
reaction mix, and providing unequal concentrations of the four dNTPs, various levels of 
mutations can be introduced into a newly synthesized gene from a template [41]. It is generally 
desirable to have a library with approximately 50% active mutants, which generally corresponds 
to 1-2 amino acid substitutions per mutant gene. Three libraries were created with 0.1 mM, 0.2 
mM, and 0.3 mM Mn2+ and 93 colonies of transformants from each were tested for activity. 
Results indicated that using 0.2 mM Mn2+ produces ~50% active mutants. 
 
With a protein size of 323 amino acids, the maximum diversity is predicted at about 6,500 
assuming single amino acid substitution per clone. However due to the nature of epPCR, the 
likelihood of 2-3 consecutive base changes for complete randomization of a single residue, is 
remote. In addition, the degeneracy of the codons further limits the maximum number of 
attainable amino acid substitutions at any position, averaging at only 6 possible substitutions per 
position. Such a bias makes the maximum diversity about 2,000 for single amino acid 
substitution or about 11,000 for two amino acid substitutions. Therefore a library of >105 would 
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easily be able to cover all possible mutations available to epPCR. This logic and conditions were 
applied to the epPCR performed on the mutant S background described above as well; although 
the test for number of active clones as a function of Mn2+ concentration was assumed the same as 
wild-type. 
 
A library of >105 was created on the wild-type background using 0.2 mM Mn2+ for epPCR and 
selected on media. Screening transformants yielded mutant Q, which showed increased D-xylose 
specificity. Characterization of Q (corresponding to mutation Leu109Gln) revealed that it had 
indeed improved D-xylose to L-arabinose preference. Since epPCR can probe only a limited 
sequence space at each position, a library randomizing Leu109 was screened, however, a better 
substitution was not found.  
 
With the identification of two positions (Phe112 and Leu109) each providing improved substrate 
specificity; it was the next logical step to see whether the two mutants could be combined 
additively or synergistically. Screening double mutant libraries randomized at positions Leu109 
or Phe112 individually, on either mutant background, and simultaneously on wild-type 
background yielded only epistatic or antagonistic mutants. This result confirmed that the 
mutations were context dependent, and explained why epPCR on the S background did not 
identify beneficial mutations at residue Leu109. 
 
Mapping the location of Q mutation on the NcXR homology model revealed that it was 
approximately 9 Å from the substrate D-xylose (Figure 2.1). Further, its location on the same β–
strand as Phe112 suggested that it may play an important role in substrate binding. Additionally, 
it has previously been postulated based on mutational analysis and crystal structure of Candida 
tenuis XR that His109 (corresponding to His111 in NcXR) plays an important role in binding D- 
xylose [42, 43]. These data together suggested that β–strand 4 in the (α/β)8 structure of XRs may 
be crucial to substrate binding and specificity. 
 
Mutagenesis thereafter included residues on and flanking this β–strand 4. Initially, only one 
residue (Ile110) was mutated along with all substrate interacting sites. With the identification of 
mutant QC (bearing the additional mutation Ile110Cys) with improved specificity, it was decided 
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to include residues on β–strand 4 (Asp106 – Pro113). A third round of saturation mutagenesis 
yielded MQC (Leu107Met). A fourth and fifth round of mutagenesis was finally performed on 
residues in β–strand 4 along with certain flanking residues (ranging from residues Asp102 to 
Tyr118), and led to the identification of MCQI (Val114Ile) and VMQCI (Leu102Val). The final 
mutant, with five substitutions, displayed ~16.5-fold preference for D-xylose over L-arabinose, 
although it also displayed approximately 9-fold decrease in catalytic efficiency toward D-xylose. 
When compared to mutant S, VMQCI retains higher overall activity and also increased substrate 
specificity. Analysis of mutations via multiple sequence alignment with other known XRs 
revealed that they were distributed among fully conserved (Leu107), strongly conserved 
(Leu102, Leu109, Ile110) and unconserved groups (Val114) (Figure 2.11). Additionally, kinetic 
characterization of mutants revealed that QC, MQC, and VMQCI mutations increased turnover 
number (kcat) for either one, or both substrates. The mode of action of each substitution in 
increasing the overall specificity toward D-xylose is difficult to analyze without a crystal 
structure, although they may directly or indirectly mold the shape of the catalytic pocket to offer 
greater steric hindrance to the C-4 hydroxyl group of L-arabinose. 
 
xylose
9 Åβ-strand 4
His111
Asn44
Tyr49
Lys78
Q (Leu109Gln)
Phe112
 
Figure 2.10 Q mutation on the NcXR homology model. Leu109Gln is shown in 
pink. Conserved active residues are in green. His111 and Phe112 are also 
indicated in proximity of β-strand 4. 
 
2.2.7. Kinetic characterization of mutant NcXRs (Book7 pg70-71) 
Michaelis-Menten kinetic parameters toward D-xylose and L-arabinose were determined for 
mutant XRs that showed a greater preference for D-xylose over L-arabinose. NADPH 
concentration was kept >100 µM at all times, making it the non-rate-limiting reagent assuming 
no significant change in KM for mutants from the 1.8 µM for wild-type NcXR toward NADPH. 
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All reactions were performed at pH 6.3 and 25 °C, allowing for easy comparison to published 
data on wild-type NcXR. Initial reaction rate at each substrate concentration was measured by 
monitoring the rate of change is A340 upon addition of purified enzyme to the substrate mix. All 
readings were taken in at least two independent data sets of two readings to minimize random 
error and eliminate experimental artifacts. His6-tag was not cleaved from the enzyme after 
purification as it has been shown its presence does not significantly affect reaction rate [24]. 
Maximum reaction rates (kcat) were calculated based on molecular weight of dimeric NcXR. The 
Michaelis-Menten parameters for mutants from each round of mutagenesis are summarized in  
Table 2.6. 
C_tenuis_XR              DLKVDYVDLFLIHFPIAFKFVPIEEKYPPGFYCGDGNNFVYED-VPILET 
P_stipitis_XR            DLQVDYVDLFLIHFPVTFKFVPLEEKYPPGFYCGKGDNFDYED-VPILET 
C_tropicalis_XR         DLNLDYVDLFLIHFPIAFKFVPIEEKYPPGFYCGDGDNFHYED-VPLLDT 
C_albicans_XR       DLNLEYLDLFLIHFPIAFKFVPLEEKYPPGFYCGDGDKFHYEN-VPLLDT 
P_guilliermondii_XR       DLKVDYLDLFLIHFPIAFKFVPFEEKYPPGFYCGDGDKFTYED-VPIIDT 
A_niger_XR           DWGIDYFDLYIVHFPISLKYVDPAVRYPPGWKSEKD-ELEFGN-ATIQET 
A_terreus_XR         DWGVDYFDLYIVHFPVALKYVDPAVRYPPGWSAKGDGSIEFSN-ASIQET 
H_jecorina_XR           DWQIDYFDLFLVHFPAALEYVDPSVRYPPGWFYDGKSEVRWSKTTTLQQT 
NcXR_WT           DWGLEYFDLYLIHFPVALEYVDPSVRYPPGWHFDGKSEIRPSK-ATIQET 
                          *  ::*.**:::*** ::::*    :****:      ..   . ..: :* 
NcXR_VMQCI              DWGVEYFDMYQCHFPIALEYVDPSVRYPPGWHFDGKSEIRPSK-ATIQET 
      ↑    ↑ 
           102   118 
Figure 2.11 Multiple-sequence alignment (MSA) of several known fungal and yeast XRs. * fully conserved 
residues (including Leu109, His111, and Phe112), : conservation of strong groups, . conservation of weak groups, 
all others are not conserved.  Mutations in MCQI are indicated in yellow and are distributed among three of the four 
conservation groups.  NcXR residues Asp106 and Tyr118 are indicated. 
 
2.2.8. Resting cell studies (Book7 pg76-99, Book10 pg2-4) 
To test whether the mutant VMQCI demonstrates improved selectivity in a whole-cell setting, 
resting cell studies were performed by using E. coli strain HZ348 that expressed either wild-type 
(wt) or mutant VMQCI XR (Figure 2.12). Cells grown and induced for transporter and XR 
expression were resuspended to high density in incomplete minimal medium containing all three 
major hemicellulosic sugars (D-xylose, L-arabinose and glucose). L-Arabinitol was produced 
more slowly compared to xylitol in both cases, and the mutant produced significantly lower 
amounts of L-arabinitol (5.5-fold), but only slightly decreased amounts of xylitol (1.2-fold) over 
four days compared to wild-type XR. As expected, glucose was used as a carbon-source and not 
reduced to sorbitol. These data are consistent with in vitro kinetic parameters of the enzymes, 
and corroborate the idea that a D-xylose-specific XR can significantly reduce the amount of 
byproducts. All results of the protein engineering strategy have been published [44]. 
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Table 2.6 Summary of kinetic parameters, relative catalytic efficiency, and xylose-to-arabinose 
selectivity for all mutants. 
 
Substrate Mutant 
KM  
(mM) ± 
kcat  
(min-1) ± 
Catalytic 
Efficiency Selectivity 
wt 34 4 3600 200 100% 2.4 
Q 82 10 2860 100 33% 8.9 
QC 100 14 3330 150 31% 10.8 
MQC 160 15 4020 125 24% 11.7 
S 450 41 3380 120 7.1% 13.8 
MQCI 190 20 2620 100 13% 16.1 D
-
X
yl
o
se
 
VMQCI 430 66 5160 380 11% 16.5 
wt 40 10 1800 100 41%  
Q 530 52 2070 90 3.7%  
QC 530 82 1640 120 2.9%  
MQC 990 210 2130 210 2.0%  
S 3400 800 1850 310 0.51%  
MQCI 1510 210 1290 100 0.81%  L-
A
ra
bi
n
o
se
 
VMQCI > 2000 >1000 n.d. n.d. 0.79%  
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Figure 2.12 Conversion of D-xylose and L-arabinose by resting cells (OD600 15) at 30 °C in minimal medium 
without a nitrogen source by (A) wt and (B) VMQCI mutant NcXR. Reduction of L-arabinose by the mutant stalls 
even before complete depletion of glucose. 
 
2.2.9. Need for orthogonal strategy – genome/metabolic engineering 
Although mutant VMQCI has much higher selectivity compared to the wild-type NcXR, it also 
adversely affected the catalytic efficiency toward D-xylose (Table 2.6). As expected, the loss in 
catalytic efficiency was due to decreased affinity toward D-xylose (higher KM), rather than 
turnover rate (kcat). This is an anticipated side-effect since increasing substrate preference 
decreases the size of the substrate binding pocket, thereby limiting the rate of substrate diffusion 
to the active Tyr49. Although the loss in affinity did not significantly impact the productivity 
(Figure 2.12), indicating that the intracellular D-xylose concentration is sufficiently high enough 
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to ensure high turnover rate; and that cellular uptake may be the rate-limiting step. While 
engineering VMQCI for improved specificity may further decrease the amount of L-arabinitol 
produced, it would have most likely resulted in further decrease in overall catalytic efficiency 
toward D-xylose. To prevent the enzymatic activity from becoming the rate-limiting step, this 
must be avoided, and an alternative strategy must be implemented to further overall selectivity. 
Thus, the host E. coli strain must be metabolically engineered such that it is highly efficient at 
utilizing L-arabinose as a carbon source, thereby sequestering it away from XR, and decreasing 
L-arabinitol production. 
 
2.2.10. Diauxie relief (Book10 pg27-29, 49-64) 
One of the major obstacles in creating such a strain is that the regulation of various catabolic 
pathways of E. coli in the presence of multiple sugars is not well understood. This is particularly 
important for selective production of xylitol from hemicellulosic hydrolysate since corn fiber 
consists of D-xylose, L-arabinose, and glucose. While diauxic growth pattern due to glucose 
repression in E. coli is well studied, little is known about the relative preference between 
pentoses, and even less in the presence of glucose. In addition, the system used so far to 
overexpress XR is IPTG (isopropyl-β-D-thiogalctopyranoside)-dependent, which is reliant on the 
lactose system, thus introducing a fourth regulatory system. Considering that the metabolism of 
all three non-glucose sugars is dependent on activation by CRP (cyclic adenosine 
monophosphate receptor protein), significant cross-talk between them is to be expected. Glucose 
de-repression for simultaneous uptake of two sugars has been documented previously, albeit 
primarily for ethanol production, which was carried out under oxygen-limited conditions [45, 
46]. The pleiotropic effects on other regulatory systems of such de-repressed mutants are poorly 
characterized. 
 
Three different catabolite de-repressed mutants were tested for co-utilization of glucose, D-
xylose and L-arabinose - HZ1743, HZ1651 and HZ1302 (∆ptsG, ∆cyaAreg, and crp*, 
respectively) (Figure 2.13). The phosphotransferase system (PTS) for simultaneous glucose 
uptake and phosphorylation has been shown to play a role in catabolite repression [47]. Strains 
with inactivated permease, PtsG, were shown to relieve said repression and used for co-
fermentation of mixed sugars [46]. Adenylate cyclase (CyaA) is responsible for forming cAMP 
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in response to low glucose concentrations. Its activity is regulated by interaction with the PTS 
protein Enzyme IIAGlc. A strain with truncated CyaA was shown to be de-regulated and did not 
show diauxic behavior when grown in glucose and maltose mixtures [48]. Several CRP (also 
known as CAP, catabolite activator protein) mutants have been isolated that show de-repressed 
behavior [49-51]. These three mutant strains plus the wild type strain were grown in minimal 
medium with 2 g/L each of glucose, D-xylose and L-arabinose under oxygen-limited conditions. 
Supernatants were analyzed at various time points to ascertain their sugar utilization patterns. 
The wild-type C600 demonstrated strong diauxie, with almost no uptake of D-xylose or L-
arabinose until complete depletion of glucose. The strain with truncated CyaA (HZ1651) showed 
slightly decreased glucose assimilation, although pentose utilization was not significantly 
improved. The PtsG knockout (HZ1743) demonstrated delayed response to glucose, as expected 
[46], yet simultaneous uptake of all three sugars, albeit with differing efficiencies. Finally, the 
crp* mutant (HZ1302) showed efficient simultaneous assimilation of all three sugars, although, 
as in all strains, D-xylose uptake was the slowest. Based on these data, HZ1651 was deemed 
unsuitable for xylitol production. After deletion of xylA in HZ1743 and HZ1302 to prevent D-
xylose catabolism, pXXR (wtXR under XylA promoter, Figure 2.16) was transformed into both 
strains to give HZ1757 and HZ1434, respectively, and tested for xylitol productivity (Figure 
2.15). Although both strains demonstrate efficient utilization of glucose and L-arabinose as 
carbon source, the stronger induction from XylA promoter in HZ1434 is evident from higher D-
xylose conversion to xylitol. Based on these experiments, the crp* mutant strain was used for 
further engineering work, which was previously described to be helpful in co-utilization of D-
xylose and glucose for the production of xylitol using an IPTG induction system [52]. 
 
2.2.11. Crabtree effect is prevalent in the crp* strain (Book18 pg7-11, 36-38) 
Glycolysis rate at high sugar concentrations often exceeds respiratory capacity, leading to build-
up of intermediate metabolites. This “Crabtree effect” is well-known for many organisms 
including S. cerevisiae and E. coli, which are known to build up ethanol and acetate, 
respectively. In E. coli acetate build-up decreases growth rate as well as recombinant protein 
production [53]. Previous work in a similar crp* strain showed that at 18 g/L glucose 
concentration, acetate production is significant, accumulating to 70 mM [54]. 
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Figure 2.13 Growth of various strains in glucose, D-xylose, and L-arabinose to test for catabolite 
repression at 30 ºC. (A) Wild-type E. coli K-12 C600 shows strong diauxie, with quick utilization 
of glucose first. (B) Deletion of the regulatory domain of adenylate cyclase (HZ1651, ∆cyaAregul) 
resulted in slightly less pronounced diauxie, although pentose assimilation is still slower than 
glucose. (C) Glucose permease knockout (HZ1743, ∆ptsG) strain showed efficient L-arabinose and 
glucose utilization, although D-xylose was relatively slower. (D) The mutant CRP (HZ1302, crp*) 
showed the most efficient co-utilization of all three sugars. All experiments were also performed 
at 37 ºC to ascertain glucose de-repressed phenotype, and similar results were obtained. 
 
When HZ1434 was grown in 40 g/L total usable sugar (glucose + L-arabinose) in minimal M9 
medium, we found that pH dropped to ~5 within 24 hours, completely inhibiting growth due to 
high level acetate production (Figure 2.14). Addition of 50 mM MOPS (4-
morpholinopropanesulfonic acid) to the medium could not buffer the pH at 7.0, as had been done 
previously at 18 g/L glucose [55]. Addition of a complex nitrogen source has been shown to 
reduce acetate production in batch cultures [56]. However, addition of 10 g/L tryptone did not 
prevent acid accumulation. Although genetic methods exist to decrease acetate production [57], 
pleitotropic effects could lead to additional complications. Therefore, we chose to use a pH-stat 
bioreactor for further studies.  
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Figure 2.14 Acetate production by HZ1434 during growth in 4% and 0.4% usable sugars (glucose + L-arabinose). 
Cells grown in high concentrations of sugars succumb to Crabtree effect and produce large amounts of acetate (~25 
mM), which inhibts cell growth, resulting in decreased final cell density. Data points are shown at 0, 6, 24, 48 h, and 
are an average of two independent experiments and error is less than 15% in all cases. 
 
2.2.12. Expression from arabinose promoter decreases Crabtree effect (Book18 pg7-34) 
In the pH-stat bioreactor with 60 g/L total sugars (equiweight D-xylose, L-arabinose, and 
glucose), there was a ~24 h lag phase. In addition, xylitol production was minimal until near-
complete depletion of L-arabinose in the medium (Figure 2.17A). It was reasoned that poor 
induction of the D-xylose pathway compared to the L-arabinose operon (Figure 2.13D) was the 
primary reason for low productivity. Since overexpression of D-xylose-proton symporter (XylE) 
was previously shown to transport D-xylose efficiently in glucose-xylose mixtures [58], it may 
help increase xylitol productivity here as well. Expression using a constitutive promoter, 
BLMAp [59] using pACYCBLMAXylE in HZ2009, did not improve xylitol conversion. On the 
other hand, expression of XylE under the AraBAD promoter from a multicopy plasmid 
(pACYCAraXylE, Figure 2.16) had the unexpected side-effect of simultaneously decreasing 
both the lag phase of HZ2008 and the total amount of alkali required to maintain pH at 7.0 
(Figure 2.17B). Unfortunately, the xylitol productivity was nearly unaltered. Another side-effect 
of this is the change of the relative rates of glucose and L-arabinose consumption. Prior to XylE 
overexpression (HZ1434), L-arabinose was assimilated faster than glucose (Figure 2.15B, Figure 
2.17A), whereas after its overexpression (HZ2008), glucose was the preferred carbon source 
(Figure 2.17B). It is a possible that promoter dilution may play a role in decreasing expression 
from the chromosomal araBAD operon, although previous reports indicate that this phenomenon 
is not significant in bacteria [60] or yeast [61]. Alternately, the presence of XylE in the cell 
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membrane either replacing AraE and AraGFH transporters, or in addition to them, could be 
retarding the rate of L-arabinose uptake. This could also explain the lower requirement for alkali 
in the bioreactor, since the respiration rate would be more capable of keeping up with the slower 
oxidation of L-arabinose. The reason behind the decreased lag phase is difficult to decipher from 
these experiments, and will probably require a more thorough characterization of the HZ1967 
and HZ2008 transcriptome, proteome, and metabolome.  
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Figure 2.15 Xylitol production in shake flasks comparing (A) HZ1757 (∆ptsG ∆xylA pXXR) and (B) HZ1434 (crp* 
∆xylA pXXR) diauxie relief strategies. Although both strains demonstrate simultaneous glucose and L-arabinose 
assimilation, stronger induction of the D-xylose pathway results in higher xylitol production using XR under XylA 
promoter in HZ1434. Neither of the two strains produces significant amounts of L-arabinitol. Data are an average of 
two independent experiments and error is less than 15% in all cases. Experiments were also performed with mutant 
VMQCI, and similar results were obtained. 
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Figure 2.16 Vector maps of pXXR, pAraXR, pTrcXR and pACYCAraXylE. pXXR has XR under xylose-inducible 
XylA promoter, pAraXR uses the L-arabinose inducible AraBAD promoter, whereas pTrcXR uses an IPTG-
inducible Trc promoter. pACYCAraXylE has the XylE D-xylose-proton symporter under the control of AraBAD 
promoter. 
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Figure 2.17 Strategies implemented to improve xylitol productivity. (A) pH-stat bioreactor allows cells to 
completely and efficiently catabolize L-arabinose and glucose simultaneously. XR expression is under control of the 
XylA promoter (HZ1434). (B) Concurrent expression of D-xylose-proton symporter (XylE) using AraBAD promoter 
decreases lag phase, but also decreases L-arabinose assimilation rate relative to glucose (HZ2008). Xylitol 
productivity does not increase significantly, however. (C) Expression of XR using AraBAD promoter instead of 
XylA promoter promotes near-stoichiometric conversion of D-xylose to xylitol (HZ2061). (D) Expression of the 
mutant XR, VMQCI, eliminates L-arabinitol production, although initial xylitol productivity also drops slightly 
(HZ2062). Data are an average of two independent experiments and error is less than 15% in all cases. 
 
Since overexpression of XylE did not improve the final xylitol titer, the poor productivity was 
probably due to low expression of XR under the control of XylA promoter, despite its extremely 
high activity. So, XR was placed under either the IPTG-inducible Trc promoter (pTrcXR, Figure 
2.1) or the AraBAD promoter (pAraXR, Figure 2.16). Induction from a lac-based promoter in 
crp* strain in glucose-xylose mixtures was previously shown to produce high levels of 
recombinant protein, even at 100 µM IPTG concentration [52]. However, expression of XR from 
the Trc promoter induced with 100 µM IPTG led to even poorer conversion than that obtained 
using the XylA promoter. Under the AraBAD promoter (HZ2061), xylitol production reached 
near stoichiometric levels, with low levels of L-arabinitol production as well (2-6 mM, Figure 
2.17C). The VMQCI mutant produced xylitol at a slightly slower rate than wtXR (HZ2062), as 
would be expected from the lower overall activity of the mutant (Figure 2.17D) [44], but it 
produced undetectable levels of L-arabinitol over the 4 day period (limit of detection < 1 mM). 
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2.2.13. Catabolic pathways: activation and competition (Book18 pg7-34) 
Catabolic pathways for sugars other than glucose are normally repressed in its presence. After 
testing four different strategies for de-repression, it was found that crp* mutant was the most 
efficient at simultaneously activating the D-xylose and L-arabinose metabolic pathways (Figure 
2.15). However, the L-arabinose pathway was more strongly activated, as evident from quicker 
uptake and assimilation compared to D-xylose. Using XR as a reporter under the control of L-
arabinose (AraBAD), D-xylose (XylA), or lactose (Trc) promoter systems, it was found again 
that AraBAD was the most strongly expressed among all three. Although the lac-based system 
was shown to be fully activatable with 100 µM IPTG in crp* strains in the presence of glucose 
and D-xylose [52], in the presence of three sugars, this promoter was weakly induced. This is 
true even in light of the fact that IPTG is the only non-transformable inducer tested. In a non-
crp* strain, strong activation of D-xylose, L-arabinose, and lactose operons simultaneously in the 
absence of glucose has been observed [44]. In wild-type E. coli, IPTG was shown to repress 
AraBAD promoter activation [62]. In crp* strain created here, however, the exact opposite 
phenomenon was observed – AraBAD repressed activation from IPTG-dependent promoters. It 
has been suggested that inducer exclusion plays a significant role in effecting diauxic growth, 
and this could play a major role here as well. Exclusion of IPTG, and to some extent D-xylose, is 
possible by L-arabinose, although there is no precedent in literature to support this possibility, 
particularly in crp* strains. The lacY1 mutation in C600 may inhibit efficient uptake of IPTG by 
cells. However, LacY deficient cells like Tuner(DE3) have been used extensively for IPTG-
dependent protein expression, indicating diffusion alone is sufficient for strong induction [63-
65]. Alternately, it is possible that all three inducers are efficient at entering the cell and that 
trans-activation by AraC is much stronger than that possible by XylR. The lac operon has no 
similar activator, and this could be the reason why its activation appears weaker than the other 
two. Additionally, all three induction systems are activated by binding of crp*, a possible source 
of direct competition between all three promoter systems.  
 
2.3. Conclusions  
The development of a highly selective process for the production of xylitol from a mixture of 
hemicellulosic sugars should help make its production more economically feasible. The major 
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hurdle in developing such a process was the inability to design a catalyst that is able to 
differentiate between the various substrates present in the hydrolysate. The regio- and 
chemoselectivity of naturally occurring XR can, to some degree, address the limitations of 
Raney-Ni based hydrogenation process, by selectively producing xylitol as the sole product from 
D-xylose. This has made biocatalysis a viable option for the production of xylitol. However, the 
inability of XRs to differentiate D-xylose from its epimer L-arabinose, which is present at high 
levels in corn fiber hemicellulosic hydrolysate, still leaves plenty of room for improvement. With 
the aim of addressing this issue, a two-pronged approach that exploited the possible synergy 
between protein and genome (metabolic) engineering, a highly selective biocatalyst was 
successfully developed. Using tools of directed evolution, a D-xylose-specific Neurospora crassa 
XR was engineered for increased substrate specificity. This mutant, called VMQCI, is the most 
D-xylose-specific XR to date, and is also one of few examples of an enzyme engineered for 
decreased activity toward a natural substrate (L-arabinose), that still retains high activity towards 
another natural substrate (D-xylose). However, as expected the increased substrate specificity 
came at the cost of catalytic efficiency towards D-xylose (Table 2.6). In order to prevent further 
loss in catalytic activity, an orthogonal strategy was implement whereby the host strain was 
engineered for efficient L-arabinose assimilation. After evaluating various diauxie relief 
strategies and overexpression constructs for both, the D-xylose transporter (XylE) as well as XR, 
a recombinant strain was developed with the desired properties. This strain was able to 
effectively decrease the amount of L-arabinitol produced even when expressing just the wild type 
XR. However, after the expression of the mutant VMQCI in this strain, L-arabinitol production 
was eliminated (limit of detection < 1 mM) from an equiweight mixture of D-xylose, L-
arabinose, and glucose – the three major sugars in hemicellulosic hydrolysate (Table 2.7). 
Considering actual corn hemicellulose has D-xylose to L-arabinose in a ~5:3 ratio [23], the tested 
equiweight mixture is a worst-case scenario. Not only is L-arabinose prevented from being 
converted to L-arabinitol, it also provides reducing equivalents in the form of NADPH for xylitol 
production, and acts as an inducer for protein expression. This demonstrates that combination of 
genome/metabolic engineering and protein engineering strategies can be used in a synergistic 
manner to develop better biocatalysts. 
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2.4. Future Work 
Although, the conversion reached 100% with 100% selectivity, the ratio of metabolizable sugars 
(glucose and L-arabinose) to xylitol produced was ~0.6 on a molar basis. Given that this system 
has only been optimized for selectivity, further improvements in productivity (yield, Equation 
2.5) would constitute the majority of future work. Cirino et al have shown that in the presence of 
glucose and D-xylose alone, the yield can reach as high as 1.8 [52], with a theoretical maximum 
of 9.2 in resting cells [66]. They have also shown that the sources of NADPH for xylitol 
production are 1) the oxidative pentose phosphate pathway (o-PPP), 2) citrate (TCA) cycle, and 
3) transhydrogenase activity (PntAB), which can produce a combined 9.2 moles of NADPH per 
mole of glucose metabolized [66]. For the production of xylitol from L-arabinose, the theoretical 
maximum is lower, since L-arabinose is not metabolized through the o-PPP, rather only through 
the non-o-PPP. Therefore, the theoretical yield of xylitol from L-arabinose should be ~7.2 in 
resting cells. Resultantly, the theoretical maximum yield of xylitol from an equimolar mixture of 
glucose and L-arabinose should be ~8.2, far higher than the current value of 0.6. Future work 
would therefore entail increasing this value by implementing previously described strategies [66, 
67]. 
 
Table 2.7 Summary of xylitol production in whole cell catalysis. The final strain, HZ2062 is 
metabolically engineered and expresses the engineered XR (VMQCI). The genome and protein 
engineering in this strain results in synergistic increase in xylitol productivity, than individual 
strategies. 
  [Initial] (mM) Xylose Con- Xylitol 
Strain Xylose Arabinose Glucose version (%) Arabinitol 
HZ348+pACYC-ncxr 46 46 210 100% 1.7 
HZ348+pACYC-VMQCI 45 45 198 89% 8.1 
HZ1434 154 163 126 32% 15 
HZ2008 161 173 98 63% n/a 
HZ2061 122 119 0.0 99% 47 
HZ2062 120 118 97 96% 170 
 
 
 [Final] (mM) 
Strain Xylose Arabinose Glucose Xylitol Arabinitol 
HZ348+pACYC-ncxr 0.0 8.9 0.0 37 22 
HZ348+pACYC-VMQCI 5.0 37 21 32 3.9 
HZ1434 105 0.0 0.0 58 3.8 
HZ2008 60 0.0 0.0 65 0.0 
HZ2061 1.8 0.0 0.0 104 2.2 
HZ2062 5.0 0.0 0.0 112 0.66 
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Equation 2.5 
moles of xylitol produced
Yield
moles of sugar metabolized
=  
 
Finally, fermentations with authentic hemicellulosic sugars can be performed and the effect of 
inhibitors on conversion, selectivity, and productivity can be evaluated. If needed, a more robust 
strain will need to be engineered that can withstand the presence of these growth inhibitors in the 
growth medium. 
 
2.5. Materials and Methods 
 
A complete list of strains, plasmids and primers can be found in Appendix A, B, and C. 
 
2.5.1. Strains, plasmids and reagents 
Expression vector plasmids pET20b and pACYCDuet-1 were obtained from Novagen (San 
Diego, CA), pTrc99A and pKK223-3 from Amersham Biosciences (Piscataway, NJ), pMAL-c2x 
from New England Biolabs (NEB, Beverly, MA), pQE-80L from Qiagen (Valencia, CA), and 
p6xHTKXb119 was a gift from postdoctoral resident Dr. Jungkul Lee (University of Illinois, 
Urbana, IL). Plasmids for E. coli gene inactivation - pKD46, pKD4, and pCP20 were a gift from 
Dr. Barry L. Wanner (Purdue University, West Lafayette, IN). DNA primers were synthesized 
by Integrated DNA Technologies (IDT, Coralville, IA). All enzymes used for cloning were 
bought from New England Biolabs (Beverly, MA) unless otherwise noted. QIAprep Spin 
Plasmid Mini-prep Kits, QIAquick PCR Purification and Gel Extraction Kits were purchased 
from Qiagen (Valencia, CA). Wizard Genomic DNA Purification Kit was obtained from 
Promega (Madison, WI). BD TALON Metal Affinity Resin was purchased from Clontech 
Laboratories, Inc. (Mountain View, CA). E. coli strains XL1-Blue, JM109 and BL21(DE3) were 
from Stratagene (La Jolla, CA), DH5α from ZymoResearch (Orange, CA), and WM1788 was 
gift from Dr. William Metcalf (University of Illinois, Urbana, IL). WM1788(DE3) was a gift 
from graduate student Ryan P. Sullivan (University of Illinois, Urbana, IL). Gluconobacter 
oxydans (Acetobacter suboxydans) was obtained from USDA Agricultural Research Service 
(Peoria, IL). All chemicals were purchased from Sigma (St. Louis, MO), except NADPH was 
also purchased from Jülich Chiral Solutions (Jülich, Germany) and growth media from BD 
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Biosciences (San Jose, CA). DNA standards for agarose gel electrophoresis and protein 
standards for SDS-PAGE were purchased from Bio-Rad (Hercules, CA). 
 
2.5.2. Polymerase chain reactions (PCR) 
Purified genomic or plasmid DNA was used as template in all cases. Typical amplification 
reactions were performed in a total volume of 100 µl and contained 1X Taq polymerase buffer 
supplemented with 1.5 mM Mg2+, 0.5 µM of each of forward and reverse primers, 0.2 mM each 
dNTP, 0.75 U Pfu Turbo DNA polymerase and 0.5 U Taq DNA polymerase. Later, the use of 
Taq/Pfu mix was replaced by 1 U Phusion DNA polymerase, which also used its own HF buffer. 
When genomic DNA was used as a template, 0.25 µl of genomic DNA solution was added to the 
PCR reaction. While when a plasmid was used, 20 – 100 ng was used as template. An MJ 
Research PTC200 (Bio-Rad, Hercules, CA) was used to perform thermal cycling. A typical PCR 
amplification using Taq/Pfu consisted of an initial denaturation step of 3:30 min at 94 ºC, 
followed by 19 cycles of 45 s of denaturation at 94 ºC, annealing for 30 s at 55 ºC, and extension 
for 60 s at 72 ºC, and then a final elongation step of 5 min at 72 ºC. When using Phusion DNA 
polymerase, initial denaturation step at 98 ºC for 30 s was followed by 19 cycles of 10 s 
denaturation at 98 ºC, annealing for 10 s at 55 ºC, and extension for 20 s at 72 ºC, and a final 
elongation step also at 72 ºC for 5 min. Exact parameters varied depending on gene size, GC-
content and primer melting temperatures. All PCR products were purified using a QIAquick PCR 
Purification Kit and stored at –20 ºC. 
 
2.5.3. SDS-PAGE analysis 
Powerpac 300 power supply, Mini-PROTEAN 3 assembly, sodium dodecyl sulfate (SDS), and 
pre-cast 15 % or 4-20 % gradient polyacrylamide gels were purchased from Bio-Rad (Hercules, 
CA). Varying amounts of samples, dependent upon protein concentration, were mixed with 4 µL 
5x SDS-PAGE loading buffer (30 % glycerol, 1 % SDS, 3% β-mercaptoethanol, 0.3 % 
bromophenol blue, 0.5 M Tris-HCl, pH 6.8) and ddH2O to a final volume of 20 µL. Samples 
were denatured at 100 °C for 5-10 min, cooled to 4 °C, and then loaded onto the gel in a Bio-Rad 
Mini-PROTEAN 3 assembly. Voltage was supplied by a Bio-Rad Powerpac 300 at a current of 
140 V for 70 minutes. Gels were stained by Coomassie Blue with microwave heating at high 
power for 50 seconds and then allowed to cool to room temperature before destaining 3 hours in 
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40% methanol and 10% glacial acetic acid solution. Destained gels were scanned and 
subsequently discarded. 
 
2.5.4. DNA sequencing 
All DNA samples were submitted for sequencing to the Biotechnology Center Core DNA 
Sequencing Laboratory at the University of Illinois at Urbana-Champaign (Urbana, IL). 
Sequencing reactions were performed as per their instructions. 
 
2.5.5. Cloning and heterologously expressing NcXR for protein engineering 
Using pET15b-ncXR as template [24], ncxr gene was PCR amplified between EcoRI/HindIII 
restriction sites, ligated into pTrc99A or pKK223-3, and electroporated into competent WM1788 
cells. Individual colonies were grown to mid log-phase in LB medium supplemented with the 
appropriate antibiotic at 37 °C and induced with 0.5 mM IPTG for 16 to 20 hours at 25 °C. Cell 
lysates were tested for activity and checked for soluble expression by SDS-PAGE. Since no 
soluble expression was observed, purified plasmids, pTrc99A-ncxr and pKK223-3-ncxr, were 
electroporated into competent XL1-Blue and JM109 cells and tested for expression, albeit to 
similar results. The ncxr gene was then re-amplified and cloned between NdeI/HindIII sites, and 
EcoRI/HindIII sites in pMAL-c2x and also between SphI/HindIII sites in pQE-80L, and 
electroporated into, and then expressed in WM1788 - all with similar results. NcXR was finally 
successfully expressed using the aforementioned protocol in pET20b (between NdeI/HindIII) 
and pACYCDuet-1 (between EcoRI/BglII to incorporate N-terminal His6-tag) in BL21(DE3), 
WM1788(DE3), and HZ353. 
 
2.5.6. NcXR cell lysate activity assay 
Cells induced to express NcXR were centrifuged, decanted and resuspended in 100 µL/(mL 
culture) 10 mM MOPS pH 7.2 supplemented with 1 mg/mL lysozyme. They were then freeze-
thawed at -80 °C and 30 °C, respectively, to enhance lysis action and finally centrifuged to 
remove cell debris and maintained on ice to minimize protease activity. Since reduction of D-
xylose or L-arabinose is accompanied by concomitant oxidation of co-factor NADPH in 1:1 
stoichiometric ratio, rate of reaction can be measured as a function of oxidation rate of NADPH 
into NADP. Reaction rates were measured at 25 °C with 100-400 µM NADPH, 5-1000 mM D-
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xylose or 5-2000 mM L-arabinose in 50 mM MOPS at pH 6.3 for all assays. Substrate solutions 
were maintained at 25 °C using a water bath and reaction cuvettes were also maintained at the 
same temperature using a UV/Vis spectrophotometer with a re-circulating water jacket. Cell 
lysate supernatant was added directly to 0.5 mL substrate solution, mixed, and decrease in A340 
was measured as a function of time. Initial reaction rate was calculated by using a linear fit 
between 0.05 min and 0.25 min.  
 
2.5.7. Selection strain construction 
WM1788(DE3) (∆(araBAD)567 ∆lacZ4787 lacIq rrnB-3 ∆(rhaBAD)568 hsdR514 ∆phoBR580 
galU95 recA ∆endA9 (DE3) uidA(∆MluI)::pir(wt)) was used as background for construction of a 
D-xylose -specific XR selection strain (HZ348). Inactivation of xylA was performed as described 
[39] with slight modifications. Briefly, expression of λ Red genes (α, β, γ) was induced with 10 
mM L-arabinose for 2 hrs in mid-log-phase WM1788(DE3) pKD46 grown in 2YT media at 30 
ºC, which were then concentrated and made electrocompetent. 2-3 µg PCR product was 
electroporated into these cells and recovered at 30 °C in SOC medium with 10 mM L-arabinose 
for 2 hrs before selection on 10 µg/mL kanamycin (Kan) or 6 µg/mL chloramphenicol (Cm) LB 
plates at 42 °C. PCR product consisted of 40 bp homologous to region flanking xylA in the target 
chromosome at either ends of an FRT/kan or FRT/cat cassette, as amplified from pKD4 or 
pKD3. Substitution of xylA with resistance marker kan or cat was confirmed using several 
colony PCRs with primers annealing at various positions inside and outside the cassette, and was 
subsequently excised using temperature induced expression of FLP-recombinase encoded by 
pCP20 and screened for simultaneous loss of antibiotic marker and helper plasmid at 42 °C. 
Several colony PCRs with primers annealing inside and outside the cassette were used to confirm 
loss of kan or cat. Loss of helper plasmid pCP20 was confirmed by testing for loss of Amp 
resistance, as well as lack of plasmid bands on an agarose gel after plasmid isolation. Next, PCR 
was used to amplify xdh (from G. oxydans) and araB (from E. coli DH5α) from chromosomal 
DNA isolated using WIZARD Genomic DNA Purification Kit. An NdeI restriction site was 
silently mutated from araB (renamed araB') and then spliced together with xdh, both using 
overlap-extension PCR (OE-PCR), with a ribosomal binding site (rbs) in between to create an 
xdharaB' construct. This was subsequently cloned at NdeI/XhoI sites in both pTKXb and 
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pET20b. Finally, HZ348 was transformed with pTKXb-xdharaB' and pET20b-xdharaB' to give 
HZ349 and HZ350, respectively. 
 
2.5.8. Determining selection conditions 
Selection media consisted of minimal media agar plates with D-xylose as the carbon source, two 
antibiotics for maintenance of the two plasmids, IPTG for induction of NcXR, and L-arabinose as 
selection pressure. IPTG concentration was varied between 0 and 0.5 mM, to find the 
concentration that gave highest growth rate. To verify positive selection, strains lacking NcXR, 
those with inactive NcXR (D44A and W21A), and those lacking NcXR, XDH and AraB were 
plated on minimal media without selection pressure or antibiotics to test for non-specific growth. 
For negative selection, L-arabinose concentration was varied between 0 and 1.0 %, to identify 
sufficient growth pressure to significantly inhibit growth of cells with wild-type NcXR at 37 °C 
or 30 °C for 7-10 days. Kan and Cm concentrations were tested between 5 µg/mL and 50 µg/mL, 
to maintain both plasmids, and minimize non-specific growth and contamination over the 
extended growth period. After several repetitions, HZ349 gave the most consistent results; hence 
use of HZ350 was not continued. 
 
2.5.9. Identification of substrate-interacting residues 
Substrate contacting residues and catalytic residues for several aldose reductases (ADRs), 
including XRs, and the closely related hydroxysteroid dehydrogenase have been identified [68-
72]. Corresponding residues were identified in NcXR by multiple sequence alignment (MSA) 
with human aldose reductase (hAR) and rat liver 3α-hydroxysteroid dehydrogenase (3α-HSD). 
D-xylose was then positioned in the active site of NcXR homology model docked with NADPH, 
in Molecular Operating Environment (MOE, Chemical Computing Group, Montreal, Canada), 
with the carbonyl group near the catalytic Tyr49, soaked in water, and subjected to iterative 
docking. The lowest total energy position was chosen and subjected to further energy 
minimization. Residues within 8 Å of substrate in the lowest energy configuration were 
identified as first-shell, substrate-interacting residues. A similar procedure was also used to dock 
L-arabinose. 
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2.5.10. His6-tagged NcXR purification 
Mid-log phase cells with ncxr in expression vector grown in rich media induced with 0.5 mM 
IPTG for 16 – 20 hr at 30 °C, centrifuged, decanted and the cell pellet re-suspended in 3 mL/(g 
pellet) 1 mg/mL lysozyme Wash/Lysis Buffer (50 mM NaH2PO4, 10 mM imidazole, 15 % 
glycerol, 300 mM NaCl, pH 8.0). They were freeze-thawed twice at -80 °C and 30 °C, and then 
sonicated in 5 s intervals with 10 s pauses for a total of 1 min. To remove cell debris, lysates 
were centrifuged and the supernatant filtered through 0.22 µm syringe-filters. After equilibrating 
BD TALON metal affinity resin in columns with 10 column volumes (CV) Wash/Lysis Buffer, 
cell extracts were loaded and subsequently washed with 10 CV Wash/Lysis Buffer. The columns 
were eluted with 2-4 CV Elution Buffer (50 mM NaH2PO4, 300 mM imidazole, 15 % glycerol, 
300 mM NaCl, pH 8.0) and then regenerated using 1-3 CV of each 0.1 M EDTA/1 M NaCl, 1 N 
NaOH/1 M NaCl, 1 N HCl, 0.1 M CoCl2, 0.5 M NaCl, and 20 % ethanol, with ddH2O in between 
each step. Eluted proteins were exchanged three times into 10 mM MOPS pH 7.2 using Amicon 
Ultra-Centrifugal Filter Units (10 or 30 KD MWCO) and concentrated to < 1.0 mL. 
Concentrated enzymes were checked for purity by SDS-PAGE. 
 
2.5.11. Determination of protein concentration 
Extinction co-efficient for wild-type NcXR was previously determined [24] and found in 
agreement with calculated values from San Diego Supercomputing Center (SDSC) Biology 
Workbench (http://workbench.sdsc.edu/) input with protein sequence. Extinction co-efficient for 
mutants was thereafter used as calculated by SDSC Biology workbench. 
 
2.5.12. Kinetic characterization of mutants 
Michaelis-Meten kinetic constants (KM, kcat) were determined as previously described [24]. All 
reactions were performed at 25 °C in 50 mM MOPS buffer pH 6.3. NADPH concentration was 
kept >100 µM, usually between 100-400 µM and substrate concentrations were between 5 and 
1500 mM for D-xylose and between 5 and 2000 mM for L-arabinose. Purified enzymes were kept 
on ice at all times to minimize thermal inactivation. Calculations were based on at least two 
independent datasets of two readings each, and were performed by least-squares fit method in 
Microcal Origin 5.0 (OriginLab Corporation, Northampton, MA). Substrate solutions were 
maintained at 25 °C in ThermoNESLAB RTE7 refrigerated water bath (Thermo Electron 
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Corporation, Waltham, MA). A water-circulating jacketed the cuvette holder in Varian Cary 100 
Bio UV-visible spectrophotometer (Varian, Palo Alto, CA). 500 µL substrate solution was added 
to a quartz cuvette with 10 mm path-length and mixed with 0.3 – 2 µg purified enzyme. Reaction 
rate was monitored as decrease in absorbance at 340 nm, corresponding to oxidation of NADPH 
(ε = 6220 M-1cm-1) to NADP. Initial reaction rate was measured as the slope between 0.05 min 
and 0.25 min. Specific activity calculated for various substrate concentrations from initial 
reaction rates was used to calculate Michaelis-Menten constants. 
 
2.5.13. P1 transduction 
Donor cells (2 mL) were inoculated with 20 µL of overnight culture and grown in LB + 5 mM 
CaCl2 + 10 mM MgCl2 + 50 mg/L Kn for 1 h at 37 °C. Wild-type P1vir (10-200 µL) was added 
to the cells and grown for another 2-4 h till cell density decreases significantly due to lysis. 
Chloroform (100 µL) was then added, and the culture was grown for another 15 min. The culture 
was then centrifuged at 3200 x g for 10 min. The supernatant was then transferred to a fresh tube 
containing 100 µL chloroform and centrifuged again. After one more transfer and centrifugation, 
the clear supernatant was transferred to a fresh tube containing 100 µL chloroform and stored at 
4 °C overnight to ensure complete donor lysis. Recipients were grown to stationary phase and 
CaCl2 and MgCl2 were added to 5 mM and 10 mM, respectively. After alliquoting 1 mL into 
centrifuge tubes, 50-100 µL donor P1 lysate was added to the cells. Sterile water was used as a 
control instead of P1 in all cases. After incubation at room temperature for 30-60 min, sodium 
citrate was added to 10 mM to sequester the Ca2+ ions. After centrifugation and removal of 
supernatant, cells were resuspended in fresh 1 mL LB supplemented with 10 mM sodium citrate 
and incubated at 37 °C for 1 h. Cells were washed twice in the same medium, resuspended to 
100 µL, spread on a single LB+Kn50 plate, and incubated at 37 °C overnight. 
 
2.5.14. Library creation and screening 
Saturation mutagenesis libraries were created using splicing overlap-extension PCR (OLE-PCR) 
using NNS primers. Two fragments of mutant ncxr gene were amplified using standard protocols 
and spliced together thereafter. 1:1 molar ratio of each fragment was mixed in a 20 µL reaction 
mix and amplified without primers using a slightly modified PCR reaction, with only 9 cycles of 
amplification to yield full-length genes. The remaining conditions were maintained as for any 
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other PCR reaction. 0.4 - 0.5 µL amplicons were used as template for further amplification using 
end-primers. Products were PCR purified and stored at -20 °C. EpPCR library inserts were 
created using 0.2 mM Mn2+ and Taq polymerase with 10 ng plasmid DNA as template, as per 
standard protocols. Inserts were subsequently PCR purified and stored at -20 °C. All inserts were 
ligated into vectors and electroporated into competent cells. After recovery, HZ349 cells were 
washed thoroughly in M9 salt solution and plated on selection media or resuspended in liquid 
selection media, whereas BL21(DE3) cells were spread on LB plates supplemented with 25 
µg/mL Cm. Transformed HZ349 grown in liquid medium were incubated for 6 days and their 
plasmid isolated and transformed into BL21 (DE3) cells and subsequently selected on Cm LB 
plates. Individual colonies were picked into 100 µL LB media 96-well plates and incubated at 37 
°C till late-log-phase and induced with an additional 100 µL LB and 1.0 mM IPTG for 16-20 hrs 
at 30 °C. Plates were centrifuged and resuspended in 1 mg/mL Lysozyme solution in 10 mM 
MOPS pH 7.2, vortexed and freeze-thawed to complete lysis. 10 – 20 µL lysate was used in a 
cell-lysate-based activity assay, as previously discussed using a plate-reader to measure 
decreasing in A340. Relative activities and selectivities were calculated Equation 2.2, Equation 
2.3) and promising mutants were further scrutinized using a second 96-well-plate based assay 
with each mutant represented in triplicate, and thereafter in tube-culture lysate-based and 
purified enzyme-based activity assays. 
 
2.5.15. Plasmid construction for selective bioconversion 
All cloning work was performed in E. coli DH5α or WM1788 (pir+ for propagating R6K 
plasmids), and a list of constructs can be found in Table 1. All XR expression plasmids were 
derivates of pTrc99A. XR and mutants were previously cloned into pACYCDuet (Novagen), and 
were used as the template for PCR [44]. The XylA promoter was amplified from E. coli MG1655 
genomic DNA, and spliced with XR using overlap extension PCR. The cassette was digested 
with NsiI and BglII and ligated into pTrc99A that had been digested with NsiI and BamHI. 
Ligation of compatible BglII-BamHI ends abolished both restriction sites. The AraBAD 
promoter was digested out of pRW2-ptdh [73] using PstI and NdeI; PCR amplified XR was 
digested with NdeI and BglII, and pTrc99A with NsiI and BamHI. All three were ligated 
together in a single reaction, which abolished the compatible PstI-NsiI and BglII-BamHI sites. 
For IPTG inducible constructs, XR (EcoRI-BglII) was directly ligated into EcoRI-BamHI 
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digested pTrc99A. D-Xylose transporter xylE was amplified from MG1655 genomic DNA and 
ligated directly into pTKXb-xdh-araB’ [44, 74] digested with NdeI and XhoI. The promoter-gene 
cassette was then digested out with EcoRI and XhoI and ligated in pACYCDuet digested with 
the same endonucleases. This construct provided expression from the constitutive BLMA 
promoter. For expression under the AraBAD promoter, xylE was first cloned into pRW2-ptdh 
between the NdeI and PciI sites. The promoter-gene cassette was then digested out using PstI and 
PciI and ligated into pACYCDuet digested with PstI and NcoI. The ligation abolished the 
compatible NcoI-PciI sites. 
 
2.5.16. Creation of arabinose/glucose co-utilization strain  
All strains used for xylitol production were E. coli K-12 C600 and its derivates, and all deletions 
were performed using the λred system [75]. Briefly, 50-100 ng PCR product containing the cat 
gene flanked by FRT (Flp recognition target) and 45-50 nt of sequence identical to the target 
locus was transformed into cells expressing λred recombinase proteins (encoded on pKD46). 
Competent cells were made by growing those harboring pKD46 to mid-log phase to and induced 
with 10 mM L-arabinose for 3 h. 25 mL cells of these cells were washed thoroughly in ice cold 
10% glycerol and resuspended in 150 µL total volume. Electroporated cells were recovered in 1 
mL SOC for 1 h and then half the cells were spread on a single plate. Gene replacement was 
selected on chloramphenicol (6 mg/L) plates and verified by functional assay and PCR. The 
resistance marker was then removed by the expression of Flp recombinases from a thermo-
inducible promoter on a temperature sensitive plasmid (pCP20). Flp recombinase plasmid loss 
and cat loss occurred simultaneously and were verified by sensitivity to ampicillin and 
chloramphenicol. Deletion of ptsG and cyaAregul was performed directly in C600, whereas 
inactivation of the xylA and xylAB genes was performed in MG1655 and then moved by P1 
transduction to the recipient strains [76]. The crp* mutation was also generated by P1 
transduction from ET23 and selecting for TetR integrants [77]. Deletions were verified by PCR 
using cell lysate as the template and appropriate flanking primers. Verification of glucose de-
repression was first done by blue/white screening on LB plates containing 10 g/L glucose. Strong 
induction of lacZ in the presence of glucose indicated the depressed phenotype. The CyaA 
mutant strain did not demonstrate significant LacZ activity. Finally, direct monitoring of sugar 
co-utilization in shake flasks was used to verify de-repression. 
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2.5.17. HPLC analysis of sugars 
Sugar concentrations were quantified using Shimadzu high performance liquid chromatography 
(HPLC) equipped with a low temperature evaporative light scattering detector (ELSD-LT) 
(Columbia, MD). A Bio-Rad Aminex 250 x 4 mm HPX-87C (Bio-Rad, Hercules, CA) 
carbohydrate column was used to separate the sugars, as per manufacturer’s recommendations. 
The column was run at 0.2 mL/min at 85 ºC for 18 minutes with water as the mobile phase.  
 
2.5.18. GC-MS analysis of acetate 
Acetate quantification was performed at the Roy J. Carver Metabolomics Center. n-Butanol (1 
mL/L) was used as internal standard to quantify acetate in media. Samples (1µL) were injected 
in split mode (5:1) to the GC/MS system consisting of an Agilent 7890 gas chromatograph, an 
Agilent 5975 mass selective detector, and HP 7683B autosampler. (Agilent Inc, Palo Alto, CA). 
Acetate samples were analyzed on a 30 m ZB-Wax-Plus column with 0.32 mm I.D. and 0.25 µm 
film thickness (Phenomenex, Torrance, CA) with an injection port temperature of 250 ºC, the 
interface set to 250 ºC, and the ion source adjusted to 230 ºC. The helium carrier gas was set at a 
constant flow rate of 2.5 ml min-1. The temperature program was 5 min isothermal heating at 90 
ºC, followed by an oven temperature increase of 10 ºC min-1 to 210 ºC for 2 min. The mass 
spectrometer was operated in positive electron impact mode (EI) at 69.9 eV ionization energy in 
m/z 50-550 scan range.  
 
The spectra of all chromatogram peaks evaluated using the HP Chemstation program (Agilent, 
Palo Alto, CA). Identification was performed using the mass spectra obtained from the authentic 
standards and additionally confirmed with NIST08 and W8N08 libraries (John Wiley & Sons, 
Inc., USA). 
 
2.5.19. Shake flask and bioreactor cultures 
For shake flask cultures, overnight cultures were grown at 37 ºC in M9 minimal medium 
supplemented with 2 mM MgSO4, 0.1 mM CaCl2, 20 mg/L leucine, 120 mg/L threonine, 10 
mg/L thiamine-HCl, 2 g/L glucose and the appropriate antibiotic(s). 125 mL unbaffled bottles 
containing 25 mL of the same medium but containing 1-2 g/L of each sugar (glucose, D-xylose, 
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and L-arabinose) were placed under vacuum, filled with nitrogen, and capped with airtight 
stoppers to maintain oxygen-limited conditions. 1 mL overnight cultures were inoculated into 
these bottles and maintained at 30 ºC or 37 ºC at 250 rpm. For bioreactor studies, 4 mL overnight 
cultures were grown at 37 ºC either in LB or M9 medium supplemented with 2 mM MgSO4, 0.1 
mM CaCl2, 20 g/L glucose, 10 g/L tryptone, and the appropriate antibiotic(s). Upon reaching 
saturation, these cultures were spun down and resuspended in 4 mL of the same medium and 
cultured for another 4 hours. These cultures were then inoculated into 400 mL bioreactors 
containing the same M9 + tryptone medium with additional 20 g/L each of D-xylose and L-
arabinose, as well as antifoam agents. Bioreactors were run at 30 ºC with 400 rpm agitation and 
0.8 L/min sparging with air. pH was maintained at 7.0 ± 0.1 with 5 N NaOH and 2 N H2SO4. 
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Chapter 3. Biosynthesis of Butanol using Recombinant Yeast 
3.1. Introduction 
Although bioethanol and biodiesel are currently the leading candidates as replacement for 
gasoline and diesel as transportation fuels, alternative renewable fuels have recently been gaining 
favor. These include methanol, n-butanol, isobutanol, and various branched alkanes. Table 3.1 
compares the physical properties of butanol and ethanol to high quality gasoline and diesel fuel 
[1, 2]. The data clearly illustrate the superiority of n-butanol compared to ethanol, particularly in 
terms of low water solubility and latent heat of vaporization. In addition, butanol is less corrosive 
than ethanol, can be used with the current design of gasoline and diesel engines, and can be 
transported by pipelines due to its non-hygroscopic nature. Other than its use as a fuel, it is also 
an industrially important chemical, and the US Department of Energy (DOE) has named it 
among one of their top 12 platform chemicals from agricultural sources (Figure 2.2) [3]. 
 
Table 3.1 Physical properties of ethanol and n-butanol compared to gasoline and diesel. n-Butanol shows several 
favorable qualities as biofuel over ethanol.  
 
Fuel Carbons 
Specific 
gravity 
Flash 
point 
(ºF) 
Freezing 
point 
(ºF) 
Latent 
heat 
(Btu/gal) 
Heating 
value 
(Btu/gal) 
Water in 
fuel 
solubility 
(%) 
Stoichiometric 
air-fuel ratio 
Ethanol 2 0.79 55  -173 2,378  84,530 100 9 
Butanol 4 0.81 95  -129 1,250  104,766 7.45 11.2 
Gasoline 4-12 ~0.75 -45 -40 ~900 124,340 Negligible 14.7 
No.2 
Diesel Fuel 18-25 ~0.85 
140-
176 -40-30 ~710 137,380 Negligible 14.7 
Biodiesel 12-22 ~0.88 
212-
338 26-66 n.d. 127,960 Negligible 13.8 
 
In spite of its advantages, there are two major issues plaguing economical production of 
biobutanol. The first issue is that the natural producers of butanol are anaerobic gram-positive 
bacteria of the genus Clostridia, which are relatively difficult to work with. The most well-
studies butanol producers, Clostridium acetobutylicum and Clostridium beijerinckii follow a 
complex sporulating lifecycle, and do not produce butanol until well into the stationary phase 
[4]. During their growth phase, these Clostridia tend to produce large amounts of acetate and 
butyrate, due to the concomitant production of the energetic molecule, ATP (adenosine 
triphosphate) (Figure 3.1). It has been suggested that the production of these acidic compounds 
decreases the pH of the growth medium and causes a shift in growth phase to solventogenesis, 
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whereby the acids are re-assimilated and converted to neutral acetone, ethanol, and butanol [5]. 
Therefore, fermentation by these two bacteria is commonly referred to as ABE (acetone-butanol-
ethanol), since large amounts of all three are produced. From a biofuel production perspective, 
acetone and ethanol, along with other major fermentation products, acetate and butyrate, are all 
undesirable. In spite of being studied extensively for decades, very few genetic tools are 
available to engineer Clostridia for improved productivity. 
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Figure 3.1 During growth (blue), Clostridia 
produce acids such as acetate and butyrate, with 
concomitant production of ATP. Once the pH of 
the medium drops due to the production of acids, 
they are converted to neutral solvents like acetone, 
butanol, and ethanol (green). Thl is thiolase, Hbd is 
hydroxybutyryl-coA, Crt is crotonase, Bcd is 
butyryl-coA dehydrogenase, EtfAB are electron 
transfer flavoproteins required for Bcd function, 
Bad is butyraldehyde dehydrogenase, and Bdh is 
butanol dehydrogenase. Pta is phosphotrans-
acetylase, Ack is acetate kinase, AdhE is a coA-
dependent aldehyde dehydrogenase, Adh is alcohol 
dehydrogenase, Abt is acetoacetly-coA-acetate/ 
butyrate-coA-transferase, Adc is acetoacetate 
decarboxylase Ptb is phosphotransbutyrylase, and 
Buk is butyrate kinase. AdhE2 is a bifunctional 
coA-dependent alcohol/aldehyde dehydrogenase 
that catalyzes both the final two reactions. Bad is 
absent in C. acetobutylicum.  
 
The second issue is that butanol is toxic to bacteria at concentrations over 20 g/L, far below its 
solubility in water (~75 g/L), and still remains an unresolved issue with current Clostridial 
fermentations. Production of butanol in more congenial organisms such as E. coli or S. cerevisiae 
(common yeast) could alleviate some problems associated with Clostridial fermentation, 
although the toxicity of butanol may still remain an issue. As well-studied model organisms, 
there are ample genetic tools available to engineer E. coli and S. cerevisiae for overproduction of 
butanol. Heterologous production of butanol has already been demonstrated in E. coli, with final 
titers of ranging from µg/L to g/L ranges in shake flask cultures [6-8]. While low compared to 
the highest titers obtained by Clostridial fermentation (~18 g/L) [9], improvements in 
fermentation conditions can be made relatively easily to increase titers and productivity in a 
heterologous host. Given the choice between E. coli and S. cerevisiae, the latter might be a better 
option as production organism. Having been evolved for high alcohol tolerance for hundreds of 
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years (tolerant to >150 g/L ethanol), it is a far more resilient organism than E. coli. It is therefore 
possible to engineer it for higher tolerance to butanol than may be possible for E. coli. Although 
butanol production by S. cerevisiae has been demonstrated, it was produced from at very low 
concentrations (~2.5 mg/L) from galactose, a relatively expensive substrate [10].  
 
The primary goal of this project is to develop a yeast strain capable of overproducing n-butanol 
from glucose. This will be realized by utilizing a strategy that combines protein engineering to 
enhance enzymatic expression level and activity, as well as genome/metabolic engineering to 
enhance metabolite flux from glucose to n-butanol. 
 
3.2. Results & Discussion 
3.1.1. Identification of constitutive promoters  (Book8 pg26-45, 52) 
Steen et al. used galactose-inducible promoters (GAL1-GAL10) to drive the expression of their 
genes in yeast. However, in order to produce n-butanol from glucose, these promoters would be 
unusable. Eight constitutive promoters ADH1p, PGK1p, PYK1p, TEF1p, TEF2p, HXT7p, 
TDH2p, and TDH3p/GPDp were chosen as they have been shown to be strong constitutive 
promoters, or are glycolytic and known to be strongly transcribed in the presence of glucose [11-
15]. Promoter sequences were determined from the S. cerevisiae promoter database (SCPD) [16], 
when possible. In other cases 500-1000 bp of sequences directly upstream of the translation start 
site was determined as the promoter sequence from the S. cerevisiae Genome Database (SGD) 
[17]. Similarly, terminator sequences were determined as 300-500 bp downstream of the stop 
codon. All promoters and terminators were amplified directly from genomic DNA of lab yeast 
strain YSG50. Green fluorescent protein (GFP) was cloned downstream of each promoter to test 
expression. Under a handheld ultraviolet (UV) source, all strains harboring plasmids were visibly 
fluorescent, indicating that all promoters were functional and could drive expression of a 
downstream gene when grown in selective glucose medium. 
 
3.1.2. Expression of C. beijerinckii genes in yeast 
Although native butanol producers use a circuitous route for the production of n-butanol, via 
butyrate and acetate, only six steps are truly required for the biosynthesis of n-butanol from 
acetyl-coA (Figure 3.2). Of the six, four steps require NADH (nicotinamide adenine dinucleotide 
hydride) as a cofactor to donate the reducing hydrides. Thiolase (Thl) condenses two molecules 
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of acetyl-coA molecules to acetoacetyl-coA with the elimination of free CoASH. 
Hydroxybutyryl-coA dehydrogenase (Hbd) reduces this specifically to produce the (S)-epimer of 
hydroxybutyryl-coA, which is distinct from the (R)-epimer that is produced in 
polyhydroxyalkanoate (PHA) biosynthesis [18]. Following dehydration by crotonase (Crt), 
a.k.a., crotonyl-coA dehydratase, it is further reduced by butyryl-coA dehydrogenase (Bcd), 
which is facilitated by oxygen-sensitive electron transfer flavoproteins (EtfAB). The final two 
steps are additional reduction steps where butyryl-coA is converted to n-butanol via the action of 
two distinct proteins, butyraldehyde dehydrogenase (Bad) and butanol dehydrogenase (AdhA) or 
a single bifunctional enzyme CoA-dependent aldehyde/alcohol dehydrogenase (AdhE2). It 
should be noted that Bdh and AdhE2 have two or more isozymes in both Clostridia. 
Heterologous expression of five C. acetobutylicum genes (including AdhE2) in E. coli and other 
bacteria has been shown to produce butanol at low levels [6-8, 19]. Heterologous expression of 
the entire pathway from C. acetobutylicum has also been demonstrated in S. cerevisiae, and led 
to the production of low levels of n-butanol when grown on galactose [10].  
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Figure 3.2 Biosynthetic pathway of butanol in 
Clostridia proceeds via six steps starting with 
two acetyl-coA molecules. Thl is thiolase, Hbd 
is hydroxybutyryl-coA dehydrogenase, Crt is 
crotonase, Bcd is butyryl-coA dehydrogenase, 
EtfAB are electron transfer flavoproteins 
required for Bcd function, Bad is 
butyraldehyde dehydrogenase, and AdhA is 
butanol dehydrogenase. AdhE2 is a 
bifunctional coA-dependent alcohol/aldehyde 
dehydrogenase that catalyzes both the final 
two reactions. Bad is absent in C. 
acetobutylicum [20]. 
 
Due to the extensive work done by Prof. Hans Blaschek (University of Illinois, Urbana, IL) in 
studying and developing C. beijerinckii as an industrial n-butanol producer, its genes were 
chosen for expression in yeast. Cloning of each gene under a distinct promoter in a set of four 
compatible 2µ plasmids was performed using the DNA Assembler technique [21]. Yeast strains 
co-transformed with all four plasmids and grown aerobically or microaerobically did not yield 
any n-butanol as detected by GC-MS (gas chromatography-mass spectrometry). Subcloning each 
gene individually with either an N-, or C-terminal His6-tag followed by affinity purification and 
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western blot analysis revealed that Crt and AdhA, were the only two genes expressed in yeast. 
HPLC analysis and spectrophotometric assays using the partially purified proteins revealed that 
both enzymes were functional as well. In order to create a complete, functional n-butanol 
pathway in yeast, it was therefore essential to find orthologs or analogs of the remaining non-
expressing genes. All cloning was performed with the assistance of Dr. Hua Zhao, Dr. Zengyi 
Shao, Dr. Ryan P. Sullivan, Dr. Tyler W. Johannes, and Michael Mclachlan. All western 
blotting, partial purification, and activity assays were performed by Dr. Zengyi Shao. 
 
3.1.3. Search for functional genes (Book8 pg2-21, 26-45, 53-66) 
C. acetobutylicum genes were the obvious candidates for substitution since they have previously 
been shown to express well in a heterologous host [6-8, 10, 19]. Atsumi et al. also attempted 
expression of genes orthologous or analogous to Bcd and AdhE2, but they found no increase in 
n-butanol titers. In fact, any attempt at using homologs resulted in drastic decrease in n-butanol 
production in E. coli [6]. Neilsen et al. found that similar substitutions had insignificant effects 
of the high obtainable n-butanol titers [8]. Similarly, Steen et al. attempted to increase n-butanol 
production by substituting C. acetobutylicum genes with homologs from other organisms, but 
found that in all cases, n-butanol production levels decreased [10]. The used codon-optimized C. 
acetobutylicum genes, which would have a positive impact on their heterologous expression in 
yeast [10], was prohibitively expensive and therefore, it was necessary to explore other 
homologs as well. 
 
In order to find enzymes to catalyze the remaining four steps, similar cloning, expression 
purification, western blot and activity assays were performed on homologs and orthologs from 
various other organisms ranging from bacteria to protists. Table 3.2 summarizes all the proteins 
analyzed and also indicates those that were found to be functionally expressed. The endogenous 
thiolase in S. cerevisiae (Erg10) has previously been reported to increase flux towards n-butanol 
more efficiently than the corresponding gene from C. acetyobutylicum [10]. However, when 
overexpressed constitutively from a plasmid, it could not be detected by western blot, and 
therefore C. acetobutylicum gene was chosen. A BLAST search against sequenced organisms for 
Hbd and Crt homologs revealed their presence and in the gram-positive bacterium Bacillus 
cereus and butyrate producer Butyrivibrio fibrisolvens  [22, 23]. The well-studied and 
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characterized Hdb-like enzyme (PhaB) involved in polyhydroxyalkanoates (PHA) biosynthesis 
from Ralstonia eutropha were not tested since it preferentially catalyze the formation of the (R)-
epimer, rather than the (S)-epimer, as required for butanol biosynthesis [24]. Hbd from C. 
acetobutylicum was found to be the most active from those tested, as was the Crt from C. 
beijerinckii. Reduction to butyryl-CoA is performed by Bcd in n-butanol producing Clostridia. 
However, its activity requires additional electron transfer flavoproteins (EtfA and EtfB) to 
mediate the transfer of electrons from NADH to (3S)-hydroxybutyryl-coA. A similar enzyme has 
also been identified in the ruminal, butyrate producing anaerobe Megasphaera elsdenii [25-27]. 
Unfortunately, both these flavoproteins are oxygen-sensitive [19], which, although a non-issue 
for the original anaerobic hosts, makes them non-ideal for n-butanol biosynthesis in yeast. Non-
oxygen sensitive analogs of Bcd exist in various Steptomyces called crotonyl-CoA reductase 
(Ccr). However, previous attempts to express them in heterologous hosts have been relatively 
unsuccessful [6, 10]. Another analog of Bcd called trans-2-enoyl-coA reductase (Ter) is involved 
in fatty acid/wax biosynthesis. The gene encoding Ter from the unicellular protist has been 
codon-optimized for expression in E. coli, and was kindly provided by Gevo, Inc. Among this set 
of proteins, TerOpt was the only protein that was functionally expressed in yeast. The reduction to 
butyraldehyde can be catalyzed by unifunctional enzymes similar to Bad or bifunctional enzymes 
like AdhE2. C. beijerinckii has one of each type of enzyme, whereas C. acetobutylicum has two 
different bifunctional enzymes [20, 28, 29]. Gevo, Inc. had synthesized a codon-optimized 
caAdhE2 gene for expression in E. coli, which they had shown to be functional in yeast we all. A 
few other enzymes have been described in literature that are able to reduce acetyl-coA to 
acetaldehyde [30], or catalyze the two-step reduction from acetyl-coA to ethanol [20, 31, 32]. 
For some of these enzymes, promiscuous activity has been demonstrated with butyryl-coA [20, 
30, 31]. Unfortunately, among the nine homologs tested, no enzyme found to functionally 
expression in yeast could be identified. For the last step, at least two isozymes butanol 
dehydrogenase exist in each Clostridia [33, 34]. Additionally, the yeast Adh6 has been shown to 
be highly non-specific with high levels of activity towards butyraldehyde [35]. Among these, C. 
acetobutylicum BdhB was found to be the most highly expressed and active when its start codon 
was changed from GTG to ATG. 
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Table 3.2 For each step in the n-butanol biosynthetic pathway, various homologs of C. beijerinckii genes were 
cloned and expressed with either N- or C- terminal His-tag. After partial purification, western blots again the His-tag 
were used to determined expression. Additionally, after one-step affinity purification on a Ni-NTA resin 
chromatographic column, the elution fraction was tested for activity. Activities were determined by 
spectrophotometric detection of formation of NADH in the appropriate reaction mixture, and/or by detection of the 
product CoA by HPLC. Although AdhB was not detectable by western blot, its activity could be detected from 
partially purified lysate, and was found to be about background. Red indicates proteins that were chosen as best-in-
class for their high expression/activity in yeast. 
 
Enzyme 
Ortholog 
Tested 
Analog 
Tested Enzyme Name 
Source 
Organism Expressed?a Functional?b 
Thl - Thiolase Clostridium beijerinckii No No 
Thl - Thiolase Clostridium 
acetobutylicum Yes Yes Thl 
Thl - Thiolase Saccharomyces 
cerevisiae No No 
Hbd - Hydroxybutyryl-CoA Dehydrogenase 
Clostridium 
beijerinckii No No 
Hbd - Hydroxybutyryl-CoA Dehydrogenase 
Clostridium 
acetobutylicum Yes Yes 
Hbd - Hydroxybutyryl-CoA Dehydrogenase Bacillus cereus No No 
Hbd 
Hbd - Hydroxybutyryl-CoA Dehydrogenase 
Butyrivibrio 
fibrisolvens Yes Yes 
Crt - Crotonase Clostridium beijerinckii Yes Yes 
Crt - Crotonase Clostridium 
acetobutylicum Yes Yes 
Crt - Crotonase Bacillus cereus Yes n.d. 
Crt 
Crt - Crotonase Butyrivibrio fibrisolvens Yes n.d. 
Bcd/EtfAB - Butyryl-CoA Dehydrogenase 
Clostridium 
beijerinckii No No 
Bcd/EtfAB - Butyryl-CoA Dehydrogenase 
Megasphaera 
elsdenii No No 
- TerOpt trans-2- Enoyl-CoA Reductase Euglena gracilis Yes Yes 
- Ccr Crotonyl-CoA Reductase 
Streptomyces 
hygroscopicus No No 
Bcd/EtfAB 
- Ccr Crotonyl-CoA Reductase 
Streptomyces 
coelicolor No No 
aSoluble expression in S. cerevisiae determined by western blot or SDS-PAGE of N-/C- His-tagged protein. All 
cloning was performed with the assistance of Dr. Hua Zhao, Dr. Zengyi Shao, Dr. Ryan P. Sullivan, Dr. Tyler W. 
Johannes, and Michael Mclachlan. Western blotting was performed by Dr. Zengyi Shao. 
bFunction tested in vitro in either forward or reverse direction toward desired substrate/product. Partial 
purification, and activity assays were performed by Dr. Zengyi Shao 
n.d. Not determined 
OptChemically synthesized gene for expression in E. coli provided by Gevo, Inc. 
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Table 3.1 continued… 
 
Enzyme Ortholog Tested 
Analog 
Tested Enzyme Name 
Source 
Organism Expressed?
a
 Functional?b 
Bad - 
CoA-dependent 
Aldehyde 
Dehydrogenase 
Clostridium 
beijerinckii No No 
- Ald 
CoA-dependent 
Aldehyde 
Dehydrogenase 
Azotobacter 
vinelandii No No 
- Ald 
CoA-dependent 
Aldehyde 
Dehydrogenase 
Escherichia coli No No 
Bad 
- Ald 
CoA-dependent 
Aldehyde 
Dehydrogenase 
Cupriavidus 
necator 
Yes No 
Aad - Butanol/Butyraldeh-yde Dehydrogenase 
Clostridium 
acetobutylicum No No 
AdhE2 - Butanol/Butyraldeh-yde Dehydrogenase 
Clostridium 
acetobutylicum No No 
- Aad Alcohol/Aldehyde Dehydrogenase Giardia lamblia No No 
- Aad Alcohol/Aldehyde Dehydrogenase 
Thermoanaerob-
acter ethanolicus No No 
- AdhE Alcohol/Aldehyde Dehydrogenase 
Lactobacillus 
reuteri  No No 
AdhE2 
- AdhE Alcohol/Aldehyde Dehydrogenase Escherichia coli Yes No 
AdhA - Butanol Dehydrogenase 
Clostridium 
beijerinckii Yes Yes 
BdhB - Butanol Dehydrogenase 
Clostridium 
acetobutylicum Yes Yes Bdh 
- Adh6 Cinnamyl Alcohol Dehydrogenase 
Saccharomyces 
cerevisiae Yes Yes 
aSoluble expression in S. cerevisiae determined by western blot or SDS-PAGE of N-/C- His-tagged protein. All 
cloning was performed with the assistance of Dr. Hua Zhao, Dr. Zengyi Shao, Dr. Ryan P. Sullivan, Dr. Tyler W. 
Johannes, and Michael Mclachlan. Western blotting was performed by Dr. Zengyi Shao. 
bFunction tested in vitro in either forward or reverse direction toward desired substrate/product. Partial 
purification, and activity assays were performed by Dr. Zengyi Shao 
 
Functional genes were then re-cloned into compatible vectors for a three-plasmid expression 
system that would enable easy screen for functional enzymes able to reduce butyryl-coA to 
butyraldehyde (Figure 3.3). The exact gene sequences for egTerOpt and caAdhE2Opt are not 
known since they were synthesized for Gevo, Inc. After transformation into YSG50, cells 
cultured in high density microaerobic conditions produced small amounts of n-butanol as 
detected by GC-MS (Figure 3.4). 
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f1 ori 1241...1707
TRP1 468...1142
caThl 3390...4568
ADH1t 4569...4896
TDH3p/GPDp 4897...5551
CYC1t 7973...8220
cbCrt 7196...7972
HXT7p 6801...7195
ADH2t 6401...6800
CaHbd 5552...6400
ColE1 ori 8478...9408
bla 10278...9419
2 micron 10411...11756
pTHC
11821 bp
ADH1p 1890...3389 f1 ori 2930...2474
LEU2 1757...663
GPDp 3107...3762
caBdhB 3763...4935
ADH2t 4936...5335
ADH1t 8054...8381
egTer(Opt) 6836...8053
ADH1p 5336...6835
pMB1 ori 8670...9610
bla 10470...9613
2 micron 10603...11948
pTB
12013 bp
 
f1 ori 1807...1351
URA3 417...1220
caADHE2(Opt) 4858...2282
pMB1 ori 5842...6782
TDH3p 5564...4910
c-MYC\Tag 4894...4859
bla 7642...6785
2 micron 7775...9120
pGV1213
9185 bp
CYC1t 2276...2015
 
 
Figure 3.3 The three-plasmid system containing all genes shown to functionally express in yeast. Exact sequences 
for egTerOpt and caAdhE2Opt are not known since they were synthesized by Gevo, Inc. for expression in E. coli. 
Changing pGV1213 for a plasmid with a gene for another enzyme would enable a screen for a functional alternative. 
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Figure 3.4 GC trace of culture supernatant after transformation of the three-plasmid system 
(pTHC, pTB, and pGV1213) in YSG50. Butanol could be detected at low levels when cells 
were cultured in high density, microaerobic conditions in SC-LWU dextrose medium. 
 
Since caAdhE2Opt and TerOpt were provided by Gevo, Inc., they cannot be used for publication 
purposes. Therefore, alternate functional proteins need to be identified to catalyze these 
reactions.  
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3.1.4. A better Ter from Treponema denticola (Book9 pg97-100, Book12 pg 2-3) 
A recently identified Ter from the pathogen Treponema denticola has been shown to have very 
high catalytic activity. When compared to the E. gracilis Ter, this prokaryotic enzyme is almost 
300-fold more active due to higher affinity for crotonyl-coA as well as higher turnover rates 
(Table 3.3). This enzyme would be a suitable replacement if it could be functionally expressed in 
yeast.  
Table 3.3 Catalytic properties of two characterized trans-2-enoyl-coA reductases 
(Ter). The enzyme from T. denticola is ~300-fold more catalytically active. 
 
  T. denticola E. gracilis Ratio 
KM (mM) 2.7 68 0.04 
kcat (U•mg-1) 43 3.9 11 
kcat / KM  
(U•mg-1mM-1) 16 0.057 277 
 
To test its expression level in yeast, tdTer was fused to GFP (green fluorescent protein) at its 
carboxy-terminus [36], with a cMyc linker between the two proteins and placed under the control 
of the constitutive GPD/TDH3 promoter. Since flow cytometric analysis is quicker and less 
laborious than affinity purification and western blotting, this technique provided an alternative 
strategy to test solubility. As can be seen in Figure 3.5, there is a large fluorescent population 
present in cells harboring plasmids with tdTer-GFP fusion protein when compared to the 
negative control. This suggests that tdTer is probably very soluble in the yeast cytoplasm. tdTer 
was subcloned to replace egTerOpt in pTB to give pT2B (Figure 3.6). 
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Figure 3.5 Flow cytometric data to demonstrate the solubility of tdTer in S. cerevisiae YSG50. GFP 
alone has a very large fluorescent population (green). (B) As a negative control, the strain harboring an 
empty plasmid has no fluorescence (black). tdTer-GFP fusion, while not as fluorescent as GFP alone, has 
a large population that is fluorescent (blue), indicating the fusion is highly soluble in yeast’s cytoplasm. 
63 
 
GPDp 3107...3762
caBdhB 3763...4935
ADH2t 4936...5335
ADH1t 8030...8357
tdTER 6836...8029
ADH1p 5336...6835
pMB1 ori 8646...9586
bla 10446...9589
2 micron 10579...11924
pT2B
11989 bp
LEU2 1757...663
f1 ori 2930...2474
 
 
Figure 3.6 Vector map of pT2B with genes for caBdhB and tdTer. 
 
3.1.5. Engineering soluble expression of AdhE2: codon optimization (Book9 pg14-17, 22-28) 
The bifunctional protein AdhE2 from C. acetobutylicum has widely been preferred to the 
monofunctional Bad for heterologous expression [6, 7, 10, 19]. Although the soluble expression 
or activity of wild-type AdhE2 could not be detected in yeast extracts, a gene optimized for 
expression in yeast may be able to functionally express [37]. In fact, Steen et al. have shown that 
a chemically synthesized gene designed to have a codon adaptation index (CAI) more amenable 
for translation by yeast does functionally express [10]. The CAI of wt caAdhE2 was determined 
to be 0.0395, far below the ideal value of 1.0 by the JCat algorithm [38]. An optimized gene 
sequence was provided by the same algorithm and has a CAI of 0.980 (Appendix E). Using a 
strategy similar to synthetic shuffling [39], the entire caAdhE2 gene was reconstructed in vitro 
by assembling 64 oligonucleotides. After cloning the gene into a plasmid, five full-length genes 
were sequenced. All clones had several mutations, with the fewest being two. Using the 
assembling primers and three-fragment splicing overlap extension PCR, the two mutations were 
corrected. After sequencing several new sub-clones, one gene was found to be completely 
mutation-free. After co-transformation of the plasmid encoding this gene along with pTHC and 
pTB (Figure 3.3), the cells were tested for the ability to produce n-butanol. Unfortunately, no n-
butanol could be detected, indicating that the codon-optimized AdhE2 was not expressed in 
yeast. 
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3.1.6. Butyraldehyde dehydrogenase bypass attempt  (Book11 pg35-76) 
Since no homolog of Bad or AdhE2 was found to functionally express in yeast, and codon-
optimization of caAdhE2 for better translation in yeast failed, an alternative strategy was 
attempted. In Clostridia, during growth phase, butyryl-coA is converted to butyrate with the 
concomitant production of ATP [5]. The expression of an aldehyde dehydrogenase (Ald) could 
reduce butyrate to butyraldehyde, thereby completing a Bad bypass pathway (Figure 3.7A). 
Yeast has several endogenous aldehyde dehydrogenases involved in oxidizing acetate to 
acetaldehyde. Ald6 is the cytosolic isozyme involved in acetyl-coA biosynthesis and has been 
shown to be promiscuous with other aldehydes as well [40]. The vector map of the bypass 
plasmid (pRS423-PBA) is shown in Figure 3.7B. Cells co-transformed with pTHC, pT2B, and 
pRS423-PBA, did not produce any detectable amounts of n-butanol. It is unclear whether this is 
due to expression-related issues, or inability to drive flux in the bypass but it was not studied any 
further. Instead directed evolution was used to engineer a soluble, functional Bad/AdhE2 
enzyme. 
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Figure 3.7 (A) Bad bypass would use a three enzyme pathway to reach butyraldehyde. (B) The vector map of 
pRS423-PBA encoding the three genes. Ptb is phosphortransbutyrylase, and Buk is butyrate kinase, both from C. 
acetobutylicum. scAld6 is a Mg2+-dependent cytosolic aldehyde dehydrogenase from yeast. 
 
3.1.7.  Directed evolution for improved soluble expression: round 1 (Book9 pg31-97) 
Directed evolution has been previously used to engineering proteins for soluble expression. Most 
high throughput screens for such endeavors involve fusion to a reporter, with the logic that the 
soluble expression and function of the reporter protein is directly correlated to the solubility of 
its fusion partner. There have been several examples of such work using various reporters assays 
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such can fluorescence [36, 41-44], colorimetry [45, 46], and antibiotic resistance [47, 48]. Due to 
the simplicity of fluorescence and ability to be used in conjunction with FACS (fluorescence 
activated cell sorting), GFP was chosen as the reporter (reviewed in [49]). Work with tdTer has 
already demonstrated that GFP fluorescence is a good reporter for soluble expression in yeast 
(Figure 3.5). To test the same concept for evolving Bad and AdhE2 solubility, fusions with GFP 
were made with caAdhE2Opt (C-terminal), wt caAdhE2 (C-terminal), and wt cbBad (N-terminal). 
Using flow cytometry, the fluorescence of these three constructs was compared to GFP alone and 
a strain carrying pGV1213 (non-fluorescent) (Figure 3.8). As expected, GFP displayed a large 
fluorescent population, whereas the strain expressing caAdhE2Opt with no GFP fusion had very 
low fluorescence. caAdhE2Opt-GFP fusion displayed a small fluorescent population, indicating 
that it was expressed solubly in the cytoplasm. The GFP-cbBad fusion, which had GFP at the N-
terminus instead of C-terminus, displayed higher than background fluorescence. Since cbBad has 
been previously shown to be insoluble, the fluorescence was probably due to a small population 
of fusion proteins with a folded, functional N-terminal GFP. This indicated that N-terminal 
fusions are a poor reporter for solubility, and that C-terminal fusions should be used for 
engineering work. 
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Figure 3.8 Flow cytometric data testing the correlation between solubility in yeast and fluorescence. As expected, 
GFP alone is the most highly fluorescent, whereas caAdhE2Opt, with no fluorescent partner is non-fluorescent. 
caAdhE2Opt fusion protein also displays a distinct fluorescent signal confirming that GFP fusion with a fluorescent 
partner would display low levels of fluorescence. The GFP-cbBad fusion, which had the GFP at the N-terminal also 
displayed a low level of fluorescence. This suggests that N-terminal fusions can lead to false positives since Bad is 
insoluble in yeast. 
 
After a library of mutants for each protein was created by error-prone PCR (epPCR), a C-
terminal GFP was fused to them by overlap extension PCR. The error rate was controlled at 2-5 
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nucleotide substitutions per gene using 0.15 mM MnCl2 concentration in the epPCR step. Initial 
attempts at creating the library first in E. coli failed since the ligation efficiency for the large 
constructs was extremely low. Therefore, DNA Assembler was used to construct the libraries, 
and the total size for both gene libraries was ~104. About 30,000 of cells in the top 0.1 percentile 
were sorted in the first enrichment (Figure 3.9A). After growth to higher cell density, plasmids 
were isolated, and transformed to DH5α. These cells were pooled and plasmid was isolated from 
them. After digestion and purification to separate the plasmid backbone from the fusion reading 
frame, it was subcloned back into the freshly prepared vector. This pooled, enriched library was 
subjected to a second enrichment, where ~300 of the top 1 percentile of cells were sorted 
individually into 96-well microtiter plates (Figure 3.9B). Re-cloning was performed to eliminate 
plasmid- and strain-borne mutations which could lead to enhanced fluorescence, and therefore 
false-positives. Flow cytometric analysis was performed on 96 individual clones from each 
library and the top ten we picked for sequencing. In both cases, all the sequenced mutants were 
identical (cbBad-BF1 and caAdhE2-AH3) (Figure 3.9C). The cbBad-BF1 mutant had five 
mutations at the nucleotide level (t126a, a648a, a914g, t1233g, t1315c), but only three were 
missense (N42K, E305G, F439L). caAdhE2-AH3 mutant was found to have a nonsense mutation 
that truncated it to one subunit only, eliminating the butanol dehydrogenase activity. Since 
caAdhE2 was truncated, it was not engineered any further. 
 
The mutant Bad was subcloned without GFP into a compatible vector (pBF1), co-transformed 
with pTHC and pT2B, and tested for n-butanol production using galactose as a carbon source 
(Figure 3.10). Since small amounts of n-butanol could be detected in the extracted supernatant, it 
was concluded that mutant Bad-BF1 was active. 
 
 
3.1.8. Directed evolution for improved soluble expression: rounds 2 and 3 (Book12 pg4-73) 
Although a soluble, functional mutant of cbBad had been identified, butanol was produced at 
very low levels (~10 mg/L) over a 16 h period. Since Bad-BF1 could not be detected by western 
blotting, it was concluded that its activity and/or expression level may still be rate-limiting. Since 
the initial attempt at engineering cbBad solubility was successful, further engineering was 
attempted. Using the same conditions as before, a library of mutants over the Bad-BF1 
background was made and enriched twice (Figure 3.11A, B). Three random mutants were picked 
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and their fluorescence profile was compared with the parent enzyme, with each showing a 
modest increased solubility (Figure 3.11C).  
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Figure 3.9 FACS/flow cytometric histograms for cbBad and caAdhE2 mutant libraries. (A) The initial library 
displayed very low overall fluorescence. (B) After enrichment, the second sort had mutants with fluorescence 
comparable to the positive control (caAdhE2Opt-GFP). (C) Screening ~100 mutants individually identified 
several highly fluorescent mutants. Sequencing revealed that the top 10 most promising mutants were 
synonymous. The mutants BF1 and AH3 have fluorescence higher than the control. 
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Figure 3.10 GC trace of extracted supernatant of HZ848 transformed with pTHC, 
pT2B, and pBF1 in HZ848. Butanol could be detected at low levels when cells were 
cultured in high density, microaerobic conditions in SC-LWU galactose medium. 
 
Since no single mutant was superior to others, all the mutants in the library were shuffled 
together to create another library [50, 51]. After one round of similar enrichment, cells were 
sorted into 96-well plates and tested individually for by flow cytometry. The three most 
promising mutants are shown in Figure 3.12A. Sequencing revealed that all three had the same 
sequence as BF1, indicating that they were all false positives. Since each round of enrichment 
was succeeded with subcloning to prevent false positives due to plasmid and strain evolution, the 
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presence of false positives was due to a different reason. Subcloning mutants from the second 
enrichment after epPCR (BA11, BE12, and BH5) into centromeric vectors revealed that BF1 was 
superior to all three (Figure 3.12B), contrary to previous results (Figure 3.11C). These results 
suggest that random copy number fluctuations of 2µ plasmids lead to false positives. Therefore, 
further engineering of Bad-BF1 was not pursued. Instead, an orthogonal strategy involving 
metabolic/genome engineering strategy was pursued in order to increase n-butanol productivity. 
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Figure 3.11 FACS/flow cytometric histograms for BF1 mutant libraries. (A) The initial library displayed low 
overall fluorescence compared to the parent. (B) After enrichment, the second sort had mutants with fluorescence 
comparable to the positive control (BF1-GFP). (C) Screening 3 random mutants individually suggested that the 
increase in solubility was modest. 
 
Most promising mutants after shuff ling
GFP-A
Co
un
t
100 101 102 103 104
0
25
50
75
100
Comparing best mutants in CEN plasmid
GFP-A
Co
u
n
t
100 101 102 103 104
0
37
74
110
147
BF1-GFP
Mutant 1
Mutant 2
Mutant 3
BH5-GFP
BA11-GFP
BE12-GFP
BF1-GFP
empty
A) B)
 
Figure 3.12 Flow cytometric histograms for BF1 mutants. (A) After shuffling all the mutants from the 
second enrichment, three random mutants were analyzed for their fluorescence. They show marked 
increased fluorescence compared to the parent BF1 and the mutants from the previous library (BA11, 
BE12, and BH5) (B) After subcloning BA11, BE12, and BH5 mutants into a CEN (single-copy) 
plasmid, their fluorescence was lower that the parent BF1, indicating they were all false positives. 
 
3.1.9. Improving n-butanol productivity by ethanol reduction  (Book9 pg18-21) 
Although the described strain possessed all the genes required for the production of n-butanol, it 
was produced at very low levels. In order to increase the n-butanol titer, metabolic fluxes would 
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have to be diverted toward n-butanol. In addition, it was able to produce n-butanol only when 
grown in galactose, and was unable to do so in glucose. Therefore, the differences in glucose and 
galactose metabolism may provide clues for metabolic engineering strategies.  
 
Ethanol production is a hallmark of S. cerevisiae growth in glucose. Even in the presence of 
oxygen, this yeast has been known to produce ethanol, a fermentation product, due to the 
Crabtree effect [52]. This phenomenon does not occur when grown in galactose as yeast is 
unable to ferment this sugar. Therefore, it is reasonable to assume that production of ethanol may 
be diverting the carbon flux away from n-butanol. In order to correct this, the pathway 
responsible for ethanol production during growth in glucose was inactivated. Deletion of adh1 
was performed as described elsewhere [53]. Briefly, a PCR product was prepared with primers 
encoding 50 bp homologies to sequences upstream and downstream of the adh1 locus. After gel 
purification, ~200 ng of the linear DNA was electroporated into competent YSG50. Cells were 
recovered for 4 h at 30 ºC in a shaker and selected on G418 (200 mg/L) YPAD plates. Individual 
colonies were tested for gene replacement by diagnostic PCR using genomic DNA as template. 
Cells with inactivated adh1 displayed significantly decreased growth rates on glucose due to 
build-up of toxic acetaldehyde (Figure 3.14) [54]. Transformation of the adh1::kanMX strain 
(HZ1119) with pTHC, pT2B, and pBF1 yielded strain HZ1773. This strain was able to produce 
n-butanol using glucose as the sole carbon source (Figure 3.13), confirming that flux to ethanol 
diverted carbon away from n-butanol. The final n-butanol titer obtained was ~10-20 mg/L over 
16 h from OD ~10 cells. 
 
3.1.10. Further attempts to decrease ethanol production (Book11 pg80-95) 
Deletion of adh1 enabled n-butanol production from glucose. However, adh1 is not the only 
enzyme responsible for ethanol production in yeast [55, 56]. Indeed, the GC-trace displays a 
major ethanol peak, even in the absence of Adh1 activity (Figure 3.13). Even a small amount of 
ethanol is undesirable since it is a dead-end product that will not be re-assimilated in the 
presence of glucose [57]. 
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Figure 3.13 GC trace of the supernatant from HZ1773 (pTHC, pT2B, and pBF1 in HZ1119). n-
Butanol could be detected at low levels when cells were cultured in high density, microaerobic 
conditions in SC-LWU glucose medium. Significant peaks of ethanol and acetaldehyde can also been 
seen in the trace. 
 
Search of the yeast genome database identified seven different alcohol dehydrogenase enzymes 
(adh1-adh7) that are able to reduce acetaldehyde to ethanol. Although adh1 is the primary 
enzyme responsible for ethanol biosynthesis under fermentative growth, in its absence the role of 
the other six enzymes may be more dominant. Among these, Adh2 expression is repressed in the 
presence of glucose [58], and it was deemed unnecessary to delete the gene encoding for it 
(adh2). Indeed, the physiological role of Adh2 is in the assimilation of ethanol, and has kinetic 
characteristics that favor oxidation of ethanol to acetaldehyde, rather than vice versa [57]. The 
physiological roles of Adh4 through Adh7 are poorly defined, and could play a role in diverting 
the acetaldehyde pool to ethanol [55, 56]. Therefore, deletion of six genes (adh1, adh3-7) using 
MIRAGE (Mutagenic inverted repeat assisted genome engineering Chapter 4, [59]) was 
attempted to decrease ethanol productivity. However, it was found that deletion of multiple 
genes decreased growth rate and maximum cell density (Figure 3.14), but did not contribute to 
producing n-butanol. Therefore, this avenue was not pursued further. 
 
 
3.1.11. Anoxic cofactor oxidation (Book16 pg2-11) 
GC-MS analysis of all metabolites present in the supernatant of HZ1713 illustrates the presence 
of large amounts of byproducts, including ethanol, acetaldehyde, and glycerol (Figure 3.15). 
Acetaldehyde formation is a byproduct of adh1 deletion, and attempts to decrease ethanol 
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concentration further did not yield any positive results. Glycerol is another major byproduct 
during fermentative growth, which is produced as a requirement for NADH re-oxidation. Indeed, 
it has been shown that reduction of glyceraldehyde-3-phosphate (GA3P) to glycerol-3-phosphae 
(G3P) with the concomitant re-oxidation of NADH to NAD+ is essential for anoxic growth [60, 
61]. Since ethanol production during anaerobic conditions is redox neutral when coupled with 
glycolysis, any additional requirements for NADH oxidation is provided by GPD (G3P 
dehydrogenase) activity. The availability of NADH, and subsequently glycerol formation, is 
affected significantly by the nitrogen source [62]. 
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Figure 3.14 Effect of sequential alcohol dehydrogenase deletions on doubling time and maximum cell density of 
yeast. Deletion of adh6 and adh7 has a significant effect on growth rates. Additional deletion of adh4 and adh5 did 
not alter doubling time further. Deletion of adh1 significantly affects doubling time as well as total cell density. 
 
n-Butanol biosynthesis consumes four NADH molecules to produce one n-butanol molecule. 
This large requirement for NADH could possibly be competing with the GA3P oxidation 
reaction. Inactivation of the genes responsible glycerol formation (gpd1 and gpd2) should 
eliminate a major competition for NADH. Sequential inactivation of both genes was performed 
using MIRAGE and the resultant strain (HZ1813) was unable to re-oxidize NADH under 
anaerobiosis. Presence of an NAD+ producing pathway has been shown to restore anaerobic 
growth in such a background [63]. Therefore, HZ1813 was transformed with the n-butanol 
biosynthetic pathway and tested for n-butanol production under strict anaerobic conditions. 
Initial attempts at growing cells in selective medium (SC-LWU) were unsuccessful as no growth 
could be detected over a period of 10 days. Subsequent attempts were made in complex, rich 
medium (YPAD). Since the n-butanol biosynthetic pathway is required for growth, it would be 
reasonable to assume that the three plasmids would be fairly stable without direct selection. 
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However, in order to ensure that retention of the full pathway may be favored, and that loss 
would not occur due to instability between various plasmids carrying the same replication origin, 
the entire n-butanol pathway was subcloned into a single plasmid using DNA Assembler by Dr. 
Zengyi Shao to give p416FuBu2 (Figure 3.16). In YPAD, after a long lag phase, the strain 
carrying the n-butanol biosynthetic pathway (HZ1814) was able to grow anaerobically, whereas 
the strain carrying an empty plasmid (HZ1818) was unable to grow (Figure 3.17). However, no 
n-butanol could be detected in the supernatant of HZ1814. This could be because of several 
possible reasons: 1) since YPAD is a complex medium, it could have compounds that can be 
reduced to regenerate NADH and rescue growth. This however does not explain the differences 
between HZ1814 and HZ1818, indicating that components of YPAD alone are unable to restore 
growth. 2) Glycerol formation re-oxidizes two NADH molecules, whereas the n-butanol 
biosynthesis oxidizes four equivalents. Therefore, only part of the biosynthetic pathway is truly 
required to rescue growth, and the accumulation of an intermediate may not be sufficient to drive 
the reaction forward. Alternatively, re-oxidation of the additional two NADH molecules may be 
unavailable during fermentative growth. 3) The pool of acetyl-coA, rather than NADH, may be 
limiting the formation of n-butanol. 4) The high reversibility of the n-butanol biosynthetic 
reactions, combined with the low expression level of the enzymes may be unable to drive the 
production of n-butanol. To test the last three hypotheses, further metabolic and genome 
engineering work was performed. 
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Figure 3.15 Metabolite profile of the supernatant from HZ1713 as determined by GC-MS. 
The peak for n-butanol is very small compared to acetaldehyde, ethanol, and glycerol. 
73 
 
3.1.12. Increasing precursors’ availability (Book17 pg11-41) 
If the availability of precursors, acetyl-coA and NADH, is limiting the production of n-butanol, 
overexpression of enzymes that are involved in their biosynthesis may enable higher-level 
production of n-butanol. There have been several strategies described in literature to increase 
pools of both these precursors and can be summarized in Figure 3.18. Acetyl-coA levels can be 
increased by (1) overexpressing a pathway that resembles the endogenous route, which includes 
yeast’s pyruvate decarboxylase (Pdc1) and aldehyde dehydrogenase (Ald6) [64], and the 
Salmonella enterica inhibition insensitive acetyl-coA synthetase mutant (Acs* or Acs-L461P). 
(2) Expression of heterologous Arabidopsis thaliana ATP-dependent citrate lyase (AclAB), 
which uses citrate from the Krebs cycle, ATP, and free CoASH to form acetyl-coA and 
oxaloacetate [65]. (3) The E. coli pyruvate-formate lyase (PflAB), which directly converts  
pyruvate and free CoASH to acetyl-coA and formate in a disproportionation reaction [66]. 
Similarly, NADH pools can be increased by (1) expressing yeast’s formate dehydrogenase 
(Fdh1), which produces NADH and CO2 as products from formate and NAD+ [67]. (2) A soluble 
transhydrogenase (Sth) from Azotobacter vinelandii that catalyzes the interconversion between 
NADH and NADPH [68, 69]. All the genes for the above strategies were first cloned 
individually (Figure 3.19A-D) and tested for their ability to increase n-butanol production in 
HZ1119 background. All the genes were cloned by Dr. Hua Zhao, Dr. Zengyi Shao, Dr. Tyler 
W. Johannes, Dr. Ryan P. Sullivan, and Dr. Tae-Hee Lee. Unfortunately, none of the 
overexpression strategies yielded any significantly increased n-butanol production. 
Subsequently, the genes were subcloned into p423pflAB, p424FSB2, and p425AAA1 in order to 
test if combined overexpression would have any synergistic effect in increasing n-butanol 
production (Figure 3.19B, E, F). Pdc1 was omitted from these constructs as acetaldehyde levels 
were significant already in the adh1 background. However, no transformants could ever be 
obtained for the four plasmid system (p416FuBu2,p423pflAB, p424FSB2, and p425AAA1) 
indicating that the combination of all proteins was toxic to yeast. Based on the individual 
overexpression experiments, it was concluded that neither the concentration of acetyl-coA, nor 
NADH were limiting the n-butanol production. Therefore other avenues to increase the butanol 
productivity were pursued. 
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cbBad-BF1 11449...12855
TDH3p 10794...11448
HXT7t 10394...10793
tdTER 9200...10393
caBdhB 13756...14928
PYK1t 14929...15328
Delta2 15329...15493
PMB1 15795...16735
bla 16738...17595
CEN 17737...17855
ARS\H4 17868...18241
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Figure 3.16 Vector map of a centromeric plasmids (single copy) carrying the entire 6-step n-butanol 
biosynthetic pathway. The transcription of each gene is driven by a different constitutive promoter. 
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Figure 3.17 Growth rescue of a strain deficient in glycerol production under anaerobic conditions 
in complex YPAD medium by the n-butanol biosynthetic pathway (HZ1814). The parent strain 
(HZ1813) carrying an empty plasmid was unable to grow under the same conditions (HZ1818). 
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Figure 3.18 Metabolic engineering strategies implemented to increase acetyl-coA and NADH pools in HZ1119. 
Acetyl-coA levels can be increased by overexpressing (1) a pathway that resembles the endogenous acetyl-coA 
biosynthetic route (pdc1 – yeast pyruvate decarboxylase, ald6 – yeast aldehyde dehydrogenase, and acs* - 
Salmonella enterica acetyl-coA synthetase mutant L461P), (2) heterologous Arabidopsis thaliana ATP-dependent 
citrate lyase (aclAB), or (3) E. coli pyruvate-formate lyase (pflAB). Similarly NADH levels can be increased by 
overexpression of (1) yeast formate dehydrogenase (fdh1) or (2) Azotobacter vinelandii transhydrogenase (sth). 
 
3.1.13. Energetics and pyruvate decarboxylase bypass (Book16 pg2-18, Book17 pg44-52) 
All the major reactions leading to n-butanol, as well as the major fermentation byproducts 
derived from glucose under anaerobic conditions, can be seen in Figure 3.20. The overall 
reaction for the production of ethanol yields two ATP molecules, making butanol production 
energetically favorable for the cell (Figure 3.20B). Conversely, the overall n-butanol biosynthetic 
reactions lead to imbalances and energy loss (Figure 3.20B). Two NADH molecules are 
converted to NAD+, whereas two NADP+ molecules are reduced to NADPH. Additionally, ADP 
(adenosine diphosphate) is converted to an energetically lower molecule, AMP (adenosine 
monophosphate). These reactions have to be balanced by other mechanisms, and would lead to 
significant inefficiencies and byproducts. Resultantly, cells would preferentially produce the 
ATP-positive ethanol, rather than n-butanol. As can be see in Figure 3.20A, imbalances manifest 
due to the two reactions downstream of pyruvate leading to acetyl-coA synthesis: 1) Ald6 
utilizes NADP+ as a cofactor preferentially to NAD+, and 2) Acs1 hydrolyzes ATP to AMP and 
diphosphate (PPi), effectively consuming energy. In order to make n-butanol production 
favorable, several changes would have to be made in the genome to alter reactions leading from 
pyruvate to acetyl-coA.  
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Figure 3.19 Plasmid maps of vectors expressing genes used to increase cellular pools of acetyl-coA and NADH. (A) 
A pathway that resembles the endogenous acetyl-coA biosynthetic route (pdc – yeast pyruvate decarboxylase, ald6 – 
yeast aldehyde dehydrogenase, and acs* - Salmonella enterica acetyl-coA synthetase mutant L461P) was 
constructed by Dr. Hua Zhao and Dr. Zengyi Shao. (B) E. coli pyruvate-formate lyase (pflAB) was cloned by Dr. 
Tae-Hee Lee. (C) Yeast formate dehydrogenase (fdh1) and (D) Azotobacter vinelandii transhydrogenase (sth) were 
cloned by Dr. Ryan P. Sullivan. (E, F) Combined overexpression plasmids were cloned without assistance. The 
vector map for the AclAB plasmid is unavailable as it was constructed by Dr. Tyler W. Johannes. 
 
Figure 3.20C illustrates the ideal overall reaction for butanol biosynthesis where ATP production 
would be concomitant and no cofactor imbalances would result. In order to realize this reaction, 
both Ald6 and Acs1 reactions would have to be replaced with alternatives that do not utilize ATP 
or NADP+. Inactivation of Pdc1 has been shown to be compensated for Pdc5 and to some degree 
Pdc6 [70]. An alternative to deleting all three is to inactivate their transcriptional activator, Pdc2 
[71, 72], which was performed using MIRAGE in strain HZ1959 to give HZ1980. Unfortunately, 
inactivation of Pdc activity renders yeast unable to produce cytosolic acetyl-coA required for 
growth under aerobic and anaerobic conditions when grown on hexoses. However, they are still 
able to use ethanol as a carbon source since growth on it does not require Pdc activity for 
cytosolic acetyl-coA synthesis.  To rescue growth in glucose, a supplemental cytosolic acetyl-
coA synthesizing enzyme would be required that is both cofactor neutral and ATP-independent. 
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Many bacteria, including E. coli have an enzyme complex called pyruvate-formate lyase that 
catalyzes this very reaction under anaerobic conditions. The enzyme catalyzes a 
disproportionation reaction that directly converts pyruvate and free CoASH to acetyl-coA and 
formate. Subsequent oxidation of formate to carbon dioxide by an NADH-dependent enzyme 
would make the overall reaction energetically favorable and redox neutral (Figure 3.20D). For 
functional expression in yeast pyruvate-formate lyase requires the expression of two subunits – 
PlfA (activation domain) and PflA (catalytic domain) [66]. Unfortunately, the active form of 
PflB contains a glycyl radical, which is oxygen sensitive, and therefore requires anaerobic 
conditions to function [73, 74]. Therefore, PflAB can rescue growth on glucose only under 
anoxic or oxygen-limited conditions. For aerobic growth on glucose, an alternative route would 
be required. The ATP-dependent citrate lyase (AclAB) has been shown to produce cytosolic 
acetyl-coA from mitochondrial citrate [65]. Since citrate is produced only during aerobic growth, 
AclAB would be able to fulfill the requirement for acetyl-coA synthesis on hexoses (Figure 
3.20D). Indeed, tests revealed that constitutive expression of AclAB was able to rescue cell 
growth on glucose and galactose. Because this route is not cofactor neutral or ATP producing, it 
would not be suitable for n-butanol biosynthesis. Therefore, n-butanol production would have to 
be biphasic – with aerobic growth used to increase biomass, and anaerobic conditions used to 
produce n-butanol. A glycerol and ethanol producing deficient mutant was used as background 
so all NADH would be oxidized by n-butanol biosynthesis, and maximize the carbon yield from 
glucose. This required no-growth conditions under anaerobic conditions, and is fulfilled by the 
inability to produce glycerol. HZ1980 transformed with p416FuBu2, p423aclAB, p425pflAB, 
and p424fdh1 was tested for the ability to produce n-butanol in high density microaerobic 
cultures. However, no butanol could be detected. This indicated that either PflAB enzyme was 
inactive, or the n-butanol biosynthetic pathway was rate-limiting.  
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Figure 3.20 (A) Cytoplasmic reactions during anaerobic growth lead to the production of ethanol and glycerol. 
Branching reactions leading to n-butanol biosynthesis are also included. The stoichiometry of the metabolites (red) 
and primary genes encoding the enzymes that catalyze the reaction are included (blue). (B) Using the cytoplasmic 
reactions, overall reactions can be determined for ethanol and n-butanol. Ethanol production is balanced and 
energetically favorable, whereas n-butanol biosynthesis is energetically unfavorable and imbalanced in cofactor 
regeneration (purple). (C) The ideal overall reaction for n-butanol would produce ATP and have no co-factor 
imbalances. (D) Implementation of the reaction from (C) required replacement of Pdc activity with PflAB for 
anaerobic environments, and AclAB for aerobic growth.  
 
3.1.14. Codon optimization of thiolase and hydroxybutyryl-coA dehydrogenase 
Experimental results suggest that the precursors, acetyl-coA and NADH were probably not 
limiting the n-butanol production. Therefore, the focus was shifted to optimizing the flux through 
n-butanol biosynthetic genes themselves. Previous western blotting results from Dr. Zengyi Shao 
suggested that among all the genes involved in butanol biosynthesis, the C. acetobutylicum 
thiolase (caThl) and C. acetobutylicum hydroxybutyryl-coA dehydrogenase (caHbd) were 
expressed at the lowest levels among all the genes identified as functional in yeast. Although the 
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expression level of tdTer was never tested by western blotting, flow cytometry data of its fusion 
with GFP suggested that its expression level was adequately high. In addition, the enzyme was 
shown to be highly active [75]. The mutant Bad-BF1 could also be rate-limiting, however, 
attempts to codon optimize the equivalent caAdhE2 failed, and cbBad had already been 
engineered for higher expression level. Therefore, caThl and caHbd were chosen as targets for 
codon-optimization as determined by DNA2.0 software, and are listed in Appendix C. 
Subsequent total gene synthesis was performed by DNA2.0. Dr. Tae-Hee Lee cloned both genes 
with N- or C- terminal His-tags and tested their expression levels in yeast. While the total protein 
production level was noticeably higher for both proteins, most of the detectable protein was in 
the insoluble fraction. This suggested that although the translation efficiency had improved by 
codon optimization, the folding efficiency was poor for both the proteins. Replacing both wt 
genes in p416FuBu2 with the codon-optimized counterparts gave the plasmid p416FuBuOpt1. 
After transformation of this plasmid into the HZ1119 background and testing for n-butanol 
production, results indicated that the codon-optimization did not improve the flux through the n-
butanol biosynthetic pathway sufficiently to increase final n-butanol titer. 
 
3.1.15. Multi-copy integration of Bad-BF1 mutant (Book17 pg44-52) 
Using LC-MS and a solid-phase extraction technique [76], Dr. Tae-Hee Lee developed a method 
to determine the concentration of most of the CoA metabolites involved in n-butanol 
biosynthesis. Among all the metabolites in HZ2103, acetyl-coA concentration was determined to 
be the highest, confirming the assumption that its concentration was not limiting the n-butanol 
production. Acetoacetyl-coA was undetectable under any conditions, and therefore it was not 
possible to determine if it builts up to any significant concentrations. Hydroxybutyryl-coA and 
crotonyl-coA concentrations were extremely low, indicating that Crt and Ter activities were 
sufficiently high. A significant peak for butyryl-coA was also seen in the samples, suggesting 
that Bad activity may be rate-limiting (Table 3.4). Although evolutionary engineering was used 
to enable Bad for functional expression in yeast, further attempts to improve expression level 
failed. An alternative strategy to increase expression level is to use a strain harboring multiple 
copies of the gene. Indeed, multicopy, δ-site based integration methods have been shown to 
successfully increase protein expression levels in yeast [77-82]. Using the method developed by 
the Da Silva laboratory [78], ~23 µg of linearized DNA consisting of the Bad-BF1 promoter-
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gene-terminator construct, the neomycin-selection marker, and two δ-sites was transformed into 
HZ1980. After recovery, transformants were selected on rich ethanol plates supplemented with 
very high concentration of G418 (5 g/L). Ten largest cfu (spell out its full name) were picked and 
their genomic DNAs were isolated to determine the copy number of integration. Two different 
concentrations of template (1x and 10x) were used to determine the copy number and the 
average between the two was used ( 
Figure 3.21). Since one copy of TDH3p naturally occurs in the chromosome, it should always be 
present at a copy number one larger than Bad-BF1. And although the differences in the 
determined copy numbers were not exactly one in most cases, TDH3p was usually more 
abundant than Bad-BF1. Two clones, #4 and #7 (Figure 3.21) were picked for further study as 
they had the highest average copy number (120 and 105, respectively). After transformation with 
p416FuBu2, p423aclAB, p425pflAB, and p424fdh1 to give HZ2145 and HZ2146, high density 
cultures were tested for the ability to produce butanol under microaerobic conditions in SC-
LWUH glucose medium. However, no n-butanol could be detected in either sample. Low density 
cells were also tested for the ability to produce n-butanol under strict anaerobic conditions since 
PflAB in known to be oxygen-sensitive. However, results were negative in this case as well. 
These results seem to indicate that PflAB was inactive in yeast, even though it has been shown to 
be functionally expressed heterologously [66]. In order to determine if δ-integrated Bad 
increased flux to butanol, a strain capable of producing acetyl-coA under anaerobic conditions 
would have to be created. 
 
Table 3.4 Intracellular concentration of the most abundant CoAs in 
HZ2103 cells grown in glucose. Data provided by Dr. Tae-Hee Lee. 
 
CoA Concentration   
0.63 mM/200 OD cells 10 mg/g cells Acetyl-CoA   
0.56 mM/400 OD cells 4.5 mg/g cells 
0.17 mM/200 OD cells 3 mg/g cells Butyryl-CoA 
0.19 mM/400 OD cells 1.6 mg/g cells 
 
3.3. Conclusions 
n-Butanol has several favorable properties that make it a superior biofuel when compared to 
ethanol. However, biosynthesis of n-butanol is hindered by the fact that natural producers are 
difficult to culture and engineer. Clostridia acetobutylicum and Clostridia beijerinckii are the 
most well studied n-butanol producers that are obligate anaerobes with slow growth rates and 
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complex, sporulating lifecycles. In fact, it has been suggested that Clostridia produce butyrate 
and acetate during exponential growth, and then convert them to n-butanol, acetone, and ethanol 
in the stationary phase when the medium is too acidic for growth [4, 5]. With limited 
understanding of their regulatory machinery, and few tools available for engineering them, future 
successes in engineering them for higher productivity may be limited. Model organisms as 
heterologous hosts for n-butanol biosynthesis provide several advantages that may enable them 
to be more productive. In particular, the absence of an innate inhibitory control mechanism that 
prevents natural hosts from overproducing n-butanol and the rich toolset available to engineer 
them makes them good candidates for industrial-scale n-butanol production. Of the two most 
well studied model organisms used for industrial-scale fuels and chemicals production, E. coli 
and S. cerevisiae (yeast) are the most popular. Between the two, yeast has several advantages 
such as higher innate resistance to phage- and bacterial contamination and tolerance to toxic 
compounds like butanol. However, yeast does not naturally produce n-butanol. The goal of this 
work was to engineer a yeast strain capable of producing n-butanol from glucose using the 
toolset available for genome and protein engineering.  
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Figure 3.21 Quantitative real-time PCR (qPCR) data to determine the number of bad-BF1 integrated into delta sites 
in HZ1980. (A) Copy numbers vary from ~60 to ~120 (blue). Gray bars represent differences between the copy 
number of Bad-BF1 and TDH3p, which should ideally be one. All copy numbers are based on the one-point 
calibration point of PGI1 gene, which has a copy number of exactly one. Error bars indicate differences in calculated 
copy number when using two different concentrations of genomic DNA template for qPCR reactions. (B) 
Representative data from qPCR shown that amplified dsDNA from larger copy number template appears quicker. 
Therefore, copy number of TDH3p is larger than Bad-BF1, which is turn is significantly larger than that of PGI1. 
n.d. is not determined. 
 
Using genome engineering tools like DNA Assembler and MIRAGE [21, 59], a n-butanol 
biosynthetic pathway was constructed in yeast and engineered to divert carbon flux away from 
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ethanol biosynthesis. In addition, protein engineering via directed evolution was used to engineer 
a functional enzyme (butyryl-coA dehydrogenase, Bad) capable of functionally expressing in 
yeast. The combination of the resulting strain from genome engineering and the enzyme from 
protein engineering enabled the creation of yeast that attained the goal of producing n-butanol 
from glucose. The strains HZ1773 and HZ2103 are capable of producing n-butanol at ~10-20 
mg/L over the period of 16 h under oxygen-limited conditions. Although several additional 
attempts to increase the productivity were attempted, none of them were successful in increasing 
the n-butanol productivity any further. These included attempts to 1) increase the availability of 
precursors acetyl-coA and NADH, 2) further increase expression level of butyryl-coA 
dehydrogenase (cbBad) mutant BF1, thiolase (caThl)  and hydroxybutyryl-coA dehydrogenase 
(caHbd), and 3) make n-butanol production redox neutral and energetically favorable. 
Unfortunately, none of these attempts were successful in increasing the final butanol titer. 
 
3.4. Future Work 
Although the goal of creating a yeast strain capable of producing n-butanol from glucose was 
attained, its productivity was insufficiently high for any industrial purpose. Indeed, the maximum 
attainable productivity from Clostridial fermentations is (~18 g/L) [9], far above the 10-20 mg/L 
obtained from engineered yeast cultures. Although several attempts were made to increase the 
titer and productivity, none of them were successful. Future work would involve further attempts 
to increase the n-butanol productivity by both, protein and genome engineering. These will 
include 1) increasing expression level of Bad-BF1 by subsequent protein engineering while 
taking precautionary steps to eliminate false positives, 2) increasing expression level of butyryl-
coA dehydrogenase (cbBad) mutant BF1 in a ∆adh1 background by multi-copy δ-integration 
into the genome, and 3) confirm the inactivity of E. coli pyruvate-formate lyase (PflAB) and 
identify an alternative that can catalyze the same reaction under anoxic conditions. These three 
should independently allow the increase of butanol productivity in yeast, and enable the creation 
of a strain that can produce n-butanol at ~1 g/L quantities, and make it industrially competitive.  
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3.5. Materials and Methods 
A complete list of strains with genotypes, plasmids, and primers can be found in Appendix D and 
F. 
 
3.5.1. Chemical, media, and reagents 
Phusion DNA polymerase, restriction enzymes, T4 DNA ligase were obtained from New 
England Biolabs (Beverly, MA). GoTaq DNA polymerase was from Promega Corp. (Madison, 
WI) and DNaseI was purchased from Roche Applied Science (Indianapolis, IN). All chemicals 
and amino acids were obtained from Sigma-Aldrich (Carlsbad, CA), media components from BD 
Biosciences (San Jose, CA), except that 5-fluoroorotic acid (5FOA) was purchased from Zymo 
Research (Orange, CA) and G418 from Cellgro MediaTech (Manassas, VA). Premixed amino 
acids for selective synthetic complete (SC or CSM) dropout media were purchased from MP 
Biomedicals (Irvine, CA) or Sigma-Aldrich (Carlsbad, CA). All oligonucleotides were 
synthesized by Integrated DNA Technologies (Coralville, IA), whereas gene synthesis was 
performed by DNA2.0 (Menlo Park, CA). All DNA purification kits were obtained from Qiagen 
(Valencia, CA), except Wizard Genomic DNA purification kit, which was purchased from 
Promega Corp. All media was made using double deionized water (ddH2O) and 1.5% agar was 
added to make solid medium.  
 
3.5.2. Growth conditions for n-butanol production 
300 µL of cells grown to saturation in SC dropout medium (0.6% yeast nitrogen base without 
amino acids or ammonium sulfate, 0.12% SC dropout, 0.05% adenine hemisulfate, and 2% 
carbon source) was used to inoculate a 40 mL fresh culture. After growing for 2 days, or till they 
reached saturation, cells were centrifuged down and washed once in sterile, ddH2O and 
resuspended in 2 mL medium or buffer. High density cultures were resuspended in SC-dropout 
glucose media or 50 mM sodium acetate at pH 5.6 with 4% glucose. The cultures were 
transferred to Bellco glass 18150 mm anaerobic tubes and covered with rubber stoppers and 
sealed with aluminum crimps. The overhead air was removed by vacuum through a syringe 
needle and replaced with sterile nitrogen to create microaerobic conditions. These were then 
cultured in a rotary shaker at 250 rpm at 30 ºC for 12-26 h before testing for n-butanol 
production. 
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Strict anaerobic cultures were performed in 125 mL anaerobic cultures flasks with 25 mL media. 
Anaerobic media was prepared by first degassing ddH2O. Autoclaved water was immediately 
transferred to a glove box (97% nitrogen, 3% hydrogen) and degassed several times before 
stirring for a week to completely remove all residual oxygen. Dry media powder was mixed with 
anaerobic water then capped, sealed, and autoclaved. Along with 100 µL of saturated cultures, 
100 µL Tween 80 and ergosterol stock was added to the flasks. This stock was made by 
dissolving 10 mg/L ergosterol and 420 mg/L Tween 80 in boiling ethanol [83-85]. Cultures were 
grown for several days at 250 rpm and 30 ºC. 
 
3.5.3. Butanol detection by gas chromatography-mass spectrometry (GC-MS) 
All samples were analyzed by Dr. Alexander Ulanov at the Roy J. Carver Metabolomics Center 
(University of Illinois, Urbana, IL). Initially, filtered culture supernatant was injected directly for 
detection with 1 g/L n-propanol (1.25 µL/mL) as internal standard. Aqueous samples were stored 
at -20 ºC prior to analysis to minimize evaporative losses. Subsequently, to increase sensitivity 
and decrease background, samples were extracted in organic solvent prior to GC-MS analysis. 
After addition of n-propanol (internal standard) to 1 g/L (1.25 µL/mL) in the filtered sample, 250 
µL ethyl acetate was added to 750 µL of the supernatant and vortexed at maximum speed for 60 
s. Thereafter, the samples were left motionless for ~5-10 min to allow phase separation to occur. 
The top phase was organic and contained the propanol and n-butanol. 100 µL of the organic 
phase was removed, ensuring no contamination from aqueous phase, and stored at -80 ºC to 
minimize evaporative loss. 
 
Samples were analyzed on a 30 m HP-INNOWax column with 0.25 mm I.D. and 0.25 µm film 
thickness (Agilent Inc, Palo Alto, CA, USA) with an injection port temperature and interface at 
250 ºC, and the ion source set to 230 ºC. The helium carrier gas was set at a constant flow rate of 
1 mL/min. The temperature program was 2 min isothermal heating at 90 ºC, followed by an oven 
temperature increase of 2 ºC min-1 to 100 ºC for 0 min and then 25 ºC min-1 to 260 ºC for final 5 
min. For ethyl acetate extracted samples, all the conditions were identical except the temperature 
program was 2 min isothermal heating at 90 ºC, followed by an oven temperature increase of 2 
ºC min-1 to 100 ºC for 0 min and then 25 ºC min-1 to 200 ºC. The mass spectrometer was 
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operated in positive electron impact mode (EI) at 69.9 eV ionization energy in m/z 30-500 scan 
range.  
 
The very last ethyl acetate extracts were analyzed on a 30 m ZB-Wax-Plus column with 0.32 
mm I.D. and 0.25 µm film thickness (Phenomenex, Torrance, CA, USA) with an injection port 
temperature of 250 ºC, the interface set to 250 ºC, and the ion source adjusted to 230 ºC. The 
helium carrier gas was set at a constant flow rate of 2.5 ml min-1. The temperature program was 5 
min isothermal heating at 90 ºC. The mass spectrometer was operated in positive electron impact 
mode (EI) at 69.9 eV ionization energy in m/z 30-500 scan range.  
 
Samples (1µL) were injected in split mode (5:1) to the GC/MS system consisted of an Agilent 
7890 gas chromatograph, an Agilent 5975 mass selective detector and HP 7683B (Agilent Inc, 
Palo Alto, CA, USA) autosampler.  
 
The spectra of all chromatogram peaks evaluated using the HP Chemstation (Agilent, Palo Alto, 
CA, USA) program. Identification was performed using the mass spectra obtained from the 
authentic standards and additionally confirmed with NIST08 and W8N08 libraries (John Wiley & 
Sons, Inc., USA). 
 
3.5.4. Polymerase chain reaction (PCR) 
For mutagenesis cassette preparation or gene amplification, reactions were performed in a total 
volume of 200 µl and contained 1x HF buffer, 0.5 µM of each of forward and reverse primers, 
0.2 mM each dNTP, 1 U Phusion DNA polymerase and 10-20 ng plasmid template. For 
verification, 25 µl and contained 1x GoTaq polymerase buffer supplemented with 1.5 mM Mg2+, 
0.5 µM of each of forward and reverse primers, 0.2 mM each dNTP, 1 U GoTaq DNA 
polymerase. Genomic DNA was used as a template, and 0.25 µl was added to the PCR reaction. 
An MJ Research PTC200 (Bio-Rad, Hercules, CA) was used to perform thermal cycling. A 
typical PCR amplification using GoTaq consisted of an initial denaturation step of 3.5 min at 94 
ºC, followed by 19 cycles of 45 s of denaturation at 94 ºC, annealing for 30 s at 55 ºC, and 
extension for 60 s at 72 ºC, and then a final elongation step of 5 min at 72 ºC. When using 
Phusion DNA polymerase, initial denaturation step at 98 ºC for 30 s was followed by 19 cycles 
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of 10 s denaturation at 98 ºC, annealing for 10 s at 55 ºC, and extension for 20 s at 72 ºC, and a 
final elongation step also at 72 ºC for 5 min. Exact parameters varied depending on gene size, 
GC-content, and primer melting temperatures. All PCR products were purified using a QIAquick 
PCR or gel purification kit and stored at –20 ºC. 
 
3.5.5. Gene reconstruction 
Codon optimized caAdhE2 was re-constructed from 64 individual single stranded 
oligonucleotides using PCR. The oligos were designed to be 60 nt long with 20 nt overlap with 
adjacent strands. They were designed to be in alternating forward and reverse orientation. Each 
oligonucleotide was added to a final concentration of 0.25 µM to the reaction mix. 100 cycles in 
thermocycler with 20 s extension was used to ensure assembly of all oligos. This assembled 
product was subsequently used as template for amplification of the entire gene using the first and 
last oligos. Using the DNA Assembler the codon optimized AdhE2 (caAdhE2-coSc) was cloned 
into pRS426 along with GPDp/TDH3p and ADH2t. After sequencing five full-length clones, the 
one with the fewest mutations was chosen and the mutations were corrected by splicing overlap 
extension PCR. After cloning these back into plasmids, several clones were sequenced again in 
order to find a mutation-free clone. 
 
3.5.6. DNA sequencing 
All DNA samples were submitted for sequencing to the Biotechnology Center Core DNA 
Sequencing Laboratory at the University of Illinois at Urbana-Champaign (Urbana, IL). 
Sequencing reactions were performed as per their instructions. 
 
3.5.7. Plasmid construction 
All expression plasmids were constructed using DNA Assembler [21]. Briefly, fragments were 
amplified with primers that had ~30-40 bp sequence identity to the adjacent fragments. They 
were co-transformed into yeast (HZ848, YSG50, or W303a) along with linearized vector by 
heat-shock and selected on appropriate medium (SC-U, SC-W, SC-L, or SC-H). Single colonies 
were picked from plates, grown in selective liquid medium, and used to isolate plasmids, which 
were subsequently transformed in E. coli DH5α and selected on LB+Amp (100 mg/L) plates. 
Plasmids isolated from E. coli cultures were first analyzed by their digestion patterns to ensure 
all fragments were assembled, and then subsequently by DNA sequencing. For assembly of 
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p416FuBu2 and p416FuBuOpt1, each promoter-gene-terminator was spliced to the adjacent 
promoter and terminator in order to increase the homology between fragments to >200 bp. After 
combining all the fragments with linearized vector, they were ethanol precipitated and 
resuspended in < 5 µL sterile, ddH2O. These were electroporated into HZ848 and selected on 
SC-U plates. Subsequent steps were similar to other plasmid constructs. 
 
3.5.8. Gene inactivation 
All genes were inactivated using MIRAGE [59]. Briefly, ura3 selection marker was PCR 
amplified from pRS406 with the appropriate 45 bp flanking homologies in T and N regions and 
25 bp in t’. The two halves of the inverted repeat (IR) construct were digested by either EcoRI or 
MfeI and ligated together overnight at 16 ºC. After re-digestion with the same two enzymes to 
remove palindromes and gel purification to isolate the mutagenesis cassette, ~200-500 ng was 
transformed into competent yeast cells using heat shock. Transformants were recovered in YPA 
medium with appropriate carbon source in a shaker at 30 ºC overnight. The next day, cells were 
washed twice in ddH2O and spread equally on 2-3 SC-U plates with the same carbon source. 
Single colonies were picked and re-streaked on fresh SC-U plates, after which they were scraped 
off and resuspended in ~50 µL sterile, ddH2O. After incubation at room temperature for ~4 h to 
deplete the intracellular medium and then spread on SC+FOA plates. The only exception to this 
was deletion of adh1, which was performed using the KanMX marker [53]. The KanMX4 
marker flanked by sequences up- and downstream of adh1 was amplified from pFA6a-KanMX4. 
After ethanol precipitation, the DNA was electroporated into YSG50 and recovered for 4 h and 
plated on YPAD plates supplemented with 200 mg/L G418. Genomic DNA was isolated from 
single colony and tested for gene deletion by diagnostic PCR. Deletion of gpd1 and gpd2 was 
performed on glucose, adh1 was performed on galactose, and pdc2 was deleted on ethanol 
medium. 
 
3.5.9. Library construction and screening 
Error-prone PCR library inserts were created using 0.15 mM Mn2+ and GoTaq polymerase with 
10 ng plasmid (pRS426-cbBad) DNA as template, as per standard protocols. GFP was amplified 
by standard protocols using Phusion DNA polymerase using pGAD424-EGFP and spliced 
together thereafter with the Bad library. Equimolar ratio of each fragment was mixed in a 20 µL 
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mix and amplified without primers using a slightly modified Phusion polymerase PCR reaction, 
with only 9 cycles of amplification to yield full-length genes. The remaining conditions were 
maintained as for any other PCR reaction. Amplicons (2 µL) were used as template for further 
amplification using long end-primers that shared homology with GPDp/TDH3p and CYC1t and 
then gel purified.  The plasmid, pRS426-GFP-cbBad was digested with KpnI and SacI to remove 
the insert leaving behind the GPDp/TDH3p and CYC1t in the vector, and gel purified. The 
vector and insert was co-transformed into W303a either by electroporation or heat shock. Library 
sizes were determined by plating a small aliquot (0.5 %) of the transformants on SC-U plates. 
After growing cells in SC-U liquid media for two days and then inoculated into a fresh culture 
and grown for one day before sorting. pRS426-GFP and pRS426-cbBad were used as controls to 
find upper and lower limits of fluorescence. For the first round of enrichment, about 30,000 in 
the top 0.1% were sorted, whereas for the second round, 300 in the top 1% were sorted. 
 
For the DNA shuffling library, 4.2 µg of combined mutant genes were included in a 50 µL 
reaction mix consisting of 10 mM MnCl2 and 50 mM Tris-HCl. After equilibrating the mix at 15 
ºC for 5 min, 0.3 U DNaseI was added, vortexed for mix thoroughly, and incubated at 15 ºC for 
an additional 60 s prior to heat-inactivating at 90 ºC for 10 min. 100 bp fragments were purified 
on a 2 % agarose gel and extracted using QIAEXII kit and then reassembled using PCR in 50 
cycles. After re-amplification, the full-length genes were used to construct libraries using DNA 
Assembly with GPDp/TDH3p, GFP and CYC1t. About 30,000 in the top 0.1% were sorted 
during enrichment using FACS. 
 
3.5.10. Heat-shock transformation and electroporation  
Yeast cells were grown in YPA medium (1% yeast extract, 2% peptone, 0.1 g/L adenine 
hemisulfate and 50 µg/mL kanamycin) supplemented with 2% of an appropriate carbon source 
(dextrose, galactose, or ethanol) for preparation of competent cells. Cells grown to stationary 
phase were used to inoculate a fresh culture (0.45 mL/15 mL media) and grown for >1 doubling 
(4 h for cells grown in glucose and 6 h for cells grown in galactose or ethanol). Cells prepared 
for heat shock were washed twice with sterile, room-temperature ddH2O and resuspended in 0.1 
M lithium acetate (LiAc). Half of the cells were pelleted and resuspended in transformation 
mixture, comprising of 240 µL 50 % (w/v) PEG 3350 (polyethylene glycol), 36 µL 1.0 M LiAc, 
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50 µL 2 mg/mL salmon-sperm ssDNA, and 34 µL of DNA (50-500 ng). After vortexing cells for 
60 s, they were incubated at 42 °C for 40-80 min (40 min for cells grown in dextrose/galactose 
and 80 min for ethanol), after which they were pelleted and spread on selective SC-dropout 
plates. 
 
3.5.11. Multi-copy integration and quantitative PCR 
Delta integration was performed using the dual δ method [78]. The TDH3p/GPDp-Bad-BF1-
TEF1t cassette was PCR amplified from p416FuBu2, digested with EcoRI and BsiWI, and 
ligated into pδ-lacZ-neo-δ vector that had also been digested with the same two enzymes to 
remove the CUP1p-LacZ insert. After verification of insert by digestion analysis and sequencing, 
~120 µg of the plasmid (pδ-BF1-neo-δ) was isolated using Qiagen Midiprep kit from a 100 mL 
cell culture. About 100 µg of plasmid was digested with 100 U of each AccI, SacII, and ApaI 
restriction enzymes for 4 h and subsequently heat inactivated. About 23 µg of the unpurified 
digestion mix was transformed into HZ1980 by heat shock and recovered overnight in 1 mL 
YPAEtOH medium. The next day, 100 µL aliquots were spread on YPAEtOH plates 
supplemented with 5 g/L G418. After 6 days of incubation at 30 °C, ten colonies were picked, 
and their genomic DNAs (gDNA) were isolated. Copy number of Bad-BF1, and TDH3p relative 
to PGI1 were determined by quantitative real-time PCR (qPCR) using the LightCycler 480 
(Roche Applied Science) according to the manufacturer’s instructions. PCR was performed in 
96-well plates and two concentrations of gDNA (1x and 10x diluted) were used to determine the 
average copy numbers. 
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Chapter 4. Tools for Genome Engineering: MIRAGE 
4.1. Introduction 
With ever mounting emphasis on creating designer organisms for efficient conversion of biomass 
to fuels, chemicals, drugs, enzymes, and therapeutic proteins, tools for engineering genomes and 
understanding regulatory networks are becoming increasingly important. In attempts to realize 
this vision of synthetic biology, several techniques have recently been described to assemble 
large genomic fragments [1-3]. Recent work by Lartigue et al has demonstrated that entire 
genomes (>1 Mb) can be transform into yeast and maintained stably episomally for several 
generations [4]. They also showed that these “recombinant genomes” can be readily modified 
using yeast genome editing techniques. While there are several techniques available to delete 
genes in yeast [5, 6], there are few efficient methods available to perform precise genomic 
modifications – such as those required to make point mutations. The advantage of methods 
enabling accurate mutagenesis is that they can be easily adapted for deletions, insertions, and 
even replacements. Apart from the classical plasmid-based pop-in/pop-out type methodology [7], 
only two other distinct strategies have been described, to our knowledge, in yeast for precise 
genomic modification using linear DNA [8, 9]. These have been improved and modified in 
subsequent works [10-13]; and while both strategies are excellent, they both suffer from certain 
disadvantages. The first strategy described by Langle-Rouault and Jacobs has a low success rate, 
with 13-45% efficiency of initial mutagenesis cassette integration and 29-35% efficiency for 
removal of said cassette [8]. Therefore, use of this method necessitates extensive screening for 
clones with the desired mutation. Delitto perfetto addresses the low efficiency issues, but adds a 
few steps in the form of replica-plating and a second transformation to remove the mutagenesis 
cassette [9].  
 
Addressing the issues of these aforementioned methods required the development of an entirely 
new technique. In order to overcome the limitations of current methods, the new technique 
should meet the following requirements – the frequency and precision of the selectable marker’s 
1) integration and, 2) removal must be high, 3) the method must be quicker than the previously 
described methods, and finally 4) it must not use helper plasmids or recombinant proteins. After 
some failed attempts at developing methods that met these requirements, MIRAGE (Mutagenic 
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Inverted Repeat Assisted Genome Engineering) was finally developed. The salient feature of this 
method is the presence of an inverted repeat (IR) of a selectable marker(s) in the mutagenesis 
cassette. After introduction into the chromosome, along with the desired mutation using yeast’s 
highly efficient homologous recombination machinery, the IR spontaneously self-excises. This 
elimination event leading to the loss of the selection marker is frequent and does not require 
growth in permissive medium. As a result, counterselection can be performed immediately after 
selection to obtain the desired chromosomal mutation. As a result, this method is precise and 
quick, allowing for fast, sequential chromosomal modifications –features particularly important 
for butanol biosynthesis (Chapter 3), which required extensive deletions. 
 
4.2. Results & Discussion 
4.2.1 Recombination in the yeast Saccharomyces cerevisiae 
Since homologous recombination in yeast is highly efficient, transformed linear DNA is readily 
incorporated into the genome by homology. This characteristic has already been exploited by 
current methods for in vivo mutagenesis [8-13] and has circumvented use of cloning and 
plasmid-based mutagenesis [7] (Figure 4.1A). In addition, it obviates the need for heterologous 
recombinases such as Flp, Cre, or ΦC31 [14, 15], the use of which would be precluded here 
anyway since they leave behind “scars” DNA sequences in the genome. Homology as low as 15-
20 bp (basepairs) have been shown to be good substrates for recombination in yeast [16, 17], 
although 30-60 bp are traditionally used, which allows PCR products to be used directly, with 
targeting sequences encoded in the primers.  
 
In spite of the efficiency of targeting the DNA by homologous recombination at the appropriate 
genomic locus, integration events are rare, and need to be selected for. Although several 
selection markers are available in yeast, such as those providing prototrophy, or resistance [18], 
the ura3 marker is by far the most popular one due to the available counterselection [19]. 
Recently, more selectable/counterselectable pairs have been devised based on similar principles 
as the ura3 system [20, 21]. 
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4.2.2 Initial attempts: single selection marker (Book8 pg46, 47, 55-66, 77-100, Book11 pg2-8) 
Figure 4.2 illustrates the first (and unsuccessful) attempt at developing a new genome 
engineering method in yeast. The mutagenic construct consisted of a selectable/counter-
selectable marker (ura3 encoding for orotidine-5'-phosphate decarboxylase) flanked by 
sequences homologous to the chromosome. The neck (N) and tail (T) sequences were identical to 
upstream and downstream, respectively, of the locus to be modified and directed the integration 
into the chromosome. A length of 45 bp was chosen for the length of N and T to ensure high 
frequency and efficiency of site-specific integration. The mutation to be introduced was encoded 
in the region between N and t’ (identical to the 5’-end of T) in the forward primer. The method 
depended on subsequent excision/deletion event between the direct repeat (DR) - t’ during 
growth in permissive conditions, leading to loss of the ura3 marker. A shorter length for t’ (20 
bp) was chosen to ensure the initial cassette integration event into the genome was using N and 
T, rather than t’ and T.  However, it was found that excision events were extremely infrequent, 
and counterselection produced spontaneous 5FOAR (5-fluoroorotic acid resistant) clones – either 
by suppressor mutations at the ura3 locus or elsewhere. Although clones that had undergone an 
excision event could have been enriched by screening for ura3 loss-of-function, an extra step 
would be in direct conflict with one of the major goals of the new method. 
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Figure 4.1 Integration of foreign DNA into the genome using homologous recombination. (A) Linear DNA 
is integrated by two-point crossover, whereas (B) circular DNA is integrated by one-point crossover. 
 
4.2.3 Inclusion of an inverted repeat (Book11 pg9-21) 
It has been previously demonstrated that deletion events between DRs is inversely correlated to 
the distance between them [22]. Very close short repeats can be deleted by replication slippage 
[23, 24]; however, recombination between distant DRs is stimulated by selective pressure such 
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as double-strand breaks (DSBs) [25, 26]. This is probably because recombination requires DR 
repeats to be brought in proximity in the act of DNA repair and in the absence of any DNA 
damage, the frequency of spontaneously juxtaposing T with t’ is extremely low. Resultantly, the 
deletion of the 1 kb region was extremely infrequent. Although frequency of recombination 
between T and t’ can be enhanced by increasing their lengths [8, 27], it would require the use of 
very long primers, making the mutagenesis process expensive, and precluding its widespread 
application. 
 
Alternatively, DSBs can be used to increase the recombination frequency between DR. Although 
DSBs are traditionally introduced using endonucleases to stimulate recombination [26, 28], in 
order to make the method more widely applicable, their use was precluded. Inverted repeats 
(IRs) or palindromes have been shown to be a source of genetic instability in bacteria and 
eukaryotes [29]. In particular, they have been shown to be hotspots of genomic rearrangements, 
caused either by replication slippage or by single-strand annealing between DR [30-34] (Figure 
4.3). The frequency of IR-mediated excision has also been shown to depend inversely on the 
distance between the two palindromic sequences [30, 35]. Encouraged by these data, use of an IR 
in the mutagenic cassette for genome engineering was considered a viable option. 
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Figure 4.2 Initial attempt at creating a genome engineering technique was 
unsuccessful. The mutagenic cassette used a single ura3 selectable/counter-selectable 
marker flanked by a 20 bp direct repeats (DR) - t’ as well as sequences homologous to 
the target locus in the chromosome (N and T, 45 bp). Symbols □ and ► denote alleles 
to be deleted and introduced, respectively. Growth in permissive conditions did not 
lead to an excision event, as was expected, leading to failure of the method. 
 
4.2.4 Design of MIRAGE (Book11 pg9-21) 
Since IR mediated rearrangements can lead to complete and precise deletion of the entire 
palindrome, the mutagenic cassette was designed as shown in Figure 4.4A. Although it keeps the 
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salient features of the first attempted method, it includes two copies of ura3 in inverted 
orientation. The outmost 45 bp in the neck (N) and tail (T) direct the integration of the 
mutagenesis cassette at the desired location by homologous recombination. The 3’-end of N 
contains a sequence identical to the 5’-end of T called t’, forming a DR. The desired mutation 
(►) is incorporated between N and t’ in the forward primer that is used for cassette preparation. 
 
Near precise excision
A) Replication slippage B) Single-strand annealing
Precise excision
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strand
Leading
strand
Leading 
strand
Double strand 
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Figure 4.3 Possible mechanism of IR mediated excision between DR. (A) Replication slippage is 
dependent of DNA polymerase fidelity whereas (B) single-strand annealing requires the action of 
a hairpin endonuclease, as well as SSA repair machinery. Both events could possibly lead to 
precise or near-precise excision of the region between the short DRs. The lagging strand is 
replicated normally, whereas the formation of hairpin in the leading strand leads to IR excision. 
 
Integration of the mutagenesis cassette in the chromosome is therefore accompanied by deletion 
of the undesired allele. Due to its inherent instability in genomic DNA, the IR catalyzes 
spontaneous self-excision between the DR, resulting in a one-step precise modification of the 
genome. Since the IR cannot be amplified directly by PCR, each half has to be amplified 
independently and then ligated to form the mutagenesis cassette (Figure 4.4B, C). Each half 
consisting of ura3 (along with its promoter and terminator) is flanked by N, ► and t’ or T as 
well as either EcoRI or MfeI restriction sites. Since EcoRI and MfeI form compatible cohesive 
ends after digestion, ligation of the two halves results in abolishment of both restriction sites thus 
enabling purification of the mutagenesis cassette from self-ligation products (palindromes). This 
~2.2 kb mutagenesis cassette was then transformed directly into yeast and selected for uracil 
prototrophy on Uracil dropout plates. After 3-4 days of incubation at 30 °C, colonies grown to ~3 
mm in diameter were scraped and resuspended in water. After incubation for 3-4 hrs at room 
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temperature to ensure complete depletion of uracil dropout media within cells, they were 
immediately selected for uracil auxotrophy on 5FOA plates. Since the self-excision of the IR 
occurs at frequencies much higher than point mutations, auxotrophs appeared only upon deletion 
of the IR within the DR. 
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Figure 4.4 Features of one-step genome modification using MIRAGE. (A) 45 bp flanking ends of neck (N) and 
tail (T) target the mutagenesis cassette into the yeast chromosome (gDNA), simultaneously replacing the 
undesired allele (€) with the desired mutation (►). The ura3-IR confers transformants with uracil prototrophy. 
Spontaneous and precise excision of the IR occurs within the DR (t’), leaving behind only the desired mutation. 
Since the mechanism of MIRAGE excision is not known, the IR is drawn with hyphenated lines. Omitting the 
mutation in the “neck” primer will lead to deletion, rather than replacement. (B) Creation of the mutagenesis 
cassette requires preparation of each ura3 fragment separately. After PCR amplification and digestion with 
EcoRI and MfeI, the two halves are ligated together. Ligation of compatible EcoRI and MfeI ends abolishes 
both restriction sites. Re-digestion with EcoRI and MfeI, followed by gel purification removes palindromic 
ligation products. (C) DNA products from each step of MIRAGE cassette preparation. M – DNA ladder; 2 – 
ura3 fragment E (1.1 kb, 3.2 µg); 3 – ura3 fragment M (1.1kb, 3.5 µg); 3 – ura3-IR fragments ligated (2.2kb, 
2.8 µg); 4 – ura3-IR re-digested (2.2kb, 1.1 µg); 5 – ura3-IR re-digested and gel purified (2.2kb, 560 ng). 
Complete removal of unligated monomers is unnecessary as they do not yield false positives. 
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4.2.5 Optimizing the direct repeat length (Book11 pg22-29) 
To optimize the integration and excision efficiency, targeted deletion of gal7 (encoding for 
galactose-1-phosphate uridyl transferase) was performed in the laboratory strain HZ848 (YSG50 
∆ura3), since it is easy to verify by PCR and loss of function. The efficiency of targeted 
mutagenesis in general relies on two major factors: first, integration of the mutagenesis cassette 
precisely at the desired location in the chromosome, and second, precise removal of the selection 
marker. In this method, the efficiency of both of these events is dependent on the length of the 
DR. As illustrated in Figure 4.5, a DR can facilitate incorrect integration of the mutagenesis 
cassette. To minimize such aberrant event, a shorter DR is preferred. Conversely, the precise 
removal of the IR relies on recombination between the DR, where longer sequences are 
desirable. By varying the t’ length from 20 to 35 bp in 5 bp increments, an optimal balance was 
found with 25 bp, for initial integration and final excision efficiency (Table 4.1). 
With a longer DR, incorrect insertion of the mutagenesis cassette occurred at a higher frequency 
than the desired targeted integration. The presence of an IR within a longer DR also created an 
extremely unstable system, decreasing the growth rate in the dropout selection media. This is 
presumably because the IR is excised at very high frequency, but the exact reason for this 
phenomenon was not investigated further. At short DR lengths, aberrant excision events take 
place, likely due to near-precise excision [36] by replication slippage [30]. Precise excision of 
the mutagenesis cassette was initially verified by sequencing PCR amplified genomic locus, 
and/or later by observing the size of the PCR product. 
 
4.2.6 More deletions, point mutagenesis (Book11 pg35-79, Book15 pg2-33) 
Having optimized the design of the mutagenesis cassette using the gal7 locus, the next step was 
to demonstrate the applicability and generality of this design for in vivo mutagenesis of other loci 
in the yeast chromosome. For this, different alteration and at several distinct loci distributed over 
the entire chromosome were performed. These included deleting the trp1 gene, reverting the 
trp1-1 allele to wild-type (i.e., TAG to GAG at the 83rd codon), making silent mutations in adh4 
(ACC to ACT at the 451st codon) and adh7 (CAA to CAG at the 149th codon), and finally a 
frameshift mutation in gpd1 (GAT to C at the 391st codon). With a 25 bp DR, 50-100% of the 
colonies had correctly integrated the mutagenesis cassette into the desired location, and all their 
revertants on 5FOA precisely excised the IR (Table 4.2). As expected, results for all loci were 
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consistent with those obtained for the gal7 deletion, thus confirming the generality of MIRAGE. 
Deletion alleles were verified by ascertaining the size of PCR product with the expected size. 
Mutations alleles were verified by sequencing the region (Figure 4.9). 
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Figure 4.5 (A) Desired integration event compared to (B) the incorrect event. Incorrect integration leads to 
parental genotype, whereas correct integration results in desired mutation after IR excision. Longer DRs favors 
the undesired event, whereas shorter DRs favor imprecise IR excision (Figure 4.6, Table 4.1). 
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Figure 4.6 Deletion of gal7 using MIRAGE to optimize DR length. (A) Expected PCR product sizes for 
parental and deletion alleles are indicated. (B) Deletion of gal7 using a 25 bp DR. 1b-7b – successful 
precise deletion of gal7; 8b – negative control, parent. (C) Deletion of gal7 using a 20 bp DR. 1c, 7c – 
successful precise deletion of gal7; 2c-6c – imprecise deletion of gal7. M, DNA ladder; bp, basepairs. 
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4.2.7 Using a dual selection marker (Book11 pg67-78) 
In order to extend the generality of MIRAGE further, it was important to demonstrate its 
applicability in other common lab yeast strains. In yeast strains with non-deletion ura3 alleles 
(ura3∆0), such as ura3-1 (point mutation) or ura3-52 (insertion allele), transformation with 
ura3-IR would result in gene conversion, preferentially, of the non-functional ura3 locus due to 
the presence of large homology to the region. Although a heterologous ura3 cassette can be used 
in such a case [37], using a different selection marker design would better serve to demonstrate 
the generality of MIRAGE. For this, a dual selection mutagenesis cassette was created using 
pDIRe3 (Figure 4.8). Instead of using the ura3-IR cassette, a dual cassette consisting of ura3-
his3-IR of ~4.5 kb was used. Since it is unlikely that false positives could occur by simultaneous 
integration of ura3 and his3 at their own respective loci, colonies could appear only upon 
integration of the entire mutagenesis cassette into the chromosome. This is indeed what was 
observed, and use of this IR with a double selection marker enabled successful deletion of gal7 
in W303a as well as diploid strain INVSc1 by first selecting on medium lacking uracil and 
histidine and then counter-selecting on 5FOA (Figure 4.7). All 5FOAR clones were found to be 
His-, as expected from excision of the entire IR. Deletion was further verified by PCR and 
inability of both resultant strains to use galactose as the sole carbon-source. All results have been 
published [38]. 
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Figure 4.7 Expected PCR product sizes before and 
after integration of DIRe3 at the gal7 locus.  
Verification of gal7 replacement with either ura3-IR or 
ura3-his3-IR. M, DNA ladder; bp, basepairs.  
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Figure 4.8 Vector map of pDIRe3, the template for dual 
selection marker construction 
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Table 4.1 Effect of varying DR length on mutagenesis accuracy, based on targeted deletion of 
gal7. A shorter DR favors desired integration event, but also favors imprecise excision. 
 
DR length 
(bp) 
Success rate of  
correct integration 
Success rate of  
precise excision 
20 66% (4/6) 28% (2/7) 
25 50% (3/6) 100% (3/3) 
30 25% (1/4) 100% (3/3) 
35 < 16% (0/6) no data 
 
Table 4.2 Success rates of gene deletion and in vivo point mutagenesis experiments. Initial integration is 
not perfect due to the presence of a DR leading to improper integration (Error! Reference source not 
found.). Excision events were always observed to have precise removal of the IR within the DR. 
Mutations introduced in adh4 and adh7 were synonymous codon changes (ACC to ACT and CAA to 
CAG, respectively). In gpd1, codon 391 (GAT) was replaced with C resulting in a substitution and 
frameshift of the reading frame). The trp1-1 allele is an amber mutation at codon 83. Exact sequences of 
all sequenced mutant loci are in Figure 4.9. 
 
 Correct Integration Event Precise Excision Event 
Parental 
allele 
 
Resulting allele Success rate 
Resulting  
allele 
Success 
rate 
GAL7wt ∆gal7::ura3-IR 50% (3/6) ∆gal7 100% 
trp1-1 ∆trp1::ura3-IR 66% (4/6) ∆trp1 100% 
ADH4wt adh4 T451::ura3-IR 60% (3/5) adh4 T451T 100% 
ADH7wt adh7 Q149::ura3-IR 50% (1/2) adh7 Q149Q 100% 
GPD1wt gpd1 D391::ura3-IR 100% (1/1) gpd1D391Lfs*27 100% 
trp1-1 trp1::ura3-IR 83% (5/6) TRP1wt 100% 
 
4.3. Conclusions 
Methods enabling genomic point mutagenesis are the most versatile tools in genome engineering 
since they can be easily adapted to other modifications such as deletions, insertions, and 
replacements [11]. A prerequisite for such a method is that the selection/counterselection marker 
should not leave any scar in the chromosome. This requirement precludes the use of FLP and Cre 
recombinases that are very popular in performing chromosomal deletions. There have been two 
distinct strategies described for performing such precise mutations in yeast using PCR products. 
The first strategy embeds a selection marker within a long DR [8, 10]. The presence of the DR 
can cause the spontaneous deletion of the selection marker at low frequencies when grown in 
permissive conditions. Unfortunately, the long DR can cause aberrant integration of the 
mutagenesis cassette, and the low frequency of excision, combined with imprecise excision 
events, makes the method relatively inefficient. The other strategy based on the delitto perfetto 
method [9] addresses some issues and is very efficient at introducing point mutations with few 
false positives. However, this method required two separate transformation steps, one to delete 
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the undesired allele and a second to introduce the desired mutation, as well as a replica plating 
step, possibly to maximize efficiency [11, 12].  
GPD1(wt): ACCCAATGAAGAACCTGCCGGACATGATTGAAGAATTAGATCTACATGAAGATTAGATTTATTGGAGAAAGATAACATATCATACTTTCCCCCACTTTTTT
a: ACCCAATGAAGAACCTGCCGGACATGATTGAAGAATTAGATCTACATGAAC__TAGATTTATTGGAGAAAGATAACATATCATACTTTCCCCCACTTTTTT
b: ACCCAATGAAGAACCTGCCGGACATGATTGAAGAATTAGATCTACATGAAC__TAGATTTATTGGAGAAAGATAACATATCATACTTTCCCCCACTTTTTT
c: ACCCAATGAAGAACCTGCCGGACATGATTGAAGAATTAGATCTACATGAAC__TAGATTTATTGGAGAAAGATAACATATCATACTTTCCCCCACTTTTTT
F Primer:  ATGAAGAACCTGCCGGACATGATTGAAGAATTAGATCTACATGAAC__TAGATTTATTGGAGAAAGATAACAT…
R Primer: …TAGATTTATTGGAGAAAGATAACATATCATACTTTCCCCCACTTT
C)
ADH7(wt): CAAGGAGGCTTTGCCTCCCACGTGAGGCTTCATGAACACTTTGCTATTCAAATACCAGAAAATATTCCAAGTCCGCTAGCCGCTCCATTATTGTGTGGTG
a: CAAGGAGGCTTTGCCTCCCACGTGAGGCTTCATGAACACTTTGCTATTCAGATACCAGAAAATATTCCAAGTCCGCTAGCCGCTCCATTATTGTGTGGTG
b: CAAGGAGGCTTTGCCTCCCACGTGAGGCTTCATGAACACTTTGCTATTCAGATACCAGAAAATATTCCAAGTCCGCTAGCCGCTCCATTATTGTGTGGTG
c: CAAGGAGGCTTTGCCTCCCACGTGAGGCTTCATGAACACTTTGCTATTCAGATACCAGAAAATATTCCAAGTCCGCTAGCCGCTCCATTATTGTGTGGTG
d: CAAGGAGGCTTTGCCTCCCACGTGAGGCTTCATGAACACTTTGCTATTCAGATACCAGAAAATATTCCAAGTCCGCTAGCCGCTCCATTATTGTGTGGTG
F Primer:  AGGCTTTGCCTCCCACGTGAGGCTTCATGAACACTTTGCTATTCAGATACCAGAAAATATTCCAAGTCCGCTA…
R Primer: …ACCAGAAAATATTCCAAGTCCGCTAGCCGCTCCATTATTGTGTGG
B)
ADH4(wt): CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACCAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
a: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
b: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
c: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
d: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
e: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
f: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
g: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
h: CTGAACACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAAAA
F Primer:    CACGCCATGCATGATGCCTGCCATTTGACTAACCCAGTTCAATTCACTAAAGAACAAGTGGTTGCCATTATCA…
R Primer: …AAAGAACAAGTGGTTGCCATTATCAAGAAAGCCTATGAATATTAA…
A)
 
 
Figure 4.9 DNA sequences of chromosomal loci before and after introducing point mutations using MIRAGE. (A) 
Mutation of ACC to ACT (451st codon) in adh4. (B) Mutation of CAA to CAG (149th codon) in adh7. (C) 
Replacement of codon 391 (GAT) with C resulting in a frameshift of the gpd1 open reading frame. Sequence of 
primers used for cassette preparation is also included. 
 
This project was developed to streamline genome engineering; particularly in light with the 
requirements of butanol biosynthesis related metabolic engineering. To this end MIRAGE 
(Mutagenic Inverted Repeat Assisted Genome Engineering) has been developed that can create 
precise alterations in the chromosome in a single transformation step. In this method, the 
mutagenesis cassette is designed to have an IR of selection marker(s) embedded within a 25 bp 
DR. Flanking these are regions of homology that target the cassette to the desired site in the 
chromosome.  
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By using an IR in the mutagenesis cassette, the low excision frequency limitations of the strategy 
introduced by Langle-Rouault and Jacobs [8] have been overcome. This may be due to any 
combination of four roles the IR may play – first, it encodes the marker(s) to select/counterselect 
for the desired genotype. Second, it introduces chromosomal instability that results in its own 
excision from the chromosome at extremely high frequencies, nullifying the need for growth on 
permissive medium for expediting its loss. However, to minimize contamination from 
surrounding non-transformants, colony purification on SC-U medium may be performed without 
any adverse effect. Third, its excision from the chromosome results in a double strand break [12] 
that may create a hotspot for recombination. And fourth, it may bring the flanking DR in close 
proximity allowing for precise homologous recombination between relatively short sequences. 
Indeed, Langle-Rouault and Jacobs used DR between 50-60 basepairs (bp) to ensure homologous 
recombination (albeit with low-efficiency) between distant sequences in the chromosome [8], 
whereas in this method DR as short as 25 bp are highly proficient at recombination.  
 
Cassette preparation takes two days, due to the requirement for high efficiency overnight 
ligation. However, compared to the two-step methods like delitto perfetto, MIRAGE requires 
only a single transformation step and no replica plating, making it a quicker method, which is 
particularly useful when dealing with slow-growing mutants. Additionally, while it has been 
demonstrated with selection/counterselection based on Ura/5FOA [19], other markers such as 
Trp/FAA [20], Lys/aminoadipate [21], or any combination thereof, could also be used.  
 
MIRAGE has demonstrated that inverted repeat, an unstable genetic element, can be employed 
as a useful genetic tool to perform one-step modifications to the S. cerevisiae genome with high 
efficiency. It does not require the use of helper plasmids, making it widely applicable. Also of 
note is that yeast seemed to propagate a relatively long IR (~4.5 kb) as stably as a shorter IR 
(~2.2 kb), while actively transcribing the genes contained. This is particularly interesting in the 
light that E. coli is conferred nonviable when IR of >240 bp is introduced in the chromosome 
[39]. It would also be interesting to test whether this method can be adapted for use in other 
systems, including mammalian and bacterial cells, since DR bracketed IR should, in theory, 
induce double-strand breaks in these chromosomes upon excision. 
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4.4. Materials and Methods 
4.4.1 Strains, plasmids, and reagents 
S. cerevisiae W303a (MATa ura3-52 his3-11 ade2-1 leu2-3,112 can1-100 trp1∆2) was obtained 
from Open Biosystems (Huntsville, AL), INVSc1 (MATa his3∆1 leu2 trp1-289 ura3-52 MATα 
his3∆1 leu2 trp1-289 ura3-52) from (Invitrogen, Carlsbad, CA), and YSG50 (MATα ura3-1 
his3-11,15 ade2-1 leu2-3,112 can1-100 trp1-1) from Peter A. B. Orlean (University of Illinois, 
Urbana, IL). Phusion DNA polymerase, restriction enzymes, T4 DNA ligase, and plasmids 
pRS406, pRS403 (New England Biolabs, Beverly, MA), and pRSFDuet-1 (Novagen, Gibbstown, 
NJ) were used for mutagenesis cassette preparation. E. coli DH5α (Invitrogen, Carlsbad, CA) 
was used for plasmid propagation. All chemicals and amino acids were obtained from Sigma-
Aldrich (Carlsbad, CA), media components from BD Biosciences (San Jose, CA), and 5FOA 
from Zymo Research (Orange, CA). Yeast were grown in YPAD or YPAGal (1% yeast extract, 
2% peptone, and 2% dextrose or galactose, supplemented with 0.1 g/L adenine hemisulfate and 
50 µg/mL kanamycin), whereas competent cells were made in 2×YPAD (2% yeast extract, 4% 
peptone, and 4% dextrose supplemented with 0.2 g/L adenine hemisulfate and 50 µg/mL 
kanamycin). Selective media was synthetic complete lacking uracil (SC-Ura), synthetic complete 
lacking tryptophan (SC-Trp), synthetic complete lacking uracil and histidine (SC-Ura/His), and 
synthetic complete supplemented with 1 g/L 5-fluoroorotic acid and adjusted to pH ~3-3.5 
(SC+5FOA). All DNA purification kits were procured from Qiagen (Valencia, CA), except 
Wizard Genomic DNA purification kit, which was purchased from Promega Corp (Madison, 
WI). 
 
4.4.2 Polymerase chain reactions (PCR) 
For mutagenesis cassette preparation or gene amplification, reactions were performed in a total 
volume of 200 µl and contained 1x HF buffer, 0.5 µM of each of forward and reverse primers, 
0.2 mM each dNTP, 1 U Phusion DNA polymerase and 10-20 ng plasmid template. For 
verification, 25 µl and contained 1x GoTaq polymerase buffer supplemented with 1.5 mM Mg2+, 
0.625 µM of each of forward and reverse primers, 0.2 mM each dNTP, 1 U GoTaq DNA 
polymerase. Genomic DNA was used as a template, and 0.25 µl was added to the PCR reaction. 
An MJ Research PTC200 (Bio-Rad, Hercules, CA) was used to perform thermal cycling. A 
108 
typical PCR amplification using GoTaq consisted of an initial denaturation step of 3:30 min at 94 
ºC, followed by 19 cycles of 45 s of denaturation at 94 ºC, annealing for 30 s at 55 ºC, and 
extension for 60 s at 72 ºC, and then a final elongation step of 5 min at 72 ºC. When using 
Phusion DNA polymerase, initial denaturation step at 98 ºC for 30 s was followed by 19 cycles 
of 10 s denaturation at 98 ºC, annealing for 10 s at 55 ºC, and extension for 20 s at 72 ºC, and a 
final elongation step also at 72 ºC for 5 min. Exact parameters varied depending on gene size, 
GC-content and primer melting temperatures. All PCR products were purified using a QIAquick 
PCR or gel purification kit and stored at –20 ºC. 
 
4.4.3 Mutagenesis cassette preparation 
Using the primers listed in Appendix G, ~1.1 kb ura3 was amplified from pRS406, or ~2.2 kb 
ura3-his3 from pDIRe3 (vide infra). Fragments were digested with a combination of DpnI and 
either EcoRI or MfeI, and ligated overnight at 16 °C. These were subsequently digested with a 
combination of EcoRI and MfeI, and the ~2.2 kb product (ura3-IR) or ~4.5kb (ura3-his3-IR) 
was gel purified. Figure 4.4C shows DNA products from each step run on an agarose gel. This 
product was directly transformed into heat-shock competent S. cerevisiae.  
 
4.4.4 Yeast transformation and reversion 
15 mL 2xYPAD was inoculated with 0.45 mL overnight yeast culture and shaken at 30 °C and 
250 rpm for 4 hrs. Cells were made competent by centrifugation at 4000 rpm, followed by 2 
washes in sterile, deionized water and one wash in 0.1 M lithium acetate (LiAc). Half of the cells 
were pelleted and resuspended in transformation mixture, comprising of 240 µL 50 % (w/v) PEG 
3350 (polyethylene glycol), 36 µL 1.0 M LiAc, 50 µL 2 mg/mL salmon-sperm ssDNA, and 34 
µL of the IR mutagenesis cassette (200-900 ng). After vortexing cells for 60 s, they were 
incubated at 42 °C for 40 min, after which they were pelleted, resuspended and recovered in 1 
mL 2xYPAD for 3-16 hrs in a 30 °C shaker. Long recovery times are favor higher 
transformation efficiency. Cells were then washed once in SC-Ura and plated evenly on three 
SC-Ura plates. We routinely obtained 2-40 colonies per 2-6 × 106 viable cells using this 
procedure. After 3-4 days, colonies grown to ~3 mm in diameter were resuspended in sterile, 
deionized water and incubated at room temperature for ~3-4 hrs. They were then streaked on a 
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SC+5FOA plate and incubated at 30 °C. Spontaneous reversion, which always observed to occur 
by IR excision, occurred at the frequency of 10-5 to 10-6. 
 
4.4.5 Verification of chromosomal modifications 
Insertion event was verified by growing transformants in 2 mL SC-Ura and isolating their 
genomic DNA using Wizard Genomic DNA Purification Kit (Promega, Madison, WI). Lack of a 
PCR product after amplification indicated deletion. A control reaction was also performed to 
ensure that lack of product was not due to PCR failure. Integration of MIRAGE cassette was also 
verified by PCR amplification between the ura3 terminator and primers annealing upstream and 
downstream of locus of interest. IR excision revertants were picked from SC+5FOA plates and 
grown overnight in 2 mL media. Genomic DNA was isolated and PCR was performed using 
external primers annealing upstream and downstream of the deleted gene. Trp1+ revertants were 
identified by re-streaking colonies from SC+5FOA plates onto SC-Trp plates and incubating for 
2-3 days. Gal7 deletions were also verified by inability of cells to grow on YPAGal plates. Point 
mutations in adh4, adh7, and gpd1 were verified by sequencing. 
 
4.4.6 DNA sequencing 
All DNA samples were submitted for sequencing to the Biotechnology Center Core DNA 
Sequencing Laboratory at the University of Illinois at Urbana-Champaign (Urbana, IL). 
Sequencing reactions were performed as per their instructions. 
 
4.4.7 Construction of pDIRe3  
PCR amplified cassettes of ura3 and his3 from pRS406 and pRS403, respectively, were spliced 
together using overlap-extension PCR. After digestion with EcoRI and BamHI, the cassette was 
ligated into linearized pRSFDuet-1 and transformed into DH5α. Transformants were then 
selected for kanamycin resistance.  
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Chapter 5. Tools for Genome Engineering: TRIIAGE  
5.1. Introduction 
For all the reasons mentioned in Chapter 4, there is a significant need for tools that are able to 
edit genomes of organisms precisely. Yeast has primarily served as a model host organism for 
technologies that enable extensive pathway and genome engineering due to its highly efficient 
homologous recombination machinery [1-9]. Although E. coli has been used as a model 
organism to study homologous recombination as well as for biocatalysis, eccentricities regarding 
the RecBCD nuclease/helicase/recombinase complex had impeded the development of genome 
engineering techniques. Indeed, it has been shown that short linear DNA fragments (such as PCR 
products) transformed into E. coli are quickly degraded by this protein complex. However, 
simple inhibition of RecBCD does not relieve this issue, since its activity is essential for RecA 
loading and subsequent recombination upon recognition of chi (χ, gctggtgg), the recombination 
inducing DNA sequence [10-13] (Figure 5.1). For this reason, it had required the use of plasmid 
pop-in-pop-out technique to perform genome modifications [14-16], since undamaged circular 
DNA is generally not a substrate for RecBCD (Figure 5.2Error! Reference source not 
found.A). The cloning and characterization of λ (Alpha, Beta, and Gamma) as well as Rac 
prophage (RecE and RecT) proteins ushered a new era of genome modification in E. coli [17-19] 
(Figure 5.2B). These systems rely on the λ Gamma protein’s ability to inhibit RecBCD activity 
[20], or mutational inactivation of RecBCD, while simultaneously using the other two protein to 
perform the nuclease, and strand annealing activities. However, this limits the applicability of 
this approach since helper plasmids are a prerequisite for performing mutagenesis. Additionally, 
this system has had the greatest success for performing deletions, and indeed the Keio collection, 
which comprises deletion of every ORF in the E. coli K-12 genome, has been constructed using 
this technology [21]. “Scarless” chromosomal mutagenesis is relatively difficult and still requires 
the construction of suicide plasmids [14-16, 22], use additional heterologous proteins [23, 24], 
specialized strains [25, 26], or extensive screening [19]. A method that is generally applicable to 
most laboratory strains of E. coli and able to generate “scarless” mutants quickly and efficiently 
without the requirement of specialized plasmids or strains would streamline genome engineering 
for a variety of applications. 
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Figure 5.1 Double-stranded (ds) DNA is a substrate for RecBCD helicase/nuclease/recombinase complex. It binds 
dsDNA and degrades both strands simultaneously, albeit at different rates. Upon recognition of chi (χ), RecBCD 
changes its activity and creates a single-strand (ss) DNA loop, which is protected from degradation by ssDNA 
nucleases [27]. This is a substrate for RecA binding, which can thereafter initiate strand exchange. 
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Figure 5.2 Current chromosomal integration techniques circumvent the use of RecBCD. (A) 
Suicide plasmids are integrated into the chromosome using RecFOR and RecA, whereas (B) 
linear DNA-dependent methods utilize phage proteins (RecET or λα, λβ). Resolution of 
recombination intermediates is performed by either RecG or RuvABC. 
 
5.2. Results & Discussion 
5.2.1. Initial attempts with chi (χ) sequences (Book13 pg2-38) 
Although methods that rely on RecA-mediated recombination for genome modification have 
used large regions of homology (usually >400 bp) to direct site-specific integration [14-16], they 
are not a pre-requisite for RecA activity. Indeed, data suggests that homologies as short as 20 bp 
are substrates for homologous recombination, although DNA >74 bp in length are significantly 
more efficient [28]. Site-specific inclusion of chi (crossover hotspot instigator, χ: gctggtgg) 
sequences in linear DNA has also been shown to initiate RecBCD-mediated recombination, 
although the processivity of RecBCD necessitated the use of long DNA molecules [29]. The 
ability of chi sequences to modulate RecBCD activity has been demonstrated in vitro and in vivo, 
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where short oligonucleotides (~14 nt) containing chi sequences were shown to degrade at lower 
rates that random oligos of the same length [30-32]. Taken together, these suggest that RecA and 
RecBCD-mediated recombination of simple PCR products presents a possibility. 
 
Figure 5.3A illustrates the initial design for the mutagenesis cassette. One or two copies of chi 
sequence cassettes were included at its termini to initiate RecBCD mediated recombination, and 
sequences flanking xylA (coding for xylose isomerase) were also included to direct integration. 
Although chloramphenicol resistant colony forming units (cfu) were obtained at very low 
frequencies, they were false positives since the cat gene (chloramphenicol acetyl-transferase) 
could not be re-amplified from the chromosome. Simultaneous re-orientation of all chi sequences 
in inverted direction also led to similar results, indicating that the chi sequences were unable to 
efficiently engage the RecBCD recombinases activity. This could be because the short length of 
the mutagenesis cassette, combined with high innate processivity of RecBCD, results in 
complete degradation of electroporated DNA. 
 
Conversely, re-orientation of only one pair of chi sequences yielded cfu at low frequencies 
(Figure 5.3B). To verify whether the integration was chi-dependent, they were replaced with 
similar or dissimilar sequences (Figure 5.4A). All sequences tested led to the identification for 
true positive cfu, albeit at different frequencies. On the other hand, when the sequences at both 
ends of the PCR product were not identical, true positive events were abolished, indicating the 
requirement for terminal repeats (TR) in direct orientation with respect to each other. To 
ascertain whether the integration was indeed site-specific, the length of homology to xylA locus 
in the neck and tail was changed from 75 bp to 65, 55, or 45 bp. The frequency of integration 
decreased with decreasing neck/tail length to the extent no true positives could be obtained when 
only 55 or 45 bp long sequences were used (Figure 5.4B). However, replacement of xylA with 
cat could not be verified in any cfu tested. 
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Figure 5.3 Initial attempts to create a phage protein and cloning independent genome editing tool. (A) The 
cat gene was flanked by 75 bp of sequences identical to the xylA locus in the chromosome. Flanking those 
were two copies of chi sequences (gctggtgg gctggtgg) as well as 12 bp of random sequence to allow 
RecBCD a foothold prior to recognition of chi. However, no integrants could be detected. (B) Inversion of 
one copy of the chi pair resulted in formation of 16 bp terminal repeat (TR) sequences in direct 
orientation. Integrants were obtained with low frequency, although the nature of integration was unkown. 
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Figure 5.4 Effect of flanking sequences on the frequency of finding transformants. (A) Although transformation 
efficiency is dependent on the identity of terminal repeats (TR), cfu are formed only when TR are present. When 
non-repeats are used, no transformants were obtained. (B) Transformation efficiency is also dependent on the length 
of homology present in the mutagenenesis cassette. Longer sequences seem to favor higher transformation 
efficiencies, while no transformants could be obtained when 55 and 45 bp long sequences identical to xylA locus 
were used. 
 
5.2.2. Hypothetical models for observations, and their validation (Book13 pg38-41) 
Since integration depended on the length of the neck/tail sequences homologous to the 
chromosome, it was probably via homologous recombination. However, replacement of xylA 
gene with cat could not be verified in any case – rather both cat and xylA fragments were 
amplified from the chromosome indicating that cat was probably integrating near the xylA locus 
using only either the neck or tail homologies (Figure 5.3B). Two possible recombination events 
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consistent with the observations are illustrated in Figure 5.5. In Model A, a single dsDNA 
molecule is circularized, with the crossover point at the TR. Upon formation of this circular 
intermediate, the DNA is no longer a substrate for RecBCD, and is integrated into the 
chromosome via the RecFOR pathway for plasmid integration [11]. In Model B, two molecules 
are linked to each other by the crossover happening at the TR. The integration would be 
independent of RecFOR since the mutagenesis cassette remains linear at all times. A simple test 
to verify either model is described in Figure 5.6. If the cassette is indeed circularized, it may be 
possible to isolate the circular intermediate as plasmid if an origin of replication is included in 
the cassette. Conversely, Model B can be verified using three different sequences for the TR. If 
crossover happens between two molecules, TR need not be identical within a molecule as long as 
two different molecules can be juxtaposed.  
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Figure 5.5 The two possible methods for integration of the cat cassette near the xylA locus via 
homologous recombination. (A) The linear DNA circularizes using the TR to form either an 
intermediate molecule. Thereafter, the circular DNA is integrated into the chromosome via the 
RecFOR pathway using the flanking homology. (B) Juxtaposition of two discrete molecules at the TR 
allows a crossover between them, allowing for insertion at the xylA locus via the RecBCD pathway. 
 
Based on these experiments, Model A was shown to be correct, since a plasmid could be isolated 
easily. A PCR amplified fragment of pACYCDuet-1 consisting of the p15A origin of replication, 
cat gene as well as TR (called ZZACYC) was successfully circularized upon transformation. The 
isolated plasmid (pZZACYC) was verified to be distinct from the template pACYCDuet-1 based 
on its digestion pattern (EcoRI and NheI) as well as TR junction sequencing. On the contrary, no 
integrants based on co-transformation of two juxtaposable cassettes were obtained, indicating 
that Model B was incorrect. 
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Figure 5.6 Two tests were designed to identify the mechanism of DNA integration. (A) If the linear DNA forms a 
circular intermediate, it would be possible to trap the circular form into a stable structure by including an origin of 
replication in the cassette. (B) If two strands need to be juxtaposed for integration, then co-transformation with two 
distict types of molecules using three different sequences in place of TR should still allow integration. However, this 
was not the case. No transformants could be obtained indicating that juxtaposition of two molecules is unncessary 
for recombination. On the other hand, a circular plasmid could be isolated when a p15A origin was included with 
cat. Sequencing of the junction of the plasmids indicated that one copy of the TR was deleted. 
 
5.2.3. Ouroborous recombination (OR) is illegitimate (Book19 pg8-13, Book13 pg44-45) 
Although Model A was verified, the mechanism of circularization of linear DNA remained 
unknown. Since circularization (or Ouroboros recombination, OR) is dependent on presence of 
identical TR, RecA mediated recombination between the two is a possibility. However, there is 
no precedence in literature for homologous recombination between such short homologies, since 
20 bp was previously described as the minimal length for detectable recombination [28]. To 
verify the dependence or non-dependence on RecA, ZZACYC was transformed into two distinct 
strains – DH5α and JW2669-1. Plasmids isolated from both strains were verified to be identical 
to pZZACYC. This confirmed that OR is independent of RecA activity and therefore probably 
illegitimate recombination. However, it is distinct from non-homologous end-joining (NHEJ) 
found in mammalian systems since it is short-homology dependent. In fact, since neither RecA, 
nor chi sequences are required for OR, sequences flanking the TR ought to be unnecessary. Their 
purpose was to act as a “foothold” for RecBCD and allow it sufficient time to recognize chi 
sequences [30]. Indeed, omission of these sequences increased the frequency of OR by >10-fold 
in all single knockouts tested (Figure 5.7), presumably because it allowed the TR to efficiently 
anneal to each other without interference from single-stranded overhangs. Finally, even though 
the TR consist of two copies of identical 8-mers, all pZZACYC sequenced crossover junctions 
were 16 bp long. This suggests that all 16 bp is accessible for annealing and the stronger binding 
probably results in preferential formation of the 16 bp junction. 
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Figure 5.7 Effect of presence and omission of 12 bp overhang flanking the TR sequences. Absence 
of the overhanging sequences increases the frequency of OR by >10-fold in all strains tested.  
 
5.2.4. Possible mechanisms of OR 
In order for the TR to anneal to each other to form the junction, the double-stranded DNA 
(dsDNA) must either unwind and/or one of the strands must be degraded to reveal single-
stranded DNA (ssDNA). Three possible mechanisms for OR via different modes for ssDNA 
formation are described in Figure 5.8. In Model A, the ends of dsDNA dissociate spontaneously, 
and in Model B, the dsDNA is unwound during either translation or transcription of the cat or 
p15A origin. In Model C, the PCR product is actively unwound and/or degraded by a cellular 
helicase and/or nuclease. Strand annealing is most likely not mediated by any protein; rather it 
probably happens spontaneously as for in vitro DNA ligation reactions. Gap-filling and ligation 
to form a covalently closed circular DNA is probably carried out by DNA polymerase I and 
DNA ligase A, respectively [11].  
 
5.2.5. OR is independent of TR melting temperature (Book20 pg22-25) 
If the end annealing is dependent on spontaneous dsDNA unwinding, then the frequency of OR 
should be inversely correlated with the melting temperature of the TR. Lower melting 
temperature should result in more widespread double-strand end (DSE) unwinding and enable 
more frequent annealing of the two TR sequences; and vice versa for higher melting temperature. 
To determine if OR happens via Model A, i.e., by spontaneous melting of the DNA ends, the TR 
sequences were changed such that the melting temperature of the 16 bp sequence was 39 ºC 
(cgtataagcgtataag), 49 ºC (cgtcgaagcgtcgaag), or 59 ºC (cgcgggagcgcgggag). Melting 
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temperatures were determined using the online OligoCalc algorithm [33]. However, as can be 
seen in Figure 5.9, there is no such correlation confirming that melting temperature is not a major 
factor in OR. 
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Figure 5.8 Three possible mechanisms for OR. (A) Initiation of transcription creates a transcription bubble. Upon 
reading the double strand break (DSB), the transcriptional machinery dissociates, creating ssDNA ends. The 
presence of cohesive ends then allows annealing of the two TR. (B) Since the two strands are held together by 
hydrogen bonds, it would be possible for them to dissociate spontaneously at a low frequency. This would create 
ssDNA at both ends of the linear DNA, allowing the cohesive TR to anneal. (C) The activity of an endo- or 
exonuclease within the cell near the TR would create cohesive ends, which would then be able to anneal. The 
annealing of cohesive ends, overhang processing, gap filling, and ligation would then complete the OR process. 
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Figure 5.9 Changing the melting temperature of the TR by altering its 
sequence did not manifest any significant change in OR frequency. 
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5.2.6. OR is independent of transcription and translation (Book20 pg15-24) 
The two DNA strands can be nearly completely separated by the formation of either the 
replication or transcriptional bubble reaching the DSE. Once the DSEs are separated, the TR can 
anneal to each other and initiate OR. It is unclear whether the transcriptional or translational 
machinery can initiate their respective actions before complete degradation of the DNA, but R-
loops have been known to mediate illegitimate recombination, making Model B a viable pathway 
[34]. Since this model requires dissociation of the two DNA strands due to the translocation of 
bubble to the DSE, the orientation of the cat gene and p15A origin in the cassette should 
significantly effect OR. In particular, if cat and p15A are in convergent orientation, the bubble 
should take much longer to reach DSE. In addition, the relative distance of the 3’ end of 
cat/p15A from the TR should also affect the frequency of OR. To test these, four constructs were 
tested (including the default construct) with varying orientations of cat/p15A and distances from 
the TR (Figure 5.10). While the total length of the construct affected the frequency of 
circularization and efficiency of TR-dependent OR, the relative orientation of cat and p15A and 
the distance of their 3’-ends from TR did not have any significant effect on OR (Figure 5.10).  
 
 
5.2.7. No single enzyme is responsible for OR (Book20 pg15-24) 
The aforementioned experiments indicate that Model A and B are incorrect, making Model C the 
leading candidate for OR.  Table 5.3 lists all the major nucleases and helicases in E. coli that 
could play a major role in OR in unwinding DSE and/or cohesive end formation. The frequency 
of OR was a measure for single knockout strains in an attempt to identify genes whose loss-of-
function caused significant perturbation from the wt strain (Figure 5.11A). The knockouts 
displaying significant variation from wt were ∆recA, ∆recB, ∆recC, and ∆recJ. A second test 
was also performed whereby the ratio between TR-dependent and TR-independent 
circularization was calculated (Figure 5.11B). This was done for two major reasons, 1) to address 
the different transformation efficiencies of the different strains tested, which is normalized when 
taking the ratio of two transformation frequencies, and 2) to find the factors that significantly 
affect the frequency of circularization via TR-dependent pathway but not the TR-independent 
pathway. The strains that demonstrated the biggest deviations from wt were ∆recA and ∆recC. 
TR-independent circularization was undetectable in ∆recA, however previous sequencing data 
has shown that OR is independent of RecA. Since no knockout completely eliminated OR, it 
121 
suggested that no single enzyme was responsible for the creation of the cohesive ends, and that 
some level of redundancy existed among the genes of E. coli that enabled the formation of 
pZZACYC. 
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Figure 5.10 (A) Re-orienting the cat reading frame and p15A origin in the OR cassette has no significant effect on 
its circularization frequency. Changing the distance of the 3’-ends of cat/p15A from the DSE did not affect the OR 
frequency significantly either. However, longer DNA strands did circularize via OR at a relatively lower efficiency. 
OR-independent circularization seemed to be more prevalent in these longer constructs as well. The same TR were 
present in all + constructs tested (cgtataagcgtataag). Control constructs without TR, –, circularized at lower 
frequencies, as expected. div: divergent orientation, conv: convergent orientation, long: longer cassettes (3.5-4 kb) 
compared to the shorter standard constructs (~2.2 kb). (B) Template plasmids used for convergent and divergent 
constructs. 
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Table 5.1 List of various proteins involved in DNA metabolism in E. coli that may play a role in OR. ss: ssDNA-
dependent exonuclease, ds: dsDNA-dependent exonuclease, endo: endonucleases, n.d.: no data. 
 
Enzyme Gene(s) Nuclease Helicase Other Activity
ExoI xonA/sbcB ss - -
ExoVII xseA, xseB ss - -
ExoX exoX ss, ds Y -
RecJ recJ ss - -
RecQJ recJ, recQ ds Y -
ExoIII xthA ds, endo Y -
RecBCD recB, recC, recD ss, ds Y Recombinase
RecE recE ds Y -
SbcCD sbcC, sbcD ds, endo n.d. -
UvrD uvrD - Y -
RecQ recQ - Y -
Rep rep - Y -
HelD helD - Y -
DinG dinG - Y -
RuvABC ruvA, ruvB, ruvC - Y Resolvase
RecG recG - Y Resolvase
RecFOR recF, recO, recR - - Recombinase
 
 
5.2.8. Role of dsDNA exonucleases (Book20 pg25-35) 
The single-knockout data suggests that certain deletions affect the relative frequencies of TR-
mediated OR. In particular, the significant effect of RecC deletion suggests that RecBCD plays a 
major role in formation of cohesive ends that enable OR. However, it does not completely 
eliminate OR, suggesting redundancy in double-stranded exonuclease activity. Based on Table 
5.1 ExoX, RecQJ, ExoIII, RecE, and SbcCD may play the redundant roles in formation of the 
cohesive ends. RecE and RecJ have been known to compensate for loss in RecBCD activity in 
certain genotypes, and therefore were the primary candidates for OR in absence of RecBCD. 
Deletion of all three genes (recE, recJ and recC) resulted in further decrease in TR-dependent 
OR suggesting that they do indeed participate in cohesive end formation (Figure 5.12). However, 
again, not all OR was eliminated, indicating further redundancy in dsDNA exonuclease activity, 
possibly due to ExoX, ExoIII, TatD, and SbcCD, which need to be pursued further. 
 
5.2.9. Development of TRIIAGE  
The ability to protect short linear DNA from being completely degraded by RecBCD created an 
opportunity to develop a genome engineering tool that does not rely on the λ or rac phage 
proteins. Since linear DNA is transitioned through a circular intermediate, the mutagenesis 
cassette would probably integrates via the RecFOR pathway. In order to develop a method that 
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does not leave “scars” in the genome, a strategy to remove the undesired elements of the marker 
is necessary. Plasmid-based genome engineering techniques traditionally rely on a counter-
selectable marker such as sacB [14, 35], tetA [24, 36], or rpsL [25, 37] for this process. However, 
the rpsL-based counter-selection requires a strain with rpsL150 mutation that confers 
streptomycin resistance. Using the rpsL marker would prevent the applicability of TRIIAGE to 
all possible strains. Therefore, initially sacB and tetA were chosen as counter-selectable markers. 
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Figure 5.11 Effect of various single deletions on OR. (A) Majority of single deletion strains do not manifest any 
significant change OR frequency. The exceptions are DH5α (RecA1), RecA-, RecB-, RecC-, and RecJ- strains when 
compared to control, wt strain (MG1655). As a negative control, TR-deficient construct was also transformed to 
MG1655 to test background circularization. (B) To compensate for transformation efficiency, ratio of TR-dependent 
and TR-independent plasmid formation frequencies are shown. RecA- and RecC- strains show significant decrease in 
relative OR frequency. TR-independent circularization frequency could not be determined for RecA- strain, 
therefore the ration was not determined (n.d.).  
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5.2.10. Counter-selections and temperature sensitivity (Book19 pg14-27, 34-35) 
Experiments performed by Wenglin Tang demonstrated that sacB and tetA counter-selections are 
highly prone to false positives, which is supported by similar observations in literature [25, 38]. 
In addition, the frequency of obtaining transformants was extremely low (~10 cfu/µg DNA 
transformed). In order to address the issue of low transformation efficiency, an “intermediate-
trap” mutagenesis strategy was developed. In this strategy, the circular intermediate was trapped 
as a conditionally replicating plasmid, and then forced to integrate under non-permissive 
conditions. Temperature sensitive plasmids have been widely used for this purpose, and 
therefore, a temperature sensitive origin of replication was included in the mutagenesis cassette. 
Plasmids with mutated pSC101 origin have been previously described, and in particular, 
pTH18ks1 plasmid has been demonstrated to exist at multiple copies at permissive conditions 
but unable to replicate at non-permissive conditions [39]. 
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Figure 5.12 Finding the dsDNA exonuclease responsible for OR. RecBCD plays a major role in OR, and its activity 
seems to mask the OR due to other dsDNA exonucleases. However in a RecC-deficient strain, loss of RecJ and 
RecE activity further decreases the frequency of OR, indicating they play a role in formation of circular DNA. 
However since TR-dependent circularization is still >1, other ds nucleases may play a role in this background. 
 
To adapt the “intermediate trap” idea to TRIIAGE, the mutagenesis cassette was as illustrated in 
Figure 5.13. To test this method, a mutagenesis cassette was designed to delete xylA. Cells 
transformed with the appropriate mutagenesis cassette were first selected at 30 ºC for the ability 
to form a stable, replicating, kanamycin resistance (KnR) conferring plasmid. Intermediate 
plasmids were verified by digestion with EcoRI and BspHI. Since template pTH18ks1 is cut 
once by each enzyme and pKS1 OR constructs are not cut by EcoRI, it allows differentiation 
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between the two. Thereafter, the cells are grown first in permissive conditions and then selected 
for the ability to retain the antibiotic resistance at non-permissive conditions. It was found that 
for cells grown between log and stationary phase at 30 ºC were able to retain antibiotic resistance 
at 43 ºC at a frequency of ~104-105. Conversely, it was found that a construct that did not contain 
any homology to the chromosome was unable to retain antibiotic resistance at non-permissive 
conditions at comparable frequencies. This indicated that homology to the chromosome directed 
the integration of the plasmid. PCR-based tests confirmed that integration was, in fact, site-
specific at the xylA locus. As for plasmid-based techniques, integration is not accompanied by 
deletion of a genomic locus; rather it is one of the possible outcomes accompanied with precise 
excision of the plasmid. Such an excision would either result in wt or deletion genotype. To 
perform excision, cells were grown at 43 ºC to mid-log phase and then selected on antibiotic-free 
plates at 30 ºC. It was found that cells grown to stationary phase prior to selection yielded a 
higher fraction of false positives, and therefore it was essential to ensure cells were grown to 
early-mid log phase (OD ~0.3 – 0.6). Since the copy number of the replication origin in 
pTH18ks1 has shown to be 14 [39], its activation in the chromosome would result in cell death, 
probably since E. coli is unable to accommodate origins of replication having a high copy 
number [40]. Resultantly, viable cells would only grow if either (a) the replication from this 
origin was suppressed, or (b) the intervening region between direct repeats (DR) in the 
chromosome was deleted. Further, the two events can be distinguished by screening for 
kanamycin sensitivity (KnS), as only (b) would lead to loss of the kan marker. These cfu were 
tested for loss of the mutagenesis cassette by PCR and it was found that majority of the clones 
led to wt genotype. This is primarily because frequency of deletion is inversely correlated to the 
distance between DR [41, 42], and deletion of xylA would require deletion of an additional ~1 kb 
DNA when compared to simple reversion to wt. However, experiments performed by Dawn 
Eriksen confirmed that 1 in 6 clones tested were ∆xylA. None of the clones tested resulted in 
imprecise excision as all non-deletion clones were able to grow on minimal medium with xylose 
as the sole carbon source indicating that the xylA function had been restored (Figure 5.14). For 
point mutations and small deletions and insertions, this ratio is expected to be higher, 
approaching ~1:1. These experiments corroborate the idea that that temperature sensitive origins 
of replication provide a sufficiently strong counter-selection for the identification of excision 
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events, and that TRIIAGE could be a good alternative to phage protein-dependent genome 
engineering tools. 
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Figure 5.13 Overview of TRIIAGE. The mutagenesis cassette consists of a kan marker along with a 
temperature sensitive origin of replication (a variant of pSC101). Flanking this core are the neck (N) and tail 
(T) sequences encoding sequences homologous to chromosomal DNA as well as terminal repeats (TR). Upon 
transformation and selection at permissive temperature, a circular plasmid is formed by OR. Growth in non-
permissive conditions would force plasmid integration based on sequence homology to the chromosome. Upon 
shifting back to permissive conditions, the origin of replication becomes unstable and it can be excised in two 
possible ways – one of which leads to the desired mutagenesis, whereas the other leads back to wt genotype. 
 
 
Figure 5.14 Functional assay of excision colonies. Cells with mutagenesis cassette integrated at xylA (encoding for 
xylose isomerase) locus were then selected at 30 ºC and then screened for KnS. Eight (1-8) colonies were re-streaked 
on M9 xylose plates and were able to grow, indicating that xylA was functionally expressed, and that cassette 
excision was precise. MG1655: parent strain used as positive control; ∆xylA: negative control unable to grow on the 
plate. 
 
5.2.11. In vivo mutagenesis studies (Book19 pg35-38) 
To demonstrate the versatility of TRIIAGE, it is necessary of to perform different types of 
mutagenesis at other loci. The lacZ and araB genes were chosen as targets due to the ability to 
test their by function directly. A silent mutation was chosen to be introduced into lacZ (c1296g), 
which also introduced a SacII restriction site into the gene. Similarly, a single basepair nonsense 
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mutation was designed into the TR of the araB mutagenesis cassette (c226t), which would 
simultaneously disrupt a BssHI restriction site but retain the adjacent PvuII site. To perform the 
mutagenesis, PCR products amplified from pTH18ks1 flanked by 75 bp of homology targeting 
them to either lacZ (ks1lacZ75) or araB (ks1araB75), were transformed into MG1655. 
Circularized plasmids were trapped at 30 ºC, and integrated into the chromosome at 43 ºC. 
Several integrants for each strain were tested, and they all demonstrated the expected phenotype. 
That is, all lacZ integrants isolated and tested remained blue when checked using blue/white 
screening; whereas araB integrants failed to grow on M9 medium supplemented with arabinose 
(Figure 5.15A, B). This suggested that all integrants were locus-specific and that the 
recombination was mediated by the flanking 75 bp homology. Excision was performed at 30 ºC, 
and resulting colonies were screened for KnS by replica plating. These clones were further tested 
for lacZ and araB activities, and genomic DNA from LacZ+ and AraB- strains were isolated. The 
mutated loci were amplified and tested for using digestion analysis (Figure 5.15C). All the 
mutants displayed the expected digestion pattern, indicating that the correct mutation had been 
introduced into the chromosome, thus demonstrating the versatility of TRIIAGE. 
 
5.2.12. Ideal length for flanking homology 
Although 75 bp of homology is sufficiently short to be incorporated into oligonucleotides, 
shorter oligonucleotides are generally cheaper to synthesize, and therefore shorter homology 
would decreased the cost of mutagenesis. Additionally, phage-dependent methods use homology 
of length in the 35-60 bp range, considerably shorter than that tested for TRIIAGE [17, 18]. 
However, shorter lengths would adversely affect the frequency of plasmidic integration and 
excision since recombination has been shown to decrease exponentially with decreasing 
homology [28]. In order to find the minimal length of flanking homology that can still direct 
integration and excision to and from the chromosome, deletion of xylA was attempted with 
shorter PCR primers. Homologies of length 50 bp and 60 bp were compared to 75 bp for their 
ability to integrate and excise in a sequence specific manner. Experiments performed by Dawn 
Eriksen and Wenglin Tang indicated that integration and excision frequency for 60 bp homology 
were comparable to 75 bp, but 50 bp was relatively inefficient. Homology of 60 bp seemed to 
strike an ideal balance between short length and efficient recombination, and was therefore used 
for all subsequent experiments. 
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Figure 5.15 Integration of circularized ks1 plasmids into the chromosome is site-specific and dependent on flanking 
homology. (A) Integration at lacZ locus inactivates it and is displayed as white cells on X-gal plates. As control, 
araB and xylA integrants are also shown as turning blue since they have functional lacZ. (B) A similar functional 
assay for araB integrants shows that it is unable to grow on M9 arabinose plates. As control, parent strain MG1655, 
a lacZ integrant, and a xylA integrant are also shown as able to grow on the same plate. (C) Digestion pattern of 
mutated locus from excision colonies. SacII digestion pattern for two excision mutants (1-2) indicate the restriction 
site has been introduced. The same locus from the parent strain cannot be cut by SacII (3). None of the araB 
integrants could be digested by BssHI (4-6), however, they can all be cut by the adjacent site for PvuII, indicating 
the mutation is highly sites-specific (7-9).  
 
5.3. Conclusions and Future Work 
Creation of efficient E. coli biocatalysts requires the ability to engineer its genome. The 
eccentricities of its recombination machinery, particularly the high activity and processivity of 
the RecBCD helicase/nuclease/recombinase complex, have significantly impeded the ability to 
make chromosomal mutations easily. This has necessitated the development strategies that 
circumvent the limitations in two primary ways. The first technique relies on using covalently 
closed circular DNA molecules (suicide plasmids) to perform chromosomal mutations [14-16]. 
Since undamaged circular DNA is not a substrate for RecBCD, suicide plasmids are then able to 
avoid complete degradation and are able to integrate into the chromosome. However the creation 
of these plasmids constructs is a multi-step process that involves cloning, making it a time-
consuming process. The most popular alternative to plasmidic method is to use heterologous 
proteins – either λ red (Alpha, Beta, Gamma), or rac prophage (RecET) proteins [17, 18]. The λ 
Gamma protein can inhibit RecBCD activity allowing the other proteins to perform nuclease and 
recombinase activities. These proteins have been used extensively to perform in vivo deletions 
using PCR products. Point mutations, however, still required the use of additional proteins such 
as homing endonucleases [23, 24] or specialize strains [25, 26], further complicating the process. 
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The development of a new technique that does not require the use of heterologous proteins yet 
uses PCR products directly would be able to overcome the limitations of the current techniques 
and provide a useful, widely applicable tool for genome engineering and biocatalyst 
development. TRIIAGE was developed to achieve this goal and has been demonstrated to 
perform precise point mutations in the chromosome efficiently. Another advantage of TRIIAGE 
is that it uses very small amount of PCR product to perform mutagenesis and is applicable to 
most recombination proficient strains of E. coli. The technique relies on a novel mechanism 
discovered here called Ouroboros Recombination (OR), whereby a blunt-ended dsDNA (such as 
a PCR product) circularizes using 16 bp terminal repeats (TR). By trapping linear DNA in 
circularized form, degradation by RecBCD is avoided. In fact, data indicates that RecBCD is the 
primary complex that mediates OR, although other dsDNA dependent exonucleases also play a 
minor role. Several mutations were made using this approach, including a deletion, an insertion, 
as well as a point mutation in the E. coli chromosome, demonstrating the versatility of TRIIAGE. 
 
Having demonstrated the applicability of TRIIAGE to a few loci in the E. coli chromosome, 
future work would comprise further demonstration its applicability to other loci in the 
chromosome. In addition, different types of mutations would be introduced – such as small or 
large deletions and insertions, as well as point mutations. The generality of TRIIAGE to other 
similar organisms such as Salmonella enterica or Pantoea ananatis could also be tested. This 
would provide powerful mutagenesis techniques in these organisms that currently also rely on 
the use of λ red system [43, 44]. Finally, additional work to conclusively verify the mechanism 
of OR would constitute the final aspect of TRIIAGE future work. 
 
5.4. Materials and Methods 
5.4.1. Strains, plasmids, and reagents 
E. coli strain DH5α from ZymoResearch (Orange, CA), WM1788 was a gift from Prof. William 
Metcalf (University of Illinois, Urbana, IL), and MG1655 (F- λ- ilvG- rfb-50 rph-1) was a gift 
from Prof. John Cronan (University of Illinois, Urbana, IL). All single deletion strains of the 
Keio Collection were obtained from E. coli Genetic Stock Collection (CGSC, Yale University, 
New Haven, CN). Genotype of all strains used is listed in Appendix I. Template plasmid 
pACYCDuet-1 was obtained from Novagen (San Diego, CA), pTH18ks1 was a gift from Prof. 
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Tamotsu Hashimoto-Gotoh (Kyoto Prefectural University of Medicine, Kyoto, Japan) [39] and 
pWM91 (template for sacB) was a gift from Prof. William Metcalf (University of Illinois, 
Urbana, IL) [45]. Plasmids for E. coli gene inactivation - pKD46, pKD4, and pCP20 were a gift 
from Dr. Barry L. Wanner (Purdue University, West Lafayette, IN). Relevant characteristics of 
all plasmids used are listed in Appendix J. Wild-type P1vir used for transduction was a gift from 
Prof. John Cronan (University of Illinois, Urbana, IL). DNA primers were synthesized by 
Integrated DNA Technologies (IDT, Coralville, IA). All enzymes used for cloning were bought 
from New England Biolabs (Beverly, MA) unless otherwise noted. QIAprep Spin Plasmid Mini-
prep Kits, QIAquick PCR Purification and Gel Extraction Kits were purchased from Qiagen 
(Valencia, CA). Wizard Genomic DNA Purification Kit was obtained from Promega (Madison, 
WI). All chemicals were purchased from Sigma (St. Louis, MO), and growth media from BD 
Biosciences (San Jose, CA). DNA standards for agarose gel electrophoresis and protein 
standards for SDS-PAGE were purchased from Bio-Rad (Hercules, CA). 
 
5.4.2. Polymerase chain reactions (PCR) 
For mutagenesis cassette preparation or gene amplification, reactions were performed in a total 
volume of 200 µl and contained 1x HF buffer, 0.5 µM of each of forward and reverse primers, 
0.2 mM each dNTP, 1 U Phusion DNA polymerase and 10-20 ng plasmid template. Difficult 
reactions were amplified in 1x GoTaq polymerase buffer supplemented with 1.5 mM Mg2+, 0.5 
µM of each of forward and reverse primers, 0.2 mM each dNTP, 1 U GoTaq and 1U Phusion 
DNA polymerase. Verification reactions were also performed in Taq buffer in a total volume of 
25 µl with GoTaq polymerase only. Genomic DNA was used as a template for these, and 0.25 µl 
was added to the PCR reaction mix. An MJ Research PTC200 (Bio-Rad, Hercules, CA) was used 
to perform thermal cycling. A typical PCR amplification using GoTaq consisted of an initial 
denaturation step of 3:30 min at 94 ºC, followed by 19 cycles of 45 s of denaturation at 94 ºC, 
annealing for 30 s at 55 ºC, and extension for 60 s at 72 ºC, and then a final elongation step of 5 
min at 72 ºC. When using Phusion DNA polymerase, initial denaturation step at 98 ºC for 30 s 
was followed by 19 cycles of 10 s denaturation at 98 ºC, annealing for 10 s at 55 ºC, and 
extension for 20 s at 72 ºC, and a final elongation step also at 72 ºC for 5 min. Exact parameters 
varied depending on gene size, GC-content and primer melting temperatures, and cassette length. 
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All PCR products were purified using a QIAquick PCR or gel purification kit and stored at –20 
ºC. Appendix H is a complete list of all primers used. 
 
5.4.3. P1 transduction 
Donor cells (2 mL) were inoculated with 20 µL of overnight culture and grown in LB + 5 mM 
CaCl2 + 10 mM MgCl2 + 50 mg/L Kn for 1 h at 37 °C. wild-type P1vir (10-200 µL) was added 
to the cells and grown for another 2-4 h till cell density decreases significantly due to lysis. 
Chloroform (100 µL) was then added and the culture was grown for another 15 min. The culture 
was then centrifuged at 3200 x g for 10 min. The supernatant was then transferred to a fresh tube 
containing 100 µL chloroform and centrifuged again. After one more transfer and centrifugation, 
the clear supernatant was transferred to a fresh tube containing 100 µL chloroform and stored at 
4 °C overnight to ensure complete donor lysis. Recipients were grown to stationary phase and 
CaCl2 and MgCl2 were added to 5 mM and 10 mM, respectively. After aliquoting 1 mL into 
centrifuge tubes, 50-100 µL donor P1 was added to the cells. Sterile water was used as a control 
instead of P1 in all cases. After incubation at room temperature for 30-60 min, sodium citrate 
was added to 10 mM to sequester the Ca2+ ions. After centrifugation and removal of supernatant, 
cells were resuspended in fresh 1 mL LB supplemented with 10 mM sodium citrate and 
incubated at 37 °C for 1 h. Cells were washed twice in the same medium, resuspended to 100 µL, 
spread on a single LB+Kn50 plate, and incubated at 37 °C overnight. Chromosomal mutations 
were verified by PCR amplification of locus using cell lysate or purified genomic DNA. 
 
5.4.4. DNA sequencing 
All DNA samples were submitted for sequencing to the Biotechnology Center Core DNA 
Sequencing Laboratory at the University of Illinois at Urbana-Champaign (Urbana, IL). 
Sequencing reactions were performed as per their instructions. 
 
5.4.5. Creation of plasmids with cat and p15A in different orientations 
The wt plasmid, pACYCDuet has cat and p15A in divergent orientation (Figure 5.10B). Using 
blunt cutters HpaI and AfeI (isozyme of Eco47III), p15A origin was digested out of the plasmid 
and re-ligated back. The direct orientation of p15A relative to cat was verified by digestion 
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analysis (EcoRI and AfeI). Thereafter, blunt-cutters SfoI and ZraI were used to isolate the cat 
cassette, which was then re-ligated back to give pACYCconv (Figure 5.10B). 
 
5.4.6. OR and mutagenesis using TRIIAGE 
Using the primers listed in Appendix H, ~0.9 kb cat and ~2 kb ACYC (cat-p15A) cassettes were 
amplified from pACYCDuet-1, whereas ~2.2 kb ks1 (kan-pSC101ts) cassettes were amplified 
from pTH18ks1. PCR purified cassettes were digested with DpnI for 1-3 h and then gel purified. 
25 mL culture in LB inoculated 1:100 from a 2 mL overnight was grown to mid-log phase 
(OD600 = 0.4-0.7) and washed twice in ice cold 10% glycerol. Cells were resuspended to 150 µL 
in 10 % glycerol maintained on ice. 10-100 ng of DNA was added with the cells and the mixture 
was transferred to a 0.2 cm gap electroporation cuvette. After electroporation cells were 
recovered in 1 mL SOC. All transformants were recovered at 37 ºC, except ks1 transformants, 
which were recovered at 30 ºC. Cells transformed with the cat cassette were recovered for 4 h, 
whereas all other transformants were recovered for 1 h. Selective plates contained one of the 
following antibiotics at the following concentrations: chloramphenicol (Cm25, 25 mg/L) and 
kanamycin (Kn50, 50 mg/L). The only exceptions were transformants of the cat cassette, which 
were selected on 6 mg/L chloramphenicol plates (Cm6). Colonies were then verified for 
integration of plasmids assembly. Assembled pACYC plasmids were verified by digestion with 
EcoRI and NheI, and pKS1 plasmids were verified by digestion with EcoRI and BspHI. Clones 
containing verified pKS1 plasmids were grown to stationary phase at 30 ºC in LB + Kn and 
various amounts (0.1 µL – 100 µL) were plated on LB+Kn50 and selected for at 43 ºC. Cfu 
formed at this temperature were verified for integration by PCR. To excise the marker, cells were 
grown to mid-log phase in LB without Kn at 43 ºC and various amounts (0.1 µL – 100 µL) were 
plated on LB plates at 30 ºC. Colonies formed on these plates were tested for KnS by replica 
plating on LB+Kn50 at 30 ºC. These cfu were then verified for loss of marker by PCR and 
introduced mutation by digestion analysis and sequencing for the PCR amplified locus. 
 
5.4.7. Verification of chromosomal modifications 
Integrants were initially verified by PCR using primers listed in Appendix H and either cell 
lysate or purified genomic DNA as template. Primer pairs were designed such that one annealed 
to the genomic locus and the other to the mutagenesis cassette. Excision events were verified by 
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KnS, as well as function, wherever possible. Size of the PCR amplified locus, as determined by 
running it on an agarose gel, was used to verify deletions. Point mutations were verified by 
endonuclease digestion to test for introduction of mutation. Direct sequencing of the PCR 
product was also used to confirm mutations. 
 
5.4.8. Construction of multiple knockout strains 
Multiple knockout strains were created by P1 transduction from single knockout strains obtained 
from the Keio Collection [21]. KnR knockouts were transformed with pCP20, encoding a 
thermally inducible Flp recombinase, recovered at 30 ºC for 1 h, spread on LB+Amp100 plates 
and selected at 30 ºC overnight. Single colonies were picked and inoculated into 0.5-1 mL LB 
cultures and grown at 43 ºC. Upon reaching mid-log phase, cell were streaked on an LB plate 
and incubated at 43 ºC overnight. Several individual cfu were re-streaked on LB, LB+Amp100, 
and LB+Kn50 plates and incubated overnight at 30 ºC to test for loss for kan and pCP20. KnS and 
AmpS colonies were further tested for relevant chromosomal modification by PCR amplification 
of locus with appropriate primers and cell lysate as template. Above process was repeated to 
perform additional deletions. 
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Appendices 
Appendix A. List of strains created and used. 
 
Name Relevant characteristics Source 
DH5α 
F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 
deoR nupG Φ80dlacZ∆M15 ∆(lacZYA-
argF)U169 hsdR17(rK- mK+), λ– 
ZymoResearch 
MG1655 Wild-type K-12 gDNA template for XylA promoter and xylE ATCC 700926 
C600 F
-
 tonA21 thi-1 thr-1 leuB6 lacY1 glnV44 rfbC1 
fhuA1 λ- CGSC, Yale University 
XL1-Blue 
endA1 gyrA96(nalR) thi-1 recA1 relA1 lac 
glnV44 F'[ ::Tn10 proAB+ lacIq ∆(lacZ)M15] 
hsdR17(rK- mK+)  
Stratagene  
JM109 
endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB+ 
∆(lac-proAB) e14- [F' traD36 proAB+ lacIq 
lacZ∆M15] hsdR17(rK-mK+)  
Stratagene  
BL21(DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) Stratagene  
WM1788 
∆(araBAD)567 ∆lacZ4787 lacIq rrnB-3 
∆(rhaBAD)568 hsdR514 ∆phoBR580 galU95 
recA ∆endA9 uidA(∆MluI)::pir(wt) 
William Metcalf, UIUC 
WM1789(DE3) 
∆(araBAD)567 ∆lacZ4787 lacIq rrnB-3 
∆(rhaBAD)568 hsdR514 ∆phoBR580 galU95 
recA ∆endA9 (DE3) uidA(∆MluI)::pir(wt) 
[78] 
HZ348 WM1789(DE3) ∆xylA::FRT This work 
HZ349 HZ348 with pTKXb-xdharaB' This work 
HZ350 HZ348 with pET20b-xdharaB' This work 
HZ353 HZ349 with pACYC-ncxr This work 
 HZ349 with pACYC-VMQCI This work 
ET23 source of crp*::Tn10 [49] 
HZ1302 C600 crp*::Tn10 This work 
HZ1743 C600 ∆ptsG::FRT This work 
HZ1651 C600 ∆cyaAregul::cat This work 
HZ1450 HZ1302 ∆xylA::FRT This work 
HZ1967 HZ1302 ∆xylAB::FRT This work 
HZ1756 HZ1743 ∆xylA::FRT This work 
HZ1434 HZ1450 with pXXR This work 
HZ1435 HZ1450 with pXVMQCI This work 
HZ1757 HZ1756 with pXXR This work 
HZ2008 HZ1450 with pXXR & pACYCAraXylE This work 
HZ2009 HZ1450 with pXXR & pACYCBLMAXylE This work 
HZ2046 HZ1967 with pTrcXR & pACYCAraXylE This work 
HZ2061 HZ1967 with pAraXR & pACYCAraXylE This work 
HZ2062 HZ1967 with pAraVMQCI & pACYCAraXylE This work 
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Appendix B. List of plasmids created and used. 
 
Name Relevant characteristics Source 
pTrc99A Amp, pBR322-derived plasmid, Trc promoter Amersham Pharmacia 
pKK223-3 Amp, pBR322-derived plasmid, Tac promoter Amersham Pharmacia 
pQE-80L Amp, pBR322-derived plasmid, T5 promoter Qiagen  
pMAL-c2x  Amp, pBR322-derived plasmid, Tac promoter New England Biolabs  
pET15b Amp, pBR322-derived plasmid, T7 promoter Novagen 
pET20b Amp, pBR322-derived plasmid, T7 promoter Novagen 
pACYCDuet Cm, p15A-derived plasmid, T7 promoter Novagen 
pTrc99A-ncxr wt NcXR This work 
pKK223-3-ncxr wt NcXR This work 
pQE-80L-ncxr wt NcXR This work 
pMAL-c2x-ncxr wt NcXR This work 
pET15b-ncxr wt NcXR w/N-terminal His-tag & thrombin site [24] 
pACYC-ncxr wt NcXR w/N-terminal His-tag This work 
pACYC-S NcXR mutant S w/N-terminal His-tag This work 
pACYC-Q NcXR mutant Q w/N-terminal His-tag This work 
pACYC-QC NcXR mutant QC w/N-terminal His-tag This work 
pACYC-QCI NcXR mutant QCI w/N-terminal His-tag This work 
pACYC-MQCI NcXR mutant MQCI w/N-terminal His-tag This work 
pACYC-VMQCI NcXR mutant VMQCI w/N-terminal His-tag This work 
pKD3 FRT::cat::FRT, R6K ori [39] 
pKD4 FRT::cat::FRT, R6K ori [39] 
pKD46 λred genes under AraBAD promoter, ts ori [39] 
pCP20 Flp under heat inducible promoter, ts ori [39] 
p6XHisTKXb119 Km, Source of BLMA promoter [79] 
pTKXb-xdharaB' G. oxydans xdh & E. coli araB under BLMAp This work 
pET20b-xdharaB' G. oxydans xdh & E. coli araB under T7p This work 
pRW2-ptdh Km, Source of AraBAD promoter [80] 
pXXR pTrc99A with XR under XylA promoter This work 
pXVMQCI pTrc99A with VMQCI under XylA promoter This work 
pAraXR pTrc99A with XR under AraBAD promoter This work 
pAraVMQCI pTrc99A with VMQCI under AraBAD promoter This work 
pTrcXR pTrc99A with XR under Trc promoter This work 
pTrcVMQCI pTrc99A with VMQCI under Trc promoter This work 
pACYCBLMAXylE pACYCDuet with xylE under BLMA promoter This work 
pACYCAraXylE pACYCDuet with xylE under AraBAD promoter This work 
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Appendix C. List of primers used. Bold indicates restriction sites, and italics are sequences identical to E. coli 
chromosome used during homologous recombination for targeted integration.  
 
Purpose Name Sequence (5' to 3') 
Primers used for protein engineering 
NN_051110_ncXR_EcoRI_fwd ATATTAGAATTCGATGGTTCCTGCTATC 
NN_050613_ncXR_rev_BglII TACAGATCTCTAACCGAAAATCCAGAG 
NN050223_XR-1 TAATGAGAATTCATGGTTCCTGCTATC 
NN050223_XR-2 ATTGCAAAGCTTCTAACCGAAAATCCAG 
NN050531-ncXR_fwd_SphI GATCGGAACGCATGCATGGTTCCTGC 
NcXR cloning 
Crassa 1-For Nde1 GTAGCTACGTCACATATGGTTCCTGC 
NN_050613_xdh_fwd_NdeI TCGAACCATATGTCGAAGAAGTTTAACGG 
NN_050613_xdh_rev_EcoRV 
GGTATATCTCCTTGATATCTCAACCGCCAGCA
ATCGG 
NN_050613_araB_fwd_EcoRV 
GATATCAAGGACATATACCATGGCGATTGCAA
TTGGC 
NN_050613_araB_rev_XhoI TCTCTCTCTCGAGTTATAGAGTCGCAACGGC 
NN_050613_pKD3+xylA_fwd 
ATATTACGACATCATCCATCACCCGCGGCATTACC
TGATTGTGTAGGCTGGAGCTGCTTC 
NN_050613_pKD3+xylA_rev 
TACCGATAACCGGGCCAACGGACTGCACAGTTAG
CCGTTACATATGAATATCCTCCTTAG 
xylA_test_fwd CGACATCATCCATCACCC 
Selection strain 
construction 
xylA_test_rev CGATAACCGGGCCAACGG 
NN_050928_W21_fwd GGCTTCGGCCTCNNSAAGGTCGACGGC 
NN_050928_D44_fwd CTACCGCCTCTTCNNSGGTGCCTGCGAC 
NN_050928_D48_fwd GATGGTGCCTGCNNSTACGGCAACGAG 
NN_050928_F112_fwd CTACCTGATCCACNNSCCCGTCGCCCTC 
NN_050928_F225_fwd CTTCTTTCCGCGAGNNSAACATGGAGCACGC 
NN_050928_N307_fwd GGCATCCGCTTCNNSCAGCCCACCAAC 
NN_050928_W80_fwd GTCTCCAAGCTCNNSAACACCTTCCAC 
NN_050928_W129_fwd GTTACCCTCCCGGCNNSCACTTTGACGGC 
NN_050928_P309_fwd CGCTTCAACCAGNNSACCAACTACTTC 
NN_050928_W21_rev GCCGTCGACCTTSNNGAGGCCGAAGCC 
NN_050928_D44_rev GTCGCAGGCACCSNNGAAGAGGCGGTAG 
NN_050928_D48_rev CTCGTTGCCGTASNNGCAGGCACCATC 
NN_050928_F112_rev GAGGGCGACGGGSNNGTGGATCAGGTAG 
NN_050928_F225_rev GCGTGCTCCATGTTSNNCTCGCGGAAAGAAG 
NN_050928_N307_rev GTTGGTGGGCTGSNNGAAGCGGATGCC 
NN_050928_W80_rev GTGGAAGGTGTTSNNGAGCTTGGAGAC 
NN_050928_W129_rev GCCGTCAAAGTGSNNGCCGGGAGGGTAAC 
Saturation 
mutagenesis of 
substrate interacting 
residues 
NN_050928_P309_rev GAAGTAGTTGGTSNNCTGGTTGAAGCG 
NN_XR_L109X_fwd CGATCTCTACNNSATCCACTCGCC 
NN_XR_L109X_rev GGCGAGTGGATSNNGTAGAGATCG 
NN_L109Q_I110_fwd GATCTCTACCAGNNSCACTTCCCCGTC 
NN_L109Q_I110_rev GACGGGGAAGTGSNNCTGGTAGAGATC 
NN_L109Q_H111_fwd CTCTACCAGATCNNSTTCCCCGTCGCC 
Saturation 
mutagenesis on Q 
template 
NN_L109Q_H111_rev GGCGACGGGGAASNNGATCTGGTAGAG 
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NN_L109QI110C_D106X_fwd CTCGAGTACTTCNNSCTCTACCAGTGC 
NN_L109QI110C_L107X_fwd GAGTACTTCGATNNSTACCAGTGCCAC 
NN_L109QI110C_Y108X_fwd GTACTTCGATCTCNNSCAGTGCCACTTCC 
NN_L109QI110C_H111X_fwd CTCTACCAGTGCNNSTTCCCCGTCGCC 
NN_L109QI110C_F112X_fwd CTACCAGTGCCACNNSCCCGTCGCCCTCG 
NN_L109QI110C_P113X_fwd CAGTGCCACTTCNNSGTCGCCCTCGAG 
NN_L109QI110C_D106X_rev GCACTGGTAGAGSNNGAAGTACTCGAG 
NN_L109QI110C_L107X_rev GTGGCACTGGTASNNATCGAAGTACTC 
NN_L109QI110C_Y108X_rev GGAAGTGGCACTGSNNGAGATCGAAGTAC 
NN_L109QI110C_H111X_rev GGCGACGGGGAASNNGCACTGGTAGAG 
NN_L109QI110C_F112X_rev CGAGGGCGACGGGSNNGTGGCACTGGTAG 
Saturation 
mutagenesis on QC 
template 
NN_L109QI110C_P113X_rev CTCGAGGGCGACSNNGAAGTGGCACTG 
NN_XR_M_L102X_fwd GCCGACTGGGGTNNSGAGTACTTCGATATG 
NN_XR_M_E103X_fwd GACTGGGGTCTCNNSTACTTCGATATG 
NN_XR_M_Y104X_fwd CTGGGGTCTCGAGNNSACTTCGATATGTAC 
NN_XR_MQ_F105X_fwd GGTCTCGAGTACNNSGATATGTACCAG 
NN_XR_MQC_D106X_fwd CTCGAGTACTTCNNSATGTACCAGTGC 
NN_XR_MQC_Y108X_fwd GTACTTCGATATGNNSCAGTGCCACTTCC 
NN_XR_MQC_H111X_fwd GATATGTACCAGTGCNNSTTCCCCGTCGCCCTC 
NN_XR_MQC_F112X_fwd GTACCAGTGCCACNNSCCCGTCGCCCTC 
NN_XR_A115X_fwd CACTTCCCCGTCNNSCTCGAGTACGTC 
NN_XR_L116X_fwd CTTCCCCGTCGCCNNSGAGTACGTCGACC 
NN_XR_E117X_fwd CCCGTCGCCCTCNNSTACGTCGACCCC 
NN_XR_Y118X_fwd GTCGCCCTCGAGNNSGTCGACCCCTCG 
NN_XR_M_L102X_rev CATATCGAAGTACTCSNNACCCCAGTCGGC 
NN_XR_M_E103X_rev CATATCGAAGTASNNGAGACCCCAGTC 
NN_XR_M_Y104X_rev GTACATATCGAAGTSNNCTCGAGACCCCAG 
NN_XR_MQ_F105X_rev CTGGTACATATCSNNGTACTCGAGACC 
NN_XR_MQC_D106X_rev GCACTGGTACATSNNGAAGTACTCGAG 
NN_XR_MQC_Y108X_rev GGAAGTGGCACTGSNNCATATCGAAGTAC 
NN_XR_MQC_H111X_rev 
GAGGGCGACGGGGAASNNGCACTGGTACATAT
C 
NN_XR_MQC_F112X_rev GAGGGCGACGGGSNNGTGGCACTGGTAC 
NN_XR_A115X_rev GACGTACTCGAGSNNGACGGGGAAGTG 
NN_XR_L116X_rev GGTCGACGTACTCSNNGGCGACGGGGAAG 
NN_XR_E117X_rev GGGGTCGACGTASNNGAGGGCGACGGG 
NN_XR_Y118X_rev CGAGGGGTCGACSNNCTCGAGGGCGAC 
NN_QC_V114X_fwd GTGCCACTTCCCCNNSGCCCTCGAGTACG 
Saturation 
mutagenesis on 
MQC and MQCI 
templates 
NN_QC_V114X_rev CGTACTCGAGGGCSNNGGGGAAGTGGCAC 
NN_051110_ACYCDuetUP1 GGATCTCGACGCTCTCCCT Sequencing primers 
T7 term GCTAGTTATTGCTCAGCGG 
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Primers used for genome/metabolic engineering  
NN F XylAp NsiI 
AGTGTACGATGCATTTCCATTTTATTTTGCGAG
CGAGCGCACAC 
NN R XylAp ncXR 
CGGAGTTGAGCTTGATAGCAGGAACCATAATC
AGGTAATGCCGCGGGTGATGG 
NN F XylAp ncXR 
CCATCACCCGCGGCATTACCTGATTATGGTTCC
TGCTATCAAGCTCAACTCCG 
NN R ncXR BglII NN_050613_ncXR_rev_BglII 
NcXR cloning 
NN F NdeI XR Crassa 1-For Nde1 
NN F NdeI xylE ATGCTACATATGAATACCCAGTATAATTCCAG 
NN R PciI xylE 
ATGCTAACATGTTTACAGCGTAGCAGTTTGTT
GTGTTTTC 
NN R XhoI xylE 
ATGCTACTCGAGTTACAGCGTAGCAGTTTGTT
GTGTTTTC 
NN F pTKxB SEQ GCCGTCATGATAATTTCAGAATAAAAGC 
NN R pTKxb SEQ CGGTGGCAGCAGCCAACTCCAGCTTCC 
NN F pRW2 SEQ 
GAAAAGTCCACATTGATTATTTGCACGGCGTC
ACAC 
NN R pRW2 SEQ GCTGTGCTTTCAGTGGATTTCGGATAAC 
NN F xylE SEQmid1 ATGAATACCCAGTATAATTCCAG 
NN F xylE SEQmid2 TTATTGCCCGTTCCGGTGATG 
xylE cloning 
  
  
  
  
  
  
  
  
  
NN F xylE SEQmid3 ACCGGGTATTGTGGCGCTAC 
NN F D(cyaAregul) pKD3 
ATCTGATCCGCTTTGCGCGTCGCAATAACCTTAGC
GTCTCCGCCAGTCCGGTGTAGGCTGGAGCTGCT
TC 
NN R D(cyaAregul) pKD3 
CCGCTAAGATTGCATGCCGGATAAGCCTCGCTTT
CCGGCACGTTCATTCACATATGAATATCCTCCTT
AG 
NN F D(cyaAregul) chk TTAAAAGTGTGCGAAAAGCTCAGCCGTGAA 
Deletion of cyaA 
regulation domain 
NN R D(cyaAregul) chk AGGAGCCGCTGCACCAGGTATGGCTGGCAA 
NN F D(ptsG) pKD3 
GGGATTATCTCCGGTGCGATCGCAGCGTACATGT
TTAACCGTTTCTACCGGTGTAGGCTGGAGCTGCT
TC 
NN R D(ptsG) pKD3 
TTAATCAGCACGCGGAAGATGGTGTAGTAAACAAT
CGCATAACCGATACCCATATGAATATCCTCCTT
AG 
NN F ptsG chk ATGTTTAAGAATGCATTTGCTAACCTGC 
Deletion of ptsG 
NN R ptsG chk TTAGTGGTTACGGATGTACTCATC 
NN F D(xylAB) pKD3 
CGCAAGTTGTTACAGCGATGGAAGCAACCCATAA
ATTGGGCGGTGAAAACGTGTAGGCTGGAGCTGC
TTC  
NN R D(xylAB) pKD3 
TAATACCGCAGGCATGCACGACATCCATGCCATC
TGCCAGCGCATAACCCCATATGAATATCCTCCT
TAG 
NN F D(xylAB) chk CACGATGTGGATGTTTCCCCTGAGGGCGCG 
Deletion of xylAB 
NN R D(xylAB) chk ACAATTCAATGAGCGATTTCTCTGGATTCG 
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Appendix D. List of organisms, strains, and plasmids used and constructed used in this study. 
 
HZ Genotype Plasmid Plasmid Construction Comments Source 
Created by Nikhil U. Nair 
672 YSG50 pRS426-ADH1-GFP ADH1p-GFP-ADH1t   
673 YSG50 pRS426-GPD-GFP GPDp-GFP-GPDt   
674 YSG50 pRS426-TEF1-GFP TEF1p-GFP-TEF1t   
675 YSG50 pRS426-TEF2-GFP TEF2p-GFP-TEF2t   
705 DH5α pRS426-ADH1-GFP ADH1p-GFP-ADH1t   
706 DH5α pRS426-GPD/TDH3-GFP TDH3p-GFP-TDH3t   
707 DH5α pRS426-TEF1-GFP TEF1p-GFP-TEF1t   
708 DH5α pRS426-TEF2-GFP TEF2p-GFP-TEF2t   
709 Bacillus cereus - -  
NRRL B-
3711 
710 YSG50 - - 
MATα ura3-1 ade2-
1 his3-11,15 leu2-
3,112 can1-100 trp1-
1 
Peter A. 
Orlean, 
UIUC 
714 
Cupriavidus 
necator - -  
NRRL B-
14690 
715 YSG50 pRS423-caAdhE2 (+2N) 
TDH3p-His6-caAdhE2-
ADH2t 
expression tested, 
none found  
716 YSG50 pRS423-caAdhE2 (-1) TDH3p-caAdhE2-ADH2t expression not tested  
717 YSG50 pRS423-cbAad (+1N) 
TDH3p-His6-cbAad-
ADH2t 
expression tested, 
none found  
718 YSG50 pRS423-cbAad (-1) TDH3p-cbAad-ADH2t expression not tested  
719 YSG50 pRS423-cbAad (-2) TDH3p-cbAad-ADH2t expression not tested  
720 YSG50 pRS423-caBdhB (+1N) 
TDH3p-His6-caBdhB-
ADH2t 
expression tested, 
active in yeast  
721 YSG50 pRS423-caBdhB (+2N) 
TDH3p-His6-caBdhB-
ADH2t expression not tested  
722 YSG50 pRS423-caBdhB (-1) TDH3p-caBdhB-ADH2t expression not tested  
723 YSG50 pRS423-cbAdhA (+1N) 
TDH3p-His6-cbAdhA-
ADH2t 
expression tested, 
none found  
724 YSG50 pRS423-cbAdhA (+2N) 
TDH3p-His6-cbAdhA-
ADH2t expression not tested  
725 YSG50 pRS423-cbAdhB (+1N) 
TDH3p-His6-cbAdhB-
ADH2t 
expression tested, 
active in yeast  
726 YSG50 pRS423-cbAdhB (+2N) 
TDH3p-His6-cbAdhB-
ADH2t expression not tested  
727 YSG50 pRS423-bfHbd (+2N) 
TDH3p-His6-bfHbd-
ADH2t 
expression tested, 
active in yeast  
728 YSG50 pRS423-bfHbd (-1) TDH3p-bfHbd-ADH2t expression not tested  
729 YSG50 pRS423-bfHbd (-2) TDH3p-bfHbd-ADH2t expression not tested  
730 YSG50 pRS423-caHbd (+1N) 
TDH3p-His6-caHbd-
ADH2t 
expression tested, 
active in yeast  
732 YSG50 pRS423-bcHbd (+2N) 
TDH3p-His6-bcHbd-
ADH2t 
expression tested, 
none found  
733 YSG50 pRS423-bcHbd (-2) TDH3p-bcHbd-ADH2t expression not tested  
734 YSG50 pRS423-caCrt (+1N) 
TDH3p-His6-caCrt-
ADH2t 
expression tested, 
active in yeast  
735 YSG50 pRS423-caCrt (+2N) 
TDH3p-His6-caCrt-
ADH2t expression not tested  
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736 YSG50 pRS423-caCrt (-1) TDH3p-caCrt-ADH2t expression not tested  
737 YSG50 pRS423-caCrt (-2) TDH3p-caCrt-ADH2t expression not tested  
738 YSG50 pRS423-cnBad (+1N) 
TDH3p-His6-cnBad-
ADH2t 
expression tested, 
none found  
739 YSG50 pRS423-cnBad (+2N) 
TDH3p-His6-cnBad-
ADH2t expression not tested  
740 YSG50 pRS423-cnBad (-1) TDH3p-cnBad-ADH2t expression not tested  
741 YSG50 pRS423-cnBad (-2) TDH3p-cnBad-ADH2t expression not tested  
742 YSG50 pRS423-scAdh6 (+1N) 
TDH3p-His6-scAdh6-
ADH2t expression not tested  
743 YSG50 pRS423-scAdh6 (+2N) 
TDH3p-His6-scAdh6-
ADH2t expression not tested  
744 YSG50 URA3+ - -   
745 HZ744 - - same as #744  
748 YSG50 pRS423-bfCrt (+2N) 
TDH3p-His6-bfCrt-
ADH2t 
Expressed in yeast. 
Activity not tested.  
749 YSG50 pRS423-bfCrt (+1C) 
TDH3p-bfCrt-His6-
ADH2t 
Expressed in yeast. 
Activity not tested.  
750 YSG50 pRS423-bfCrt (+2C) 
TDH3p-bfCrt-His6-
ADH2t expression not tested  
751 YSG50 pRS423-bcCrt (+2N) 
TDH3p-His6-bcCrt-
ADH2t 
Expressed in yeast. 
Activity not tested.  
752 YSG50 pRS423-bcCrt (+1C) 
TDH3p-bcCrt-His6-
ADH2t 
Expressed in yeast. 
Activity not tested.  
753 YSG50 pRS423-bcCrt (+2C) 
TDH3p-bcCrt-His6-
ADH2t expression not tested  
754 YSG50 pRS423-caCrt (+1C) 
TDH3p-caCrt-His6-
ADH2t 
expression tested, 
active in yeast  
755 YSG50 pRS423-caCrt (+2C) 
TDH3p-caCrt-His6-
ADH2t expression not tested  
756 YSG50 pRS423-cnBad (+1C) 
TDH3p-cnBad-His6-
ADH2t 
Active in yeast, but 
not twd butyryl-CoA  
757 YSG50 pRS423-cnBad (+2C) 
TDH3p-cnBad-His6-
ADH2t expression not tested  
758 YSG50 pRS423-scAdh6 (+1C) 
TDH3p-scAdh6-His6-
ADH2t 
expression tested, 
active in yeast  
759 YSG50 pRS423-scAld4 (+1C) 
TDH3p-scAld4-His6-
ADH2t 
1st 3 residues 
deleted. Doesn't 
express.  
760 YSG50 pRS423-scAld4 (+2C) 
TDH3p-scAld4-His6-
ADH2t 
see #759. Expression 
not tested.  
761 YSG50 pRS423-caPtb (+2N) 
TDH3p-His6-caPtb-
ADH2t 
expression tested, 
none found  
762 YSG50 pRS423-caPtb (+1C) 
TDH3p-caPtb-His6-
ADH2t 
Expressed in yeast. 
Activity not tested.  
763 YSG50 pRS423-caPtb (+2C) 
TDH3p-caPtb-His6-
ADH2t 
Expression not 
tested  
764 YSG50 pRS423-caBuk (+1N) 
TDH3p-His6-caBuk-
ADH2t 
expression tested, 
none found  
765 YSG50 pRS423-caBuk (+2N) 
TDH3p-His6-caBuk-
ADH2t 
Expression not 
tested  
766 YSG50 pRS423-caBuk (+1C) 
TDH3p-caBuk-His6-
ADH2t 
Expressed in yeast. 
Activity not tested.  
767 YSG50 pRS423-caBuk (+2C) 
TDH3p-caBuk-His6-
ADH2t 
Expression not 
tested  
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842 YSG50 pRS423-teAad (+1N) 
TDH3p-His6-teAad-
ADH2t 
expression tested, 
none found 
T. 
ethanolicus 
39E from 
Herbert 
Strobel 
843 YSG50 pRS423-teAad (+2N) 
TDH3p-His6-teAad-
ADH2t expression not tested  
844 YSG50 pRS423-teAad (+1C) 
TDH3p-teAad-His6-
ADH2t 
expression tested, 
none found  
845 YSG50 pRS423-teAad (+2C) 
TDH3p-teAad-His6-
ADH2t expression not tested  
846 YSG50 pRS423-teAad (-1) TDH3p-teAad-ADH2t expression not tested  
847 YSG50 pRS423-teAad (-2) TDH3p-teAad-ADH2t expression not tested  
848 HZ744 ∆ura3 - - 
for gene deletion 
studies  
856 YSG50 p423PBA 
pRS423-
caPtb/caBuk/scAld6 
TDH3p,t, TEF2p,t, 
PGKp,t, resp.  
857 YSG50 pTB pRS425-caBdhB/egTer 
TDH3p-ADH2t, 
ADH1p,t, resp.  
1035 YSG50 
pRS426-full but/pRS423-
caAdhE2 see #1000, #716 
Does not produce 
butanol  
1036 YSG50 
pRS426-full but/pRS425-
caAad see #1000, #703 
Does not produce 
butanol  
1037 W303a 
pRS426-full but/pRS423-
caAdhE2 see #1000, #716 
Does not produce 
butanol  
1038 W303a 
pRS426-full but/pRS425-
caAad see #1000, #703 
Does not produce 
butanol  
1039 W303a pRS423-caAdhE2Opt see #716 
caAdhE2 codon 
optim for E coli 
recloned from #948  
1040 YSG50 pRS423-caAdhE2Opt see #716 
caAdhE2 codon 
optim for E coli 
recloned from #948  
1041 YSG50 
pRS426-full but/pRS424-
glAad see #1000, #   
1042 HZ348 pET26b-NcXR 
wt NcXR (NdeI-
BamHI/BglII) see #1029  
1043 HZ348 pET26b-VMQCI-XR 
NcXR mutant VMQCI 
(NdeI-BamHI/BglII) see #1028,#1029  
1045 W303a - - 
MATa ura3-52 
ade2-1 his3-11,15 
leu2-3,112 can1-100 
trp1∆2 
Open 
Biosystems 
YSC1058 
1046 YSG50 
pRS426-full but/pRS423-
caAdhE2Opt see #1000, #1040 
Does not produce 
butanol  
1047 YSG50 pRS426-full but/p423PBA see #1000, #856 
Does not produce 
butanol  
1048 W303a 
pRS426-full but/pRS423-
caAdhE2Opt see #1000, #1040 
Does not produce 
butanol  
1049 W303a pRS426-full but/p423PBA see #1000, #856 
Does not produce 
butanol  
1052 YSG50 pTHC/pTB see #947, #857   
1053 W303a pTHC/pTB see #947, #857   
1054 W303a pRS426-full but see #1000   
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1055 YSG50 pTHC/pTB/pGV1213 see #947, #857, #948 
Does not produce 
butanol  
1056 W303a pTHC/pTB/pGV1213 see #947, #857, #948 
Resting cells 
produce v. small 
amounts of butanol  
1119 
YSG50 
∆adh1::kanMX4 - - 
G418 resitant. Adh1- 
strain  
1120 
YSG50 
∆adh1::kanMX4 - - 
G418 resitant. Adh1- 
strain, Same as 
HZ1119 
 
1150 YSG50 pCoSc5.8 
pRS426-TDH3p-
caAdhE2-coSc5.8-ADH2t 
codon-optim using 
JCat. Sequenced 
clone.  
1153 DH5α pTB pRS425-caBdhB/egTer see #857  
1154 DH5α pCoSc5.8 
pRS426-TDH3p-
caAdhE2-coSc5.8-ADH2t see #1150  
1157 W303a pTHC/pTB/pCoSc5.8 see #947, #857, #1150 
Does not produce 
butanol  
1158 W303a pNHis-CoSc5.8 
pRS423-TDH3p-His6-
caAdhE2-coSc5.8-ADH2t N-His tagged #1150  
1159 HZ1116 pTHC/pTB/pCoSc5.8 see #947, #857, #1150 
Does not produce 
butanol  
1160 HZ1116 pTHC/pTB/pGV1213 see #947, #857, #948 
Resting cells 
produce butanol  
1192 DH5α pCA3 
pRS426-TDH3p-SacI-
caAdhE2(gevo)-cMyc-
GFP-KpnI-CYC1t 
Full length, 
fluorescent. 
Sequenced.  
1193 DH5α pCA1 
pRS426-TDH3p-SacI-
caAdhE2(trunc)-cMyc-
GFP-KpnI-CYC1t 
Truncated, 
fluorescent. 
Sequenced.  
1194 DH5α pNB3 
pRS426-TDH3p-SacI-
GFP-cMyc-cbBad-KpnI-
CYC1t 
Full length, 
fluorescent. 
Sequenced.  
1297 
HZ848 
∆adh6::ura3-IR-
LN25 - - Adh6- Ura+  
1298 HZ848 ∆adh6 - - Adh6- Ura-  
1304 W303a pepAdhE2*-GFP 
pRS426-TDH3p-
epAdhE2*-GFP-CYC1t 
epPCR library of 
caAdhE2. Diversity 
= 3e5  
1305 W303a pepAdhE2*-GFP 
pRS426-TDH3p-
epAdhE2*-GFP-CYC1t same as #1304  
1306 W303a pepBad-GFP 
pRS426-TDH3p-epBad-
GFP-CYC1t 
epPCR library of 
cbBad. Diversity = 
1e5.  
1307 W303a pepBad-GFP 
pRS426-TDH3p-epBad-
GFP-CYC1t same as #1306  
1308 W303a pepAdhE2*-GFP 
pRS426-TDH3p-
epAdhE2*-GFP-CYC1t 
Enriched #1304 by 
FACS. Diversity = 
2e4  
1309 W303a pepBad-GFP 
pRS426-TDH3p-epBad-
GFP-CYC1t 
Enriched #1306 by 
FACS. Diversity = 
3e4  
1430 W303a pepAdhE2*-GFP 
pRS426-TDH3p-
epAdhE2*-GFP-CYC1t 
Enriched #1308 by 
FACS. Diversity = 
288  
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1431 W303a pepBad-GFP 
pRS426-TDH3p-epBad*-
GFP-CYC1t 
Enriched #1306 by 
FACS. Diversity = 
192  
1436 HZ1116 pTHC, pTB, pCA3 see #947, #857, #1192   
1437 DH5α pBA2-GFP 
pRS426-TDH3p-epBad-
GFP-CYC1t 
Full-length mutant 
Bad+GFP w/high 
fluorescence 
 
1438 DH5α pBA3-GFP 
pRS426-TDH3p-epBad-
GFP-CYC1t 
Full-length mutant 
Bad+GFP w/high 
fluorescence 
 
1439 DH5α pBF1-GFP 
pRS426-TDH3p-epBad-
GFP-CYC1t 
Full-length mutant 
Bad+GFP w/high 
fluorescence 
 
1440 W303a pBA2-GFP see #1437 Plasmid from #1437  
1441 W303a pBA3-GFP see #1438 Plasmid from #1438  
1442 W303a pBF1-GFP see #1439 Plasmid from #1439  
1443 HZ1116 pTHC, pTB, pBA2-GFP see #947, #857, #1437 Produces butanol  
1444 HZ1116 pTHC, pTB, pBA3-GFP see #947, #857, #1438 Produces butanol  
1445 HZ1116 pTHC, pTB, pBF1-GFP see #947, #857, #1439 Produces butanol  
1452 DH5α pRS426-epAdhE2*-GFP see #1430 
Plasmid library of 
#1430 electroporated  
1453 DH5α pRS426-epBad-GFP see #1431 
Plasmid library of 
#1431 electroporated  
1492 W303a pAPRlibr 
pRS426-TDH3p-
epAdhE2*-CYC1t 
full-length 
epAdhE2* libr 
Rnd2.1 w/o GFP  
1493 W303a pBPRlibr 
pRS426-TDH3p-epBad-
CYC1t 
full-length epBad 
libr Rnd2.1 w/o GFP  
1494 
HZ1298 
∆adh7::ura3-IR 
LN25 - - Adh7- Ura+  
1495 HZ1298 ∆adh7 - - Adh7- Ura-  
1496 DH5α pRS426-epAdhE2* see #1492 
plasmids from 
#1492 transformed  
1497 DH5α pRS426-epBad see #1493 
plasmids from 
#1493 transformed  
1498 HZ1116 pTHC, pTB, pAPR1 see #947, #857, #1492 
mutant caAdhE2* 
APR1. Produces 
butanol.  
1499 HZ1116 pTHC, pTB, pAPR2 see #947, #857, #1492 
mutant caAdhE2* 
APR2. Produces 
butanol.  
1500 HZ1116 pTHC, pTB, pAPR3 see #947, #857, #1492 
mutant caAdhE2* 
APR3. Produces 
butanol.  
1501 HZ1116 pTHC, pTB, pAPR4 see #947, #857, #1492 
mutant caAdhE2* 
APR4. Produces 
butanol.  
1502 HZ1116 pTHC, pTB, pAPR5 see #947, #857, #1492 
mutant caAdhE2* 
APR5. Produces 
butanol.  
1503 HZ1116 pTHC, pTB, pAPR6 see #947, #857, #1492 
mutant caAdhE2* 
APR6. Produces 
butanol.  
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1504 HZ1116 pTHC, pTB, pAPR7 see #947, #857, #1492 
mutant caAdhE2* 
APR7. Produces 
butanol. 
 
1505 HZ1116 pTHC, pTB, pAPR8 see #947, #857, #1492 
mutant caAdhE2* 
APR8. Produces 
butanol. 
 
1506 HZ1116 pTHC, pTB, pBPR1 see #947, #857, #1493 
mutant cbBad* 
BPR1. Not tested for 
butanol prod'n. 
 
1507 HZ1116 pTHC, pTB, pBPR2 see #947, #857, #1493 
mutant cbBad* 
BPR2. Not tested for 
butanol prod'n. 
 
1550 DH5α pAPR1 see #1492   
1551 DH5α pAPR2 see #1492   
1552 DH5α pAPR4 see #1492   
1553 DH5α pTdenTER pET28a-TdTER 
provided by Sara 
Tucci Sara Tucci 
1554 DH5α pTdenTER pET28a-TdTER same as #1553  
1555 DH5α pTdTER 
pRS425-TDH3p-TdTER-
CYC1t   
1556 DH5α pTdTER-CGFP 
pRS425-TDH3p-TdTER-
GFP-CYC1t   
1557 W303a pTdTER-CGFP 
pRS425-TDH3p-TdTER-
GFP-CYC1t   
1644 
HZ1495 
∆adh4::ura3-IR 
LN25 - - Adh4- Ura+  
1645 HZ1495 ∆adh4 - - Adh4- Ura-  
1646 HZ1116 pTHC, pGV1213, pTdTER see #947, #948, #1555 Produces butanol.  
1649 
HZ1645 
∆adh5::ura3-IR 
LN25 - - Adh5- Ura+  
1652 HZ1645 ∆adh5 - - Adh5- Ura-  
1653 DH5α pT2B pRS425-caBdhB/tdTer   
1654 DH5α pBF1 
pRS426-TDH3p-cbBad-
BF1-CYC1t   
1655 DH5α p423AclAB pRS423-aclAB   
1656 
HZ1652 
∆gpd1::ura3-IR 
LN25 - - Gpd1- Ura+  
1657 HZ1652 ∆gpd1 - - Gpd1- Ura-  
1658 W303a pBF1-GFP epPCR library 
pRS426-TDH3p-epBad-
BF1-GFP-CYC1t 
epPCR library of 
BF1. Size ~6,000  
1659 W303a ptdTer-GFP epPCR library 
pRS426-TDH3p-
epTdTER-GFP-CYC1t 
epPCR library of 
tdTER. Size ~21,000  
1660 W303a ptdTer-GFP epPCR library R1 
pRS426-TDH3p-
epTdTER-GFP-CYC1t 
enriched #1659. 
~10,000 of top 1%.  
1663 W303a pBF1-GFP epPCR library R1.1 
pRS426-TDH3p-epBad-
BF1-GFP-CYC1t 
enriched #1658. 
~20,000 of top 1%. 
Plugged FACS.  
1714 W303a pBF1-GFP epPCR library R2.2 
pRS426-TDH3p-epBad-
BF1-GFP-CYC1t 
enriched #1661. Top 
1%.  
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1715 W303a ptdTer-GFP epPCR library R2 
pRS426-TDH3p-
epTdTER-GFP-CYC1t 
enriched #1660. Top 
1%.  
1716 DH5α see #1713 see #1713 
transformed library 
of #1713  
1717 DH5α see #1715 see #1715 
transformed library 
of #1715  
1718 DH5α see #1714 see #1714 
transformed library 
of #1714  
1744 DH5α pBH5-GFP 
pRS426-TDH3p-epBad-
BH5-GFP-CYC1t 
One of the most 
fluorecent mutants 
from #1714 
 
1745 DH5α pBE12-GFP 
pRS426-TDH3p-epBad-
BE12-GFP-CYC1t 
One of the most 
fluorecent mutants 
from #1714 
 
1746 DH5α pBC12-GFP 
pRS426-TDH3p-epBad-
BC12-GFP-CYC1t 
One of the most 
fluorecent mutants 
from #1714 
 
1747 DH5α pBA11-GFP 
pRS426-TDH3p-epBad-
BA11-GFP-CYC1t 
One of the most 
fluorecent mutants 
from #1714 
 
1748 DH5α pTG12-GFP 
pRS426-TDH3p-
epTdTER-TG12-GFP-
CYC1t 
One of the most 
fluorecent mutants 
from #1715 
 
1749 DH5α pTC8-GFP 
pRS426-TDH3p-
epTdTER-TC8-GFP-
CYC1t 
One of the most 
fluorecent mutants 
from #1715 
 
1750 DH5α pTB5-GFP 
pRS426-TDH3p-
epTdTER-TB5-GFP-
CYC1t 
One of the most 
fluorecent mutants 
from #1715 
 
1751 DH5α pTA6-GFP 
pRS426-TDH3p-
epTdTER-TA6-GFP-
CYC1t 
One of the most 
fluorecent mutants 
from #1715 
 
1759 DH5α pBE12 
pRS426-TDH3p-epBad-
BE12-CYC1t 
mutant cbBad-BE12 
w/o GFP. Active.  
1760 DH5α pBH5 
pRS426-TDH3p-epBad-
BH5-CYC1t 
mutant cbBad-BH5 
w/o GFP. Active.  
1768 DH5α pTA6 
pRS426-TDH3p-
epTdTER-TA6-CYC1t 
mutant tdTer-TA6 
w/o GFP. Active.  
1769 DH5α pTB5 
pRS426-TDH3p-
epTdTER-TB5-CYC1t 
mutant tdTer-TB5 
w/o GFP. Activity 
unverified.. 
 
1770 DH5α pTC8 
pRS426-TDH3p-
epTdTER-TC8-CYC1t 
mutant tdTer-TC8 
w/o GFP. Active.  
1771 HZ1116 pTHC, pT2B, pBA11 see #947, #1653, #1758 
butanol production 
not verified.  
1772 HZ1116 pTHC, pT2B, pBE12 see #947, #1653, #1758 
Resting cells 
produce butanol.  
1773 HZ1116 pTHC, pT2B, pBH5 see #947, #1653, #1758 
Resting cells 
produce butanol.  
1774 HZ1116 pTHC, pBF1, pTA6 see #947, #1654, #1758 
Resting cells 
produce butanol.  
1775 HZ1116 pTHC, pBF1, pTB5 see #947, #1654, #1758 
butanol production 
not verified.  
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1776 HZ1116 pTHC, pBF1, pTC8 see #947, #1654, #1758 
Resting cells 
produce butanol.  
1758 DH5α pBA11 
pRS426-TDH3p-epBad-
BA11-CYC1t 
mutant cbBad-BA11 
w/o GFP. Activity 
unverified. 
 
1784 W303a pBAEHShuffLibr 
pRS426-TDH3p-
BadLibrary-GFP-CYC1t 
Shuffled 
BA11,BE12,BH5 
w/C-GFP. Size 
~17,000.  
1785 W303a pBAEHShuffLibr 
pRS426-TDH3p-
BadLibrary-GFP-CYC1t 
Enriched top 1% of 
#1784  
1808 W303a pBAEHShuffLibr 
pRS426-TDH3p-
BadLibrary-GFP-CYC1t 
Enriched top 0.1% 
of #1785. Size 
~10,000  
1809 W303a pBAEHShuffLibr 
pRS426-TDH3p-
BadLibrary-GFP-CYC1t 
Enriched top 0.01% 
of #1785. Size ~400  
1811 DH5α pBAEHShuffLibr 
pRS426-TDH3p-
BadLibrary-GFP-CYC1t 
Enriched top 0.1% 
of #1785. Size 
~10,000 transf. 
 
1812 DH5α pBAEHShuffLibr 
pRS426-TDH3p-
BadLibrary-GFP-CYC1t 
Enriched top 0.01% 
of #1785. Size 
~10,000 transf. 
 
1813 HZ1781 ∆gpd2 - - Gpd1- Gpd2- Ura-  
1814 HZ1813 pTHC,pT2B,pBF1 see #947, #1653, #1654   
1815 W303a pBA1-GFP 
pRS426-TDH3p-Bad-
BA1-GFP-CYC1t top 3 from #1809.  
1816 W303a pBC2-GFP 
pRS426-TDH3p-Bad-
BC2-GFP-CYC1t top 3 from #1809.  
1817 W303a pBD12-GFP 
pRS426-TDH3p-Bad-
BD12-GFP-CYC1t top 3 from #1809.  
1818 HZ1813 pRS424,pRS425,pRS426 empty vectors control for #1814  
1661 W303a pBF1-GFP epPCR library R1.2 
pRS426-TDH3p-epBad-
BF1-GFP-CYC1t 
enriched #1658. 
~6,000 of top 1%.  
1662 W303a 
ptdTer-GFP epPCR library 
THL R1 
pRS426-TDH3p-
epTdTER-GFP-CYC1t 
enriched #1735, top 
1%  
1713 W303a pBF1-GFP epPCR library R2.1 
pRS426-TDH3p-epBad-
BF1-GFP-CYC1t 
enriched #1663. Top 
1%.  
1782 
HZ848 gpd1 
D391::ura3-IR 
LN25 - - Ura+  
1941 DH5α pBA1 
pRS426-TDH3p-Bad-
BA1-CYC1t 
sequence is same as 
Bad-BA11  
1942 DH5α pBC2 
pRS426-TDH3p-Bad-
BC2-CYC1t 
sequence is same as 
Bad-BA11  
1943 DH5α pBD12 
pRS426-TDH3p-Bad-
BD12-CYC1t 
sequence is same as 
Bad-BA11  
1947 W303a pCEN-BF1-GFP 
pRS416-TDH3p-Bad-
BF1-GFP-CYC1t   
1948 W303a pCEN-BA11-GFP 
pRS416-TDH3p-Bad-
BA11-GFP-CYC1t   
1949 W303a pCEN-BE12-GFP 
pRS416-TDH3p-Bad-
BE12-GFP-CYC1t   
1950 W303a pCEN-BH5-GFP 
pRS416-TDH3p-Bad-
BH5-GFP-CYC1t   
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1954 
HZ1813 
∆adh1::ura3-IR - - 
Gpd1- Gpd2- Adh1- 
Ura+  
1955 DH5α pCEN-BF1-GFP see #1947   
1956 DH5α pCEN-BA11-GFP see #1948   
1957 DH5α pCEN-BE12-GFP see #1949   
1958 DH5α pCEN-BH5-GFP see #1950   
1959 HZ1813 ∆adh1 - - 
Gpd1- Gpd2- Adh1- 
Ura-  
1960 HZ1813 p416FuBu2 
full butanol pathway in 
pRS416   
1961 HZ1813 pRS416 -   
1962 HZ1959 p416FuBu2 
full butanol pathway in 
pRS416   
1963 HZ1959 pRS416 -   
1965 HZ1119 p416FuBu2 see #1982 
Resting cells 
produce butanol  
1968 
HZ1959 
∆pdc2::ura3-IR - - 
Gpd1- Gpd2- Adh1- 
Pdc2- Ura+. Grows 
on EtOH.  
1969 
HZ1959 
∆pdc2::ura3-IR - - 
Different clone than 
#1968, but isogenic.  
1980 HZ1959 ∆pdc2 - - 
Gpd1- Gpd2- Adh1- 
Pdc- Ura-. Grows on 
EtOH.  
1981 HZ1959 ∆pdc2 - - 
Gpd1- Gpd2- Adh1- 
Pdc- Ura-. Grows on 
EtOH.  
1982 DH5α p416FuBu2 
full, functional butanol 
pathway 
Plasmid constr by 
Zengyi. Last 6 aa of 
Ter missing  
1983 DH5α p424PAA1 pdc-acs-ald6 
Plasmid constr by 
Zengyi & Hua  
1984 DH5α p424PAA2 pdc-acs-ald6 
Plasmid constr by 
Zengyi & Hua  
1985 DH5α p424PAA3 pdc-acs-ald6 
Plasmid constr by 
Zengyi & Hua  
1986 HZ1119 
p416FuBu2,p423AclAB,p424,
p425 see #1982, #1655   
1987 HZ1119 
p416FuBu2,p423,p424Fdh1,p4
25 see #1982, #802   
1988 HZ1119 
p416FuBu2,p423,p424PAA1,p
425 see #1982, #1983   
1989 HZ1119 
p416FuBu2,p423,p424,p425St
h see #1982, #803   
1990 HZ1119 p416FuBu2,p423,p424,p425 
positive control for above. 
See #1982.   
1991 HZ1119 p416,p423,p424,p425 negative control for above.   
2000 DH5α p425AAA1 
PGK1-ald6, TEF1-
acs*(L641P), PYK1-
aclA1   
2001 DH5α p424FSB2 
HXT7-fdh1, TDH3-sth, 
TDH2-aclB2   
2012 DH5α p425pflAB 
his3 replaced w/leu2 in 
#2066 
ORF sequences 
verified  
2013 HZ1959 p416FuBu2,p423,p424,p425 
positive control for above. 
See #1982.   
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2014 HZ1959 p416,p423,p424,p425 negative control for above.   
2025 HZ1119 
p416FuBu2,p423PflAB,p424F
SB2,p425AAA1 
see #1982, #2001, #2000, 
#2066 
pflB may have 
mutations  
2026 HZ1119 
p416FuBu2,p423PflAB,p424,p
425 see #1982, #2066 
pflB may have 
mutations  
2027 HZ1119 
p416FuBu2,p423PflAB,p424F
dh1,p425 see #1982, #802, #2066 
pflB may have 
mutations  
2048 DH5α p416FuBuOpt1 see #1982 
Opt thl (#2089) and 
hbd (#2090) in 
#1982. ORFs seq  
2049 HZ1980 
p416FuBu2,p423PflAB,p424F
dh1,p425 see #1982, #802, #2066 
pflB may have 
mutations  
2050 HZ1980 
p416FuBu2,p423AclAB,p424,
p425 see #1982, #1655   
2051 HZ1980 
p416FuBu2,p423PflAB,p424,p
425 see #1982, #2066 
pflB may have 
mutations  
2052 HZ1980 p416FuBu2,p423,p424,p425 
see #1982. Positive 
control for above.   
2053 HZ1980 p416,p423,p424,p425 negative control for above   
2066 DH5α p423pflAB 
GPDp-pflA-ADH1t-
PGK1p-pflB-CYC1t 
(KpnI/SacI) 
Plasmid constr. by 
Tae-Hee. ORF 
sequences verified  
2067 HZ1119 p416FuBuOpt1 see #2012   
2088 W303a p426Bad-BF1-His see #2110 
C-term his for 
purification  
2089 NEB-10 pJ201_cathl_opt - 
KnR. Codon-optim 
caThl from DNA2.0  
2090 NEB-10 pJ201_cahbd_opt - 
KnR. Codon-optim 
caHbd from DNA2.0  
2102 HZ1116 p416FuBuOpt1 see #2012   
2103 HZ1116 p416FuBu2 see #1982 control for #2093  
2104 HZ1116 pRS416 - control for #2093  
2107 W303a p416FuBuOpt1 see #2012   
2108 W303a p416FuBu2 see #1982   
2109 W303a pRS416 -   
2110 DH5α p426Bad-BF1-His 
GPDp-SacI-badBF1-His-
KpnI-CYC1t   
2111 DH5α p426Bad-BF1-His 
GPDp-SacI-badBF1-His-
KpnI-CYC1t 
different clone of 
#2110  
2115 HZ1980 
p416FuBuOpt1, p423aclAB, 
p424fdh1, p425pflAB 
see #2048, #1655, #802, 
#2066   
2116 HZ1980 
p416, p423aclAB, p424fdh1, 
p425pflAB see #1655, #802, #2066 control for #2115  
2117 HZ1980 
p416FuBuOpt1, p423, 
p424fdh1, p425pflAB see #2048, #802, #2066 control for #2115  
2118 HZ1980 
p416FuBuOpt1, p423aclAB, 
p424fdh1, p425 see #2048, #1655, #802 control for #2115  
2119 HZ1980 
p416FuBuOpt1, p423aclAB, 
p424, p425pflAB see #2048, #1655, #2066 control for #2115  
2120 HZ1980 p416, p423, p424, p425 all empty control for #2115  
2121 HZ1980 p416, p423aclAB, p424, p425 see #1655 control for #2115  
2122 HZ1980 
p416FuBu2, p423aclAB, 
p424fdh1, p425pflAB 
see #1982, #1655, #802, 
#2066 control for #2115  
2136 HZ848 p416FuBu2 see #1982   
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2137 HZ848 p416FuBuOpt1 codon optim Thl, Hbd   
2138 HZ848 pRS416 - 
Negative control for 
above 2.  
2139 XL1-Blue pd-lacZ-neo-d - 
double delta vector 
from N. Da Silva  
2140 DH5α pd-BF1-neo-d 
TDH3-Bad-BF1-TEF2t 
replacing lacZ 
(EcoRI/BsiWI) 
Small fragment for 
lacZ remains  
2141 HZ1980 δBF(4) 
may contain p416FuBu2, 
p425pflAB, p424fdh1, 
p423aclAB - 
delta integrated BF1, 
120 copies. 5g/L 
G418.  
2142 HZ1980 δBF(4) 
may contain p416FuBu2, 
p425pflAB, p424fdh1, 
p423aclAB - 
delta integrated BF1, 
120 copies. 5g/L 
G418.  
2143 HZ1980 δBF(7) 
may contain p416FuBu2, 
p425pflAB, p424fdh1, 
p423aclAB - 
delta integrated BF1, 
105 copies. 5g/L 
G418.  
2144 HZ1980 δBF(7) 
may contain p416FuBu2, 
p425pflAB, p424fdh1, 
p423aclAB - 
delta integrated BF1, 
105 copies. 5g/L 
G418.  
2145 HZ1980 δBF(4) 
p416FuBu2, p423aclAB, p424, 
p425pflAB 
see #2048, #1655, #802, 
#2066 
delta integrated BF1, 
120 copies. 5g/L 
G418.  
2146 HZ1980 δBF(7) 
p416FuBu2, p423aclAB, p424, 
p425pflAB 
see #2048, #1655, #802, 
#2066 
delta integrated BF1, 
105 copies. 5g/L 
G418.  
Created by Dr. Hua Zhao 
943 YSG50 pTHC 
caThl, caHbd(w/His tag), 
and cbCrt   
947 DH5α pTHC 
caThl, caHbd(w/His tag), 
and cbCrt    
948 DH5α pGV1213 
TDH3p-caAdhE2Opt-
CYC1t 
caAdhE2 optimized 
for E. coli Gevo Inc. 
949 DH5α pGV1136 TDH3p-caAadOpt-CYC1t 
caAad optimized for 
E. coli Gevo Inc. 
955 YSG50 
pRS426-full but, pRS423-
cnBad see #1000, #740   
956 YSG50 
pRS426-full but, pRS424-
ecAdhE see #1000, #741   
1000 YSG50 pRS426-full but 
scThl, caHbd, cbCrt, 
egTer, ecBad, and caBdhB   
Created by Dr. Zengyi Shao 
700 YSG50 pRS424-N-Histag-Eg TER 
ADH1p-His-egTEROpt-
ADH1t 
egTer optimized for 
E. coli  
701 YSG50 pRS424-C-Histag-Eg TER 
ADH1p-egTEROpt-His-
ADH1t 
egTer optimized for 
E. coli  
702 YSG50 pRS424-Eg TER ADH1p-egTEROpt-ADH1t 
egTer optimized for 
E. coli  
1371 DH5α pRS426-GPM1p-GFP-GPMIt GPM1p-GFP-GPMIt   
1372 DH5α pRS426-TPI1p-GFP-TPI1t TPI1p-GFP-TPI1t   
1373 DH5α pRS426-TDH2p-GFP-TDH2t TDH2p-GFP-TDH2t   
1374 DH5α pRS426-ENO2p-GFP-ENO2t ENO2p-GFP-ENO2t   
1375 DH5α pRS426-PDC1p-GFP-PDC1t PDC1p-GFP-PDC1t   
1376 DH5α pRS426-FBA1p-GFP-FBA1t FBA1p-GFP-FBA1t   
1377 DH5α pRS426-PYK1p-GFP-PYK1t PYK1p-GFP-PYK1t   
1378 DH5α pRS426-TEF2p-GFP-TEF2t TEF2p-GFP-TEF2t   
1379 DH5α pRS426-HXT7p-GFP-HXT7t HXT7p-GFP-HXT7t   
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1380 DH5α pRS426-TEF1p-GFP-TEF1t TEF1p-GFP-TEF1t   
1381 DH5α pRS426-GPDp-GFP-GPDt GPDp-GFP-GPDt   
1382 DH5α pRS426-PGIp-GFP-PGIt PGIp-GFP-PGIt   
1383 DH5α pRS426-PGK1p-GFP-PGK1t PGK1p-GFP-PGK1t   
1384 DH5α pRS426-ADH1p-GFP-ADH1t ADH1p-GFP-ADH1t   
1385 YSG50 pRS426-GPM1p-GFP-GPMIt GPM1p-GFP-GPMIt   
1386 YSG50 pRS426-TPI1p-GFP-TPI1t TPI1p-GFP-TPI1t   
1387 YSG50 pRS426-TDH2p-GFP-TDH2t TDH2p-GFP-TDH2t   
1388 YSG50 pRS426-ENO2p-GFP-ENO2t ENO2p-GFP-ENO2t   
1389 YSG50 pRS426-PDC1p-GFP-PDC1t PDC1p-GFP-PDC1t   
1390 YSG50 pRS426-FBA1p-GFP-FBA1t FBA1p-GFP-FBA1t   
1391 YSG50 pRS426-PYK1p-GFP-PYK1t PYK1p-GFP-PYK1t   
1392 YSG50 pRS426-TEF2p-GFP-TEF2t TEF2p-GFP-TEF2t   
1393 YSG50 pRS426-HXT7p-GFP-HXT7t HXT7p-GFP-HXT7t   
1394 YSG50 pRS426-TEF1p-GFP-TEF1t TEF1p-GFP-TEF1t   
1395 YSG50 pRS426-GPDp-GFP-GPDt GPDp-GFP-GPDt   
1396 YSG50 pRS426-PGIp-GFP-PGIt PGIp-GFP-PGIt   
1397 YSG50 pRS426-PGK1p-GFP-PGK1t PGK1p-GFP-PGK1t   
1398 YSG50 pRS426-ADH1p-GFP-ADH1t ADH1p-GFP-ADH1t   
Created by Dr. Ryan P. Sullivan 
699 
Pseudomonas 
fluorescens Pf-5 - -  
NRRL B-
23932 
746 
Azotobacter 
vinelandii DJ - -  
ATCC 
BAA-1303 
801 DH5α p424CbFDH HXT7p-CbFDH-HXT7t   
802 DH5α p424fdh1 HXT7p-ScFDH-HXT7t   
803 DH5α p425sth GPDp-AvSth-GPDt   
804 DH5α p425EcUdhA GPDp-EcUdhA-GPDt   
805 DH5α p425PfSth GPDp-PfSth-GPDt   
806 DH5α p425ReSth GPDp-ReSth-GPDt   
807 YSG50 p424CbFDH HXT7p-CbFDH-HXT7t   
808 YSG50 p424fdh1 HXT7p-ScFDH-HXT7t   
809 YSG50 p425sth GPDp-AvSth-GPDt   
810 YSG50 p425EcUdhA GPDp-EcUdhA-GPDt   
811 YSG50 p425PfSth GPDp-PfSth-GPDt   
812 YSG50 p425ReSth GPDp-ReSth-GPDt   
813 YSG50 pRS423 -   
814 YSG50 pRS424 -   
815 YSG50 pRS425 -   
816 YSG50 pRS426 -   
Created by Michael Mclachlan 
649 BL21 pGAD424 ADH1p-GFP  Clontech 
703 YSG50 pRS425-N-Histag-Ca Aad       
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Appendix E. Nucleotide sequences of codon-optimized caAdhE2, caThl, and caHbd for higher soluble expression 
in yeast. AdhE2 was optimized using JCat [38], whereas the other two were optimized using DNA2.0 software. 
 
caAdhE2-coSc 
atgaaggttactaaccaaaaggaattgaagcaaaagttgaacgaattgagagaagctcaaaagaagttcgctacttacactcaagaacaagttgacaagatcttcaagca
atgtgctatcgctgctgctaaggaaagaatcaacttggctaagttggctgttgaagaaactggtatcggtttggttgaagacaagatcatcaagaaccacttcgctgctgaat
acatctacaacaagtacaagaacgaaaagacttgtggtatcatcgaccacgacgactctttgggtatcactaaggttgctgaaccaatcggtatcgttgctgctatcgttcca
actactaacccaacttctactgctatcttcaagtctttgatctctttgaagactagaaacgctatcttcttctctccacacccaagagctaagaagtctactatcgctgctgctaag
ttgatcttggacgctgctgttaaggctggtgctccaaagaacatcatcggttggatcgacgaaccatctatcgaattgtctcaagacttgatgtctgaagctgacatcatcttg
gctactggtggtccatctatggttaaggctgcttactcttctggtaagccagctatcggtgttggtgctggtaacactccagctatcatcgacgaatctgctgacatcgacatg
gctgtttcttctatcatcttgtctaagacttacgacaacggtgttatctgtgcttctgaacaatctatcttggttatgaactctatctacgaaaaggttaaggaagaattcgttaaga
gaggttcttacatcttgaaccaaaacgaaatcgctaagatcaaggaaactatgttcaagaacggtgctatcaacgctgacatcgttggtaagtctgcttacatcatcgctaag
atggctggtatcgaagttccacaaactactaagatcttgatcggtgaagttcaatctgttgaaaagtctgaattgttctctcacgaaaagttgtctccagttttggctatgtacaa
ggttaaggacttcgacgaagctttgaagaaggctcaaagattgatcgaattgggtggttctggtcacacttcttctttgtacatcgactctcaaaacaacaaggacaaggtta
aggaattcggtttggctatgaagacttctagaactttcatcaacatgccatcttctcaaggtgcttctggtgacttgtacaacttcgctatcgctccatctttcactttgggttgtg
gtacttggggtggtaactctgtttctcaaaacgttgaaccaaagcacttgttgaacatcaagtctgttgctgaaagaagagaaaacatgttgtggttcaaggttccacaaaag
atctacttcaagtacggttgtttgagattcgctttgaaggaattgaaggacatgaacaagaagagagctttcatcgttactgacaaggacttgttcaagttgggttacgttaac
aagatcactaaggttttggacgaaatcgacatcaagtactctatcttcactgacatcaagtctgacccaactatcgactctgttaagaagggtgctaaggaaatgttgaacttc
gaaccagacactatcatctctatcggtggtggttctccaatggacgctgctaaggttatgcacttgttgtacgaatacccagaagctgaaatcgaaaacttggctatcaacttc
atggacatcagaaagagaatctgtaacttcccaaagttgggtactaaggctatctctgttgctatcccaactactgctggtactggttctgaagctactccattcgctgttatca
ctaacgacgaaactggtatgaagtacccattgacttcttacgaattgactccaaacatggctatcatcgacactgaattgatgttgaacatgccaagaaagttgactgctgct
actggtatcgacgctttggttcacgctatcgaagcttacgtttctgttatggctactgactacactgacgaattggctttgagagctatcaagatgatcttcaagtacttgccaa
gagcttacaagaacggtactaacgacatcgaagctagagaaaagatggctcacgcttctaacatcgctggtatggctttcgctaacgctttcttgggtgtttgtcactctatg
gctcacaagttgggtgctatgcaccacgttccacacggtatcgcttgtgctgttttgatcgaagaagttatcaagtacaacgctactgactgtccaactaagcaaactgctttc
ccacaatacaagtctccaaacgctaagagaaagtacgctgaaatcgctgaatacttgaacttgaagggtacttctgacactgaaaaggttactgctttgatcgaagctatctc
taagttgaagatcgacttgtctatcccacaaaacatctctgctgctggtatcaacaagaaggacttctacaacactttggacaagatgtctgaattggctttcgacgaccaatg
tactactgctaacccaagatacccattgatctctgaattgaaggacatctacatcaagtctttctaa 
 
caThl_opt 
atgaaagaagtagtaattgcttccgcagtgcgtaccgccattggctcttacgggaaatcactgaaagatgtccctgcagtggatcttggtgcaacagccatcaaggaggct
gttaagaaggctggtatcaaaccagaggatgttaacgaggttatcttgggtaatgtcttgcaagctggactaggtcaaaacccagccagacaagcaagtttcaaggccgg
tttaccagtagagattccagccatgacaatcaataaggtgtgtggctctgggttaagaacagtgtctctagcagcacaaatcattaaggctggcgacgctgatgtcataatc
gcaggcggaatggagaatatgagtagagcaccatacttggccaacaatgccagatggggttacagaatggggaatgccaaattcgtagatgaaatgatcactgatggg
ctttgggatgccttcaatgactatcacatggggatcacagctgagaacatagcagaaagatggaacatatcaagagaagaacaagacgaatttgctctggcatctcagaa
aaaggcagaagaggcaatcaagtctggtcaattcaaggacgaaattgttccagttgtcatcaagggtagaaaaggcgaaaccgtggttgacactgacgagcacccaag
atttggttccacaatagagggtctggccaaattgaagcctgctttcaagaaggatggaacagttacagccgggaatgcatcaggcttaaacgattgtgcagctgtgctagtt
atcatgtcagctgaaaaggcaaaagagttgggtgttaagcctttagcaaagatcgtttcatacggttctgctggtgttgatccagccattatgggctatggtccattctacgct
actaaagctgcaattgaaaaagctggctggactgtcgatgaattagatcttatagaatctaacgaagcatttgccgctcagtcattggctgtagcaaaagatcttaagtttgat
atgaacaaggtgaatgtcaacggaggagctatagcattgggtcatcctatcggtgcctccggtgctaggattcttgtaactttggttcatgctatgcaaaagcgtgatgccaa
gaaaggattagctactctatgcattggtggcggacaaggaaccgccatattgctggaaaagtgttaa 
 
caHbd_opt 
atgaaaaaggtgtgtgttattggggctggtactatgggatctggaatagctcaggcctttgcagctaagggttttgaagttgtgttaagagacatcaaagatgagtttgtggat
agaggtttagacttcatcaataagaacttatcaaagttagtcaaaaaggggaagatcgaagaagcaacaaaggtggaaattcttactagaatttctggcaccgttgatttgaa
catggctgctgactgcgatttggtcatagaagccgcagttgagagaatggacataaagaaacaaatctttgccgacctagataacatttgtaagcctgaaacaatcttggct
tcaaacacttcttctctatcaataactgaagttgcttctgcaactaaaagacctgataaagtcatcggcatgcatttcttcaatccagccccagttatgaaacttgttgaagtaat
ccgtgggattgctacatcccaagaaactttcgatgcagtaaaggagacatctattgcaattggcaaagatccagtagaggtggcagaggcaccaggattcgtcgtcaata
gaatcctaatacctatgataaacgaggctgttggtatccttgctgagggcattgcatccgtagaggatattgataaagctatgaagttaggcgccaatcacccaatgggtcc
actggaacttggtgatttcatcggattggacatctgtttggccataatggatgttttgtatagtgaaacaggcgacagtaagtacagaccacataccttgctgaagaagtacgt
cagggccggttggctgggtagaaaatccggtaaaggtttctatgattactcaaagtaa 
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Appendix F. List of primers used in this study. 
 
Purpose Name Sequence (5’ to 3’) 
NN PGK1 BamHI AvrII fwd tatggatcctatgcttcctaggttaagccacaatag 
NN PGK1 BamHI BsiWI fwd tatggatcctatgcttcgtacgttaagccacaatag 
NN PGK1 BamHI fwd tattggatccttaagccacaatag 
NN CYC1 KpnI rev ttatggtaccgcaaattaaagc 
NN CYC1 AvrII rev ttatcctagggcaaattaaagc 
NN CYC1 BsiWI rev ttatcgtacggcaaattaaagc 
NN PGK1 butA fwd caaatataaaacaatgagagaggtag 
NN PGK1 butB fwd caaatataaaacaatgaatatagcag 
NN PGK1 butC fwd caaatataaaacaatggaaaatattaag 
NN PGK1 butA rev ctacctctctcattgttttatatttg 
NN PGK1 butB rev ctgctatattcattgttttatatttg 
NN PGK1 butC rev cttaatattttccattgttttatatttg 
NN butA CYC1 fwd gaaagaatttaaatcatgtaattag 
NN butB CYC1 fwd gagcgctgaataaatcatgtaattag 
NN butC CYC1 fwd ctatttaaaggatgttaaatcatgtaattag 
NN butA CYC1 rev ctaattacatgatttaaattctttc 
NN butB CYC1 rev ctaattacatgatttattcagcgctc 
Used to clone thl, hbd, and 
crt from Clostridium 
beijerinckii 
NN butC CYC1 rev ctaattacatgatttaacatcctttaaatag 
NN BamHI ADH1p fwd tgcaatggatccgcttgcatgcaac 
NN ADH1p:cbAdhA/2 fwd caatcaactccaaatggcacgttttactttacca 
NN ADH1p:cbAdhA/2 rev tggtaaagtaaaacgtgccatttggagttgattg 
NN ADH1p:cbAdhB fwd caatcaactccaaatggcacgttttactttacct 
NN ADH1p:cbAdhB rev aggtaaagtaaaacgtgccatttggagttgattg 
NN cbAdhA2 mid fwd cgaattaattaatggattaaatgataagttagaa 
NN cbAdhA2 mid rev ttctaacttatcatttaatccattaattaattcg 
NN cbAdhA/A2/B:CYC1t rev cataactaattacatgatttacaaattaactttag 
NN cbAdhA/A2/B:CYC1t fwd ctaaagttaatttgtaaatcatgtaattagttatg 
NN EcoRI CYC1t rev attgcagaattcgcaaattaaagcc 
NN SalI TEF1p fwd tatgcagtcgacatagcttcaaaatg 
NN TEF1p:cbBad fwd ctaagttttaattacaaaatgaataaagacacac 
NN TEF1p:cbBad rev gtgtgtctttattcattttgtaattaaaacttag 
NN cbBad:ADH1t rev gaagaagtccaaagctttagccggcaagtac 
NN cbBad:ADH1t fwd gtacttgccggctaaagctttggacttcttc 
Used to clone adhA, adhA2, 
adhB, and bad from 
Clostridium beijerinckii 
NN XhoI ADH1t rev2 tgcatactcgagcatgccggtagagg 
NN pRS413 SEQ fwd gtgtgaaattgttatccgct Sequencing primers for bad, 
bdhB and adhA/A2 NN pRS413 SEQ rev caacttaatcgccttgcagc 
NN ADH1p:caBdhA fwd caatcaactccaaatgctaagttttg 
NN ADH1p:caBdhA rev caaaacttagcatttggagttgattg 
NN ADH1p:caBdhB fwd caatcaactccaaatggttgatttcg 
NN ADH1p:caBdhB rev cgaaatcaaccatttggagttgattg 
NN caBdhA:CYC1t fwd taaaaaatcttattaaatcatgtaattagttatg 
NN caBdhA:CYC1t rev cataactaattacatgatttaataagatttttta 
NN caBdhB:CYC1t fwd caaaaaatctgtgtaaatcatgtaattagttatg 
Used to clone bdhA and 
bdhB from Clostridium 
acetobutylicum 
NN caBdhB:CYC1t rev cataactaattacatgatttacacagattttttg 
NN F pRS425-GPDp see above 
NN R GPDp-SacI-tdTER see above 
Used to clone ter from 
Treponema denticola 
NN F GPDp-SacI-tdTER  see above 
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NN R tdTER-KpnI-CYC1t 
cataactaattacatgatggtaccttaaatcctgtcgaacctttcta
cctc 
NN F tdTER-KpnI-CYC1t 
gaggtagaaaggttcgacaggatttaa ggtacc 
atcatgtaattagttatg 
NN R pRS426-CYC1t see above 
NN R SEQ PGK1t see above 
NN R SEQ TDH2t see above 
NN F SEQ TDH2p see above 
NN R SEQ TEF1t see above 
NN R SEQ HXT7t see above 
NN F SEQ TDH3p see above 
NN F SEQ GPM1p tcttaattctgttgtaattaccttcctttg 
NN F SEQ TPI1p ctaaatcaatctttttcaattttttgtttg 
NN F SEQ ENO1p ttttcttttcttagtttctttcataacacc 
NN R SEQ TEF2t ctatatgaaaagaaaatgataagcagatag 
NN F SEQ PGI1p ttgcattcagtgaattttaatacatattcc 
NN R SEQ PYK1t atgttatttaagtaacttataaatctttatttg 
NN F SEQ Thl mid catgggaataacagcagaaaacata 
NN F SEQ Hdb mid gtggcatcagcaactaaaagacc 
NN F SEQ Crt mid gtggaggatgcgaattatcaatg 
NN F SEQ Ter mid aactaaaagaaatctccgccgaac 
NN F SEQ BdhB mid acgtgggcagtaataaataatatggatac 
NN F GPM1p caThl_opt 
ataatccaaacaaacacacatattacaataatgaaagaagtagta
attgcttccgcagtg 
NN R GPM1p caThl_opt 
cactgcggaagcaattactacttctttcattattgtaatatgtgtgttt
gtttggattat 
NN F caThl_opt PGK1t 
ggaaccgccatattgctggaaaagtgttaaattgaattgaattga
aatcgatagatcaat 
NN R caThl_opt PGK1t 
attgatctatcgatttcaattcaattcaatttaacacttttccagcaat
atggcggttcc 
NN F TPI1p caHbd_opt 
aactacaaaaaacacatacataaactaaaaatgaaaaaggtgtg
tgttattggggctggt 
NN R TPI1p caHbd_opt 
accagccccaataacacacacctttttcatttttagtttatgtatgtg
ttttttgtagtt 
NN F caHbd_opt GPDt 
ggtaaaggtttctatgattactcaaagtaagtgaatttactttaaat
cttgcatttaaat 
NN R caHbd_opt GPDt 
atttaaatgcaagatttaaagtaaattcacttactttgagtaatcata
gaaacctttacc 
NN F SEQ caThl_opt mid ttcaatgactatcacatggggatca 
Used for sequencing 
p416FuBu2 and 
p416FuBuOpt1 
NN F SEQ caHbd_opt mid tggcttcaaacacttcttctctatc 
NN F ADH1p tdTER 
ccaagcatacaatcaactatctcatatacaatgattgtaaaacca
atggttaggaacaat 
NN R ADH1p tdTER 
attgttcctaaccattggttttacaatcattgtatatgagatagttgat
tgtatgcttgg 
NN F tdTER ADH1t 
gccgaggtagaaaggttcgacaggatttaaagctttggacttctt
cgccagaggtttggt 
Used to clone ter from 
Treponema denticola into 
pT2B 
NN R tdTER ADH1t 
accaaacctctggcgaagaagtccaaagctttaaatcctgtcga
acctttctacctcggc 
Ued for cloning for bad-BF1 NN F EcoRI TDH3p tgatagggaattcagtttatcattatcaatactcgccatttc 
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NN R XhoI TEF2t ggggtagcgacggattaatgctcgagcctatca 
NN R BsiWI TEF2t ggggtagcgacggattaatgcgtacgcctatca 
NN F qPCR TDH3p agtttattcctggcatccactaaatataatgg 
NN R qPCR TDH3p ctctgtagttgcgctaagagaatgg 
NN F qPCR Bad ttctagaagaaacacatatgggaagatatgag 
NN R qPCR Bad gacatttctacaactgtaagaccattatcac 
NN F qPCR PGI1 cggtttgagagatgctatgttcaaag 
into δ vector and copy # 
determination 
NN R qPCR PGI1 cagagtcgacttctggagcaac 
NN pRS423:TEF1p F 
gtaaaacgacggccagtgagcgcgcgtaatacgatagcttcaa
aatg 
NN TEF1p:AvrII:GFP F gttttaattacaaaatgcctaggatgagtaaaggag 
NN TEF1p:AvrII:GFP R ctcctttactcatcctaggcattttgtaattaaaac 
NN GFP:AvrII:TEF1t F gaactatacaaatagcctaggggagattgataagac 
NN GFP:AvrII:TEF1t R gaactatacaaatagcctaggggagattgataagac 
Used to clone gfp under 
TEF1p 
NN TEF1t:pRS423 R 
ggaacaaaagctggagctccaccgcggtggatagcgccgatc
aaag 
NN pRS423:TEF2p F 
gtaaaacgacggccagtgagcgcgcgtaatacgggggccgta
tacttac 
NN TEF2p:AvrII:GFP F ctataattaactaaacatgcctaggatgagtaaaggagaag 
NN TEF2p:AvrII:GFP R cttctcctttactcatcctaggcatgtttagttaattatag 
NN GFP:AvrII:TEF2t F gaactatacaaatagcctagggagtaataattattg 
NN GFP:AvrII:TEF2t R caataattattactccctaggctatttgtatagttc 
NN TEF2t:pRS423 R 
ggaacaaaagctggagctccaccgcggtggggggtagcgac
ggattaatg 
Used to clone gfp under 
TEF2p 
NN pRS423:TEF2p F2 
gtaaaacgacggccagtgagcgcgcgtaatacgatatggggc
cgtatac 
NN GPDp:AvrII:GFP F cttagtttcgacggatatgcctaggatgagtaaaggagaag 
NN GPDp:AvrII:GFP R cttctcctttactcatcctaggcatatccgtcgaaactaag 
NN GFP:AvrII:GPDt F gaactatacaaatagcctagggtgaatttactttaaatc 
NN GFP:AvrII:GPDt R gatttaaagtaaattcaccctaggctatttgtatagttc 
Used to clone gfp under 
TDH3/GPDp 
NN GPDt:pRS423 R 
ggaacaaaagctggagctccaccgcggtggggaatctgtgtat
attac 
NN ADH1p:AvrII:GFP F caatcaactccaaatgcctaggatgagtaaaggag 
NN ADH1p:AvrII:GFP R ctcctttactcatcctaggcatttggagttgattg 
NN GFP:AvrII:ADH1t F gaactatacaaatagcctaggagctttggacttc 
NN GFP:AvrII:ADH1t R gaagtccaaagctcctaggctatttgtatagttc 
NN ADH1p(1.5):AvrII:GFP F caactatctcatatacaatgcctaggatgagtaaaggag 
Used to clone gfp under 
ADH1p 
NN ADH1p(1.5):AvrII:GFP R ctcctttactcatcctaggcattgtatatgagatagttg 
NN F pRS425-GPDp see above 
NN R GPDp-SacI-GFP see above 
NN F GPDp-SacI-GFP see above 
NN R GFP-cMyc see above 
NN F cMyc-cbBad 
gaacaaaaactcatctcagaagaagat 
atgaataaagacacactaatac 
NN R cbBad-KpnI-CYC1t cataactaattacatgatggtaccttagccggcaagtacacatc 
NN F cbBad-KpnI-CYC1t gatgtgtacttgccggctaa ggtacc atcatgtaattagttatg 
Used to construct pRS426-
GFP-cbBad 
NN R pRS426-CYC1t see above 
Used to construct pRS426- NN F pRS425-GPDp see above 
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NN R GPDp-SacI-cbBad 
gtattagtgtgtctttattcatgagctccatatccgtcgaaactaag
ttc 
NN F GPDp-SacI-cbBad 
gaacttagtttcgacggatatggagctcatgaataaagacacact
aatac 
NN R cbBad-cMyc atcttcttctgagatgagtttttgttcgccggcaagtacacatcttc 
NN F cMyc-GFP see above 
NN F GFP-KpnI-CYC1t see above 
cbBad-GFP 
NN R pRS426-CYC1t see above   
NN F pRS425-GPDp see above 
NN R GPDp-SacI-GFP gttcttctcctttactcatgagctccatatccgtcgaaactaagttc 
NN F GPDp-SacI-GFP  
gaacttagtttcgacggatatggagctcatgagtaaaggagaag
aac 
NN R GFP-cMyc atcttcttctgagatgagtttttgttctttgtatagttcatccatg 
NN F cMyc-caAdhE2-coEc 
gaacaaaaactcatctcagaagaagatatgaaagttacaaatca
aaaag 
NN R caAdhE2-coEc-KpnI-
CYC1t cataactaattacatgatggtaccttaaaatgattttatatag 
NN F caAdhE2-coEc-KpnI-
CYC1t  ctatataaaatcattttaaggtaccatcatgtaattagttatg 
Used to construct pRS426-
GFP-caAdhE2Opt 
NN R pRS426-CYC1t  
caatttcacacaggaaacagctatgaccatgattacgccagcaa
attaaagccttcg 
NN F pRS425-GPDp see above 
NN R GPDp-SacI-caAdhE2-
coEc 
ctttttgatttgtaactttcatgagctccatatccgtcgaaactaagt
tc 
NN F GPDp-SacI-caAdhE2 
gaacttagtttcgacggatatggagctcatgaaagttacaaatca
aaaag 
NN R caAdhE2-coEc-cMyc  atcttcttctgagatgagtttttgttcaaatgattttatatagatatc 
NN F cMyc-GFP  
gaacaaaaactcatctcagaagaagatatgagtaaaggagaag
aac 
NN R GFP-KpnI-CYC1t gacataactaattacatgatggtaccctatttgtatagttcatcc 
NN F GFP-KpnI-CYC1t   ggatgaactatacaaatagggtaccatcatgtaattagttatgtc 
Used to construct pRS426-
caAdhE2Opt-GFP 
NN R pRS426-CYC1t see above   
NN F epLibrHR AdhE2* 
ttttagttttaaaacaccagaacttagtttcgacggatatggagctc
atgaaagttacaaatcaaaaag 
NN F epLibrHR Bad 
ttttagttttaaaacaccagaacttagtttcgacggatatggagctc
atgaataaagacacactaatac 
NN R epLibrHR C-GFP 
gggagggcgtgaatgtaagcgtgacataactaattacatgatgg
taccctatttgtatagttcatcc 
NN F epLibrHR C-GFP 
ggatgaactatacaaatagggtaccatcatgtaattagttatgtca
cgcttacattcacgccctccc 
NN F pGV1213 mid1 acattgatatggcggtttctagtatcattc 
NN F pGV1213 mid1 atggttcaaagttccacagaagaattac 
NN R pGV1213 mid1 gaatgatactagaaaccgccatatcaatgt 
NN R pGV1213 mid2 gtaattcttctgtggaactttgaaccat 
NN F SEQ caAdhE2 mid1 attaattttagatgcagctgttaaagcagg 
NN F SEQ caAdhE2 mid2 gacatttattaacatgccttcttcacaggg 
NN F SEQ GPDp aggttgaaaccagttccctgaaattattcc 
NN R SEQ GFP gttttccagtagtgcaaataaatttaaggg 
NN F SEQ GFP cccttaaatttatttgcactactggaaaac 
Used to create and sequence 
cbBad and caAdhE2 epPCR 
libraries 
NN F cbBad mid ctgaaaatctagtaacaactataaaaaatccaac 
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NN F 425 PGK1p 
gacggccagtgagcgcgcgtaatacgactcactatagggcga
attgggtaacgcacagatattataacatctgcac 
NN R PGK1t TEF1p 
aaaaaaggagtagaaacattttgaagctatcaggaagaatacac
tatactggatctaaag 
NN F PGK1t TEF1p 
ctttagatccagtatagtgtattcttcctgatagcttcaaaatgtttct
actcctttttt 
NN R TEF1t PYK1p 
actgagattaatctccaaaatagtagcattatagcgccgatcaaa
gtatttgttacgaca 
NN F TEF1t PYK1p 
tgtcgtaacaaatactttgatcggcgctataatgctactattttgga
gattaatctcagt 
NN R PYK1t 425 
cacacaggaaacagctatgaccatgattacgccaagcgcgca
attaaccccatttatgtacccatgtataaccttc 
A1: NN F SEQ PGK1p caatgcaagaaatacatatttggtcttttc 
A2: NN F SEQ Ald6 mid tcttgaaacccgctgctgtcacacc 
A3: NN R SEQ PGK1t tatatatacgtatataaataaaaaatattc 
A4: NN F SEQ TEF1p tatttaagttaataaacggtcttcaatttc 
A5: NN R SEQ Acs mid1 ggtttttcagcgcgtcatcgacattc 
A6: NN R SEQ Acs mid2 aaggacgggtggcggaaccggctttc 
A7: NN R SEQ TEF1t gaatttttagatactgaaatgatattttag 
A8: NN F SEQ PYK1p caaagttattctctactctttttcatattc 
Used for cloning and 
sequencing pRS425-ald6-
acs-aclA1 
A9: NN R SEQ PYK1t aatgtatgttatttaagtaacttataaatc 
NN F HXT7t TDH3p 
atcttctttttctgtatcccgcttcaaaaagtgtctaatgagtcagtt
atagtttatcattatcaatactcgccatttc 
NN R TDH3t TDH2p 
gacaaataatcattcactggaaaaaccaatggaatctgtgtatatt
actgcatctagata 
NN F TDH3t TDH2p 
tatctagatgcagtaatatacacagattccattggtttttccagtga
atgattatttgtc 
NN R TDH2t 424 
tctccccgcgcgttggccgattcattaatgcagctggcacgaca
ggtttcgcgaaaagccaattagtgtgatac 
NN F 424 HXT7p 
tgcaaggcgattaagttgggtaacgccagggttttcccagtcac
gacgttacttctcgtaggaacaatttcgggcccctg 
NN R HXT7t TDH3p 
gaaatggcgagtattgataatgataaactataactgactcattag
acactttttgaagcg 
F1: NN F SEQ HXT7p ttcgaatctattcttcatttgcagctattg 
F2: NN R SEQ HXT7t aactgtattattttgtatatattaaaaacg 
F3: NN F SEQ TDH3p ctaataagtatataaagacggtaggtattg 
F4: NN R SEQ TDH3t gcatcaagaaaaaacacaaagctttcaatc 
F5: NN F SEQ TDH2p aggttgcactcattcaagatagtttttttc 
F6: NN F SEQ AclB2 mid gcaagctatacagacctggatctg 
Used for cloning and 
sequencing pRS424-fdh-sth-
aclB2 
F7: NN R SEQ TDH2t gaatccctgaggaatctttaatacattttc 
NN F SEQ PflA mid ggcattcatacctgtctggac 
NN F SEQ PflB mid1 cgcgaagaaatcgctgaacagc 
NN F SEQ PflB mid2 tatgatgaagtgatggagcgc 
NN R SEQ ADH1t ggcaaggtagacaagccg 
NN R SEQ CYC1t aaataaatagggacctagacttcagg 
NN F SEQ AclA1 mid1 ggttgcagcataagcttttctg 
NN R SEQ AclA1 mid2 gcgacaagaggtgcacatatttc 
NN F SEQ AclA1 mid3 gcatctgaacttggcaactatg 
Used for sequencing 
p423plfAB, p425pflAB and 
p423aclAB 
NN R SEQ AclB2 mid2 gttaaaccgaaggatgtggtcag 
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NN R SEQ AclB2 mid3 cacaacaccattgtaacagcaag 
NN F SEQ AclB2 mid1 gcaagctatacagacctggatctgseeabove 
NN F ADH1t PGK1p cacctctaccggcatgcacgcacagatattataacatctgcac 
NN R PGK1p pflB 
ctaacttttcattaagctcggacatgtaacaatcgattgttttatattt
gttgtaaaaag 
NN F PGK1p pflB 
ctttttacaacaaatataaaacaatcgattgttacatgtccgagctt
aatgaaaagttag 
Used for cloning pflA and 
pflB from Escherichia coli 
NN R pflB CYC1t 
gacataactaattacatgactcgagatctaattacatagattgagt
gaaggtacga 
Fwd pRS-GPDp 
gtaaaacgacggccagtgagcgcgcgtaatacggagtttatca
ttatcaatactc 
Rev GPDp-EcUdhA gtaatcgtaggaatgtggcatatccgtcgaaactaagttctg 
Fwd GPDp-EcUdhA cagaacttagtttcgacggatatgccacattcctacgattac 
Rev EcUdhA-GPDt gcaagatttaaagtaaattcacttaaaacaggcggtttaagc 
Fwd EcUdhA-GPDt gcttaaaccgcctgttttaagtgaatttactttaaatcttgc 
Used to clone udhA from 
Escherichia coli 
Rev GPDt-pRS 
ggaacaaaagctggagctccaccgcggtggggaatctgtgtat
attactgcatc 
Fwd pRS-GPDp 
gtaaaacgacggccagtgagcgcgcgtaatacggagtttatca
ttatcaatactc 
Rev GPDp -AvSth catcgtagttatatacagccatatccgtcgaaactaagttctg 
Fwd GPDp -AvSth cagaacttagtttcgacggatatggctgtatataactacgatg 
Rev AvSth- GPDt gcaagatttaaagtaaattcactcaaaaaagccgattgagacc 
Fwd AvSth- GPDt ggtctcaatcggcttttttgagtgaatttactttaaatcttgc 
Used to clone sth from 
Azotobacter vinelandii 
Rev GPDt-pRS 
ggaacaaaagctggagctccaccgcggtggggaatctgtgtat
attactgcatc 
Fwd pRS-GPDp 
gtaaaacgacggccagtgagcgcgcgtaatacggagtttatca
ttatcaatactc 
Rev GPDp -PfSth cgtcgtagttgtagacagccatatccgtcgaaactaagttctg 
Fwd GPDp-PfSth cagaacttagtttcgacggatatggctgtctacaactacgacg 
Rev PfSth- GPDt 
gcaagatttaaagtaaattcactcaaaaaagccggttgaggcca
tc 
Fwd PfSth- GPDt gatggcctcaaccggcttttttgagtgaatttactttaaatcttgc 
Used to clone sth from 
Pseudomonas fluorescens 
Rev GPDt-pRS 
ggaacaaaagctggagctccaccgcggtggggaatctgtgtat
attactgcatc 
Fwd pRS-GPDp 
gtaaaacgacggccagtgagcgcgcgtaatacggagtttatca
ttatcaatactc 
Rev GPDp -ReSth ctcggattggaaatggaatcatatccgtcgaaactaagttctg 
Fwd GPDp-ReSth cagaacttagtttcgacggatatgattccatttccaatccgag 
Rev ReSth- GPDt gcaagatttaaagtaaattcactcacagttccgatttgatgtcg 
Fwd ReSth- GPDt cgacatcaaatcggaactgtgagtgaatttactttaaatcttgc 
Used to clone sth from 
Rhizobium etli 
Rev GPDt-pRS 
ggaacaaaagctggagctccaccgcggtggggaatctgtgtat
attactgcatc 
Fwd pRS-HXT7p 
gtaaaacgacggccagtgagcgcgcgtaatacggacttctcgt
aggaacaatttcg 
Rev HXT7p –ScFDH1 gcaaaacctttcccttcgacattttttgattaaaattaaaaaaac 
Fwd HXT7p –ScFDH1 gtttttttaattttaatcaaaaaatgtcgaagggaaaggttttgc 
Rev ScFDH1- HXT7t catgaattaataaaagtgttcgcaaattatttcttctgtccataagc 
Used to clone fdh1 from 
Saccharomyces cerevisiae 
Fwd ScFDH1- HXT7t gcttatggacagaagaaataatttgcgaacacttttattaattcatg 
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Rev HXT7t-pRS 
ggaacaaaagctggagctccaccgcggtggataactgactcat
tagacac 
Fwd pRS- HXT7p 
gtaaaacgacggccagtgagcgcgcgtaatacggacttctcgt
aggaacaatttcg 
Rev HXT7p –CbFDH1 
cgtataagactaaaacgatcttcattttttgattaaaattaaaaaaa
c 
Fwd HXT7p – CbFDH1 gtttttttaattttaatcaaaaaatgaagatcgttttagtcttatacg 
Rev CbFDH1 – HXT7t catgaattaataaaagtgttcgcaaattatttcttatcgtgtttacc 
Fwd CbFDH1 – HXT7t 
ggtaaacacgataagaaataatttgcgaacacttttattaattcat
g 
Used to clone fdh1 from 
Candida boidinii 
Rev HXT7t-pRS 
ggaacaaaagctggagctccaccgcggtggataactgactcat
tagacac 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
Fwd start-HisTag-nostartCbEtfA see above 
NN Fwd CbEtfA-ADH2t  gaaataaagagcgctgaataatcatgtttatcaag 
NN Rev CbEftA-ADH2t cttgataaacatgattattcagcgctctttatttc 
Used to clone etfA from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
Fwd start-HisTag-nostartCbEtfB see above 
NN Fwd CbEtfB-ADH2t  gaaaaacactacatctaatcatgtttatcaag 
NN Rev CbEftB-ADH2t  cttgataaacatgattagatgtagtgtttttc 
Used to clone etfB from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd start-HisTag-
nostartCbBcd atgcatcatcatcatcatcacaatttccaattaac 
NN Fwd CbBcd-ADH2t gaagcattttaagatagtcatgtttatcaag 
NN Rev CbBcd-ADH2t cttgataaacatgactatcttaaaatgcttc 
Used to clone bcd from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
Fwd start-HisTag-
nostartMeEtfA see above 
NN Fwd MeEtfA-ADH2t  gaaaggcattgcataatcatgtttatcaag 
NN Rev MeEftA-ADH2t  cttgataaacatgattatgcaatgcctttc 
Used to clone etfA from 
Megasphaera elsdenii w/N-
HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-PGK1p see above 
Rev PGK1p-start-HisTag gtgatgatgatgatgatgcattgttttatatttgttg 
Fwd start-HisTag-nostartCbBcd atgcatcatcatcatcatcacaatttccaattaactag  
Used to clone bcd from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH1t- pRS425 
catgccggcatctagaccaccgcggtggagctccagcttttgtt
cc 
Fwd pRS425-PGK1p see above 
Rev CbBcd-nostop-HisTag-stop ctagtgatgatgatgatgatgtcttaaaatgcttcctg 
Fwd HisTag-stop-ADH1t catcatcatcatcatcactagtaattccgggcgaatttc  
Used to clone bcd from 
Clostridium beijerinckii 
w/C-HisTag 
Rev ADH1t-pRS425 see above 
Fwd pRS425-PYK1p 
gtaaaacgacggccagtgagcgcgcgtaatacgggatccaaa
tgtaaataaac 
Used to clone etfA from 
Clostridium beijerinckii 
w/N-HisTag Rev PYK1p-start-HisTag gtgatgatgatgatgatgcattgtgatgatgttttatttg 
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Fwd start-HisTag-nostartCbEtfA atgcatcatcatcatcatcacaatatagcagattac  
Rev ADH2t-pRS425 
ggaacaaaagctggagctccaccgcggtggactagtggcatg
cgaagg 
Fwd pRS425-PYK1p see above 
Rev CbEtfA-nostop-HisTag-stop ctagtgatgatgatgatgatgttcagcgctctttatttc 
Fwd HisTag-stop-ADH2t catcatcatcatcatcactaggacacttctaaataagc  
Used to clone etfA from 
Clostridium beijerinckii 
w/C-HisTag 
Rev ADH2t-pRS425 see above 
Fwd pRS425-GPDp 
gtaaaacgacggccagtgagcgcgcgtaatacgg  
agtttatcattatcaatac  
Rev GPDp-start-HisTag gtgatgatgatgatgatgcatatccgtcgaaactaagttc 
Fwd start-HisTag-nostartCbEtfB atgcatcatcatcatcatcacaatatagtagtttgtg   
Used to clone etfB from 
Clostridium beijerinckii 
w/N-HisTag 
Rev CYC1t-pRS425 see above 
Fwd pRS425-GPDp see above 
Rev CbEtfB-nostop-HisTag-stop ctagtgatgatgatgatgatggatgtagtgtttttc 
Fwd HisTag-stop-CYC1t catcatcatcatcatcactagatcatgtaattagttatgtc  
Used to clone etfB from 
Clostridium beijerinckii 
w/C-HisTag 
Rev CYC1t-pRS425 see above 
Fwd pRS425-PGK1p see above 
Rev PGK1p-start-HisTag gtgatgatgatgatgatgcattgttttatatttgttg 
Fwd start-HisTag-nostartMeBcd atgcatcatcatcatcatcacgattttaacttaacagatattc  
Used to clone bcd from 
Megasphaera elsdenii w/N-
HisTag 
Rev ADH1t-pRS425 see above 
Fwd pRS425-PGK1p see above 
Rev MeBcd-nostop-HisTag-stop ctagtgatgatgatgatgatgtcttaacagagcaccgcctg 
Fwd HisTag-stop-ADH1t see above  
Used to clone bcd from 
Megasphaera elsdenii w/C-
HisTag 
Rev ADH1t-pRS425 see above 
Fwd pRS425-PYK1p see above 
Rev PYK1p-start-HisTag see above  
Fwd start-HisTag-
nostartMeEtfA atgcatcatcatcatcatcacgatttagcagaatataaagg 
Used to clone etfA from 
Megasphaera elsdenii w/N-
HisTag 
Rev ADH2t-pRS425 see above 
Fwd pRS425-PYK1p see above 
Rev MeEtfA-nostop-HisTag-
stop ctagtgatgatgatgatgatgtgcaatgcctttctgtttc 
Fwd HisTag-stop-ADH2t see above  
Used to clone etfA from 
Megasphaera elsdenii w/C-
HisTag 
Rev ADH2t-pRS425 see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
Fwd start-HisTag-nostartMeEtfB atgcatcatcatcatcatcacgaaatattggtatgtgtcaaac 
Used to clone etfB from 
Megasphaera elsdenii w/N-
HisTag 
Rev CYC1t-pRS425 see above 
Fwd pRS425-GPDp see above 
Rev MeEtfB-nostop-HisTag-
stop ctagtgatgatgatgatgatgaatgattttctgggcaaccag 
Fwd HisTag-stop-CYC1t see above 
Used to clone etfB from 
Megasphaera elsdenii w/C-
HisTag 
Rev CYC1t-pRS425 see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd start-HisTag-
nostartCaAdhE2 atgcatcatcatcatcatcacaaagttacaaatcaaaaag 
NN Fwd CaAdhE2-ADH2t  ctatataaaatcattttaatcatgtttatcaag  
NN Rev CaAdhE2-ADH2t  cttgataaacatgattaaaatgattttatatag 
Used to clone adheE2 from 
Clostridium acetobutylicum 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
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Fwd pRS425-GPDp see above 
NN Fwd GPDp-CaAdhE2 cttagtttcgacggatatgaaagttacaaatcaa 
NN Rev GPDp-CaAdhE2 ttgatttgtaactttcatatccgtcgaaactaag 
NN Fwd CaAdhE2-ADH2t  see above 
NN Rev CaAdhE2-ADH2t  see above 
Used to clone adhE2 from 
Clostridium acetobutylicum 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd start-HisTag-
nostartCbAad atgcatcatcatcatcatcacagagttacgaatccag 
NN Fwd CbAad-ADH2t  ggcagcaataaataatcatgtttatcaag 
NN Rev CbAad-ADH2t  cttgataaacatgattatttattgctgcc 
Used to clone aad from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd GPDp-CbAad cttagtttcgacggatatgagagttacgaatccag  
NN Rev GPDp-CbAad ctggattcgtaactctcatatccgtcgaaactaag 
NN Fwd CaAdhE2-ADH2t  see above 
NN Rev CaAdhE2-ADH2t  see above 
Used to clone aad from 
Clostridium beijerinckii 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd start-His-
nostCbAdhA/B atgcatcatcatcatcatcacgcacgttttactttac 
NN Fwd CbAdhA/B-ADH2t  ggaactaaagttaatttgtaatcatgtttatcaag  
NN Rev CbAdhA/B-ADH2t  cttgataaacatgattacaaattaactttagttcc 
Used to clone adhA from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd start-HisTag-
nostartCbAdhA/B see above 
NN Fwd CbAdhB-ADH2t  see above  
NN Rev CbAdhB-ADH2t  see above 
Used to clone adhB from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd st-HisTag-nostCaBdhA atgcatcatcatcatcatcacctaagttttgattattc 
NN Fwd CaBdhA-ADH2t  aaaatcttattaatcatgtttatcaagagctctag 
NN Rev CaBdhA-ADH2t  ctagagctcttgataaacatgattaataagatttt 
Used to clone bdhA from 
Clostridium acetobutylicum 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-CaBdhA caaaacttagcatatccgtcgaaactaagttc 
NN Fwd GPDp-CaBdhA gaacttagtttcgacggatatgctaagttttg 
NN Fwd CaBdhA-ADH2t  see above 
NN Rev CaBdhA-ADH2t  see above 
Used to clone bdhA from 
Clostridium acetobutylicum  
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd st-HisTag-nostCaBdhB atgcatcatcatcatcatcacgttgatttcgaatattc 
Used to clone bdhB from 
Clostridium acetobutylicum 
w/N-HisTag 
NN Fwd CaBdhB-ADH2t  aaaatctgtgtaatcatgtttatcaagagctctag 
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NN Rev CaBdhB-ADH2t  ctagagctcttgataaacatgattacacagatttt 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-CaBdhB gaatattcgaaatcaaccatatccgtcgaaactaagttc 
NN Fwd GPDp-CaBdhB gaacttagtttcgacggatatggttgatttcgaatattc 
NN Fwd CaBdhB-ADH2t  see above 
NN Rev CaBdhB-ADH2t  see above 
Used to clone bdhB from 
Clostridium acetobutylicum 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-nostCaHbd atgcatcatcatcatcatcacaaaaaggtatgtg 
NN Fwd CaHbd-ADH2t  cgattattcaaaataatcatgtttatcaagagctc 
NN Rev CaHbd-ADH2t  cgattattcaaaataatcatgtttatcaagagctc 
Used to clone hbd from 
Clostridium acetobutylicum 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-nostBfHbd1 atgcatcatcatcatcatcacaaagtaggcgtaattg 
NN Fwd st-HisTag-nostBfHbd2 atgcatcatcatcatcatcacaaggtaggcgttatcg 
NN Fwd st-HisTag-nostBfHbd3 atgcatcatcatcatcatcacaaagtagctgtaattg 
NN Fwd BfHbd3-ADH2t  ctgttgacaagctttaatcatgtttatcaagagctc 
NN Rev BfHbd3-ADH2t  gagctcttgataaacatgattaaagcttgtcaacag 
NN Fwd BfHbd1/2-ADH2t  cagtagatgctcagtaatcatgtttatcaagagctc 
NN Rev BfHbd1/2-ADH2t  gagctcttgataaacatgattactgagcatctactg 
Used to clone hbd1, hbd2, 
and hbd3 from Butyrivibrio 
fibrisolvens w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-BfHbd1 cgcctactttcatatccgtcgaaactaagttc 
NN Fwd GPDp-BfHbd1 gaacttagtttcgacggatatgaaagtaggcg 
NN Rev GPDp-BfHbd2 cgcctaccttcatatccgtcgaaactaagttc 
NN Fwd GPDp-BfHbd2 gaacttagtttcgacggatatgaaggtaggcg 
NN Rev GPDp-BfHbd3 caattacagctactttcatatccgtcgaaactaagttc 
NN Fwd GPDp-BfHbd3 gaacttagtttcgacggatatgaaagtagctgtaattg 
NN Fwd BfHbd1/2-ADH2t  see above 
NN Rev BfHbd1/2-ADH2t  see above 
Used to clone hbd1, hbd2, 
and hbd3 from Butyrivibrio 
fibrisolvens 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN Fwd st-HisTag-nostEcBad atgcatcatcatcatcatcacagtaagcgtaaagtcg 
NN Fwd EcBad-ADH2t  ggagaagcggcatgatcatgtttatcaagagctctag 
NN Rev EcBad-ADH2t  ctagagctcttgataaacatgatcatgccgcttctcc 
Used to clone ald from 
Escherichia coli w/N-
HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-EcBad gactttacgcttactcatatccgtcgaaactaagttc 
NN Fwd GPDp-EcBad gaacttagtttcgacggatatgagtaagcgtaaagtc 
NN Fwd EcBad-ADH2t  see above 
NN Rev EcBad-ADH2t  see above 
Used to clone ald from 
Escherichia coli 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-EcBad see above 
NN Fwd GPDp-EcBad see above 
NN Fwd HisTag-stop-ADH2t  catcatcatcatcatcactaatcatgtttatcaagagctctag 
Used to clone ald from 
Escherichia coli w/C-
HisTag 
NN Rev EcBad-C-HisTag-stop ttagtgatgatgatgatgatgtgccgcttctcctgcc 
164 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-nostCpHbd atgcatcatcatcatcatcacgaaaagatttttgtaattg 
NN Fwd CpHbd-ADH2t  caactacaacgcataatcatgtttatcaagagctc 
NN Rev CpHbd-ADH2t  gagctcttgataaacatgattatgcgttgtagttg 
Used to clone hbd from 
Clostridium perfringens 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-CpHbd caaaaatcttttccatatccgtcgaaactaagttc 
NN Fwd GPDp-CpHbd gaacttagtttcgacggatatggaaaagatttttg 
NN Fwd CpHbd-ADH2t  see above 
NN Rev CpHbd-ADH2t  see above 
Used to clone hbd from 
Clostridium perfringens  
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-nostCnHbd1 atgcatcatcatcatcatcacacaatcaggattgtgg 
NN Fwd CnHbd1-ADH2t  cgtatacacctactagtcatgtttatcaagagctc 
NN Rev CnHbd1-ADH2t  gagctcttgataaacatgactagtaggtgtatacg 
NN Fwd st-HisTag-nostCnHbd2 atgcatcatcatcatcatcacgcaatcaggacagtgg 
NN Fwd CnHbd2-ADH2t  cgtctacagcaagtaatcatgtttatcaagagctc 
NN Rev CnHbd2-ADH2t  gagctcttgataaacatgattacttgctgtagacg 
Used to clone hbd1 and 
hbd2 from Cupriavidus 
necator w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-CnHbd1 caatcctgattgtcatatccgtcgaaactaagttc 
NN Fwd GPDp-CnHbd1 gaacttagtttcgacggatatgacaatcaggattg 
NN Fwd CnHbd1-ADH2t  see above 
NN Rev CnHbd1-ADH2t  see above 
NN Rev GPDp-CnHbd2 ctgtcctgattgccatatccgtcgaaactaagttc 
NN Fwd GPDp-CnHbd2 gaacttagtttcgacggatatggcaatcaggacag 
NN Fwd CnHbd2-ADH2t  see above 
NN Rev CnHbd2-ADH2t  see above 
Used to clone hbd1 and 
hbd2 from Cupriavidus 
necator 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-nostBcHbd atgcatcatcatcatcatcacggtgtacaaaacattg 
NN Fwd BcHbd-ADH2t  gatggttaggggcgtaatcatgtttatcaagagctc 
NN Rev BcHbd-ADH2t  gagctcttgataaacatgattacgcccctaaccatc 
Used to clone hbd from 
Bacillus cereus w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-BcHbd gttttgtacacccatatccgtcgaaactaagttc 
NN Fwd GPDp-BcHbd gaacttagtttcgacggatatgggtgtacaaaac 
NN Fwd BcHbd-ADH2t  see above 
NN Rev BcHbd-ADH2t  see above 
Used to clone hbd from 
Bacillus cereus  
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-nostRrHbd atgcatcatcatcatcatcacgtcgaaaagattggcg 
NN Fwd RrHbd-ADH2t  cgttcccacccgttaatcatgtttatcaagagctc 
NN Rev RrHbd-ADH2t  gagctcttgataaacatgattaacgggtgggaacg 
Used to clone hbd from 
Rhodospirillum rubrum 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-RrHbd caatcttttcgaccatatccgtcgaaactaagttc 
Used to clone hbd from 
Rhodospirillum rubrum 
NN Fwd GPDp-RrHbd gaacttagtttcgacggatatggtcgaaaagattg 
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NN Fwd RrHbd-ADH2t  see above 
NN Rev RrHbd-ADH2t  see above 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-CnBad atgcatcatcatcatcatcacatggcgacaaggaaactc 
NN Fwd CnBad-ADH2t  ccgcactgactgcttgatcatgtttatcaagagctc 
NN Rev CnBad-ADH2t  gagctcttgataaacatgatcaagcagtcagtgcgg 
Used to clone ald from 
Cupriavidus necator w/N-
HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-CnBad gagtttccttgtcgccatatccgtcgaaactaagttc 
NN Fwd GPDp-CnBad gaacttagtttcgacggatatggcgacaaggaaactc 
NN Rev CnBad-C-HisTag-stop ttagtgatgatgatgatgatgagcagtcagtgcggcctg 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone ald from 
Cupriavidus necator w/C-
HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-ScADH6 atgcatcatcatcatcatcacatgtcttatcctgagaa 
NN Fwd ScADH6-ADH2t  caaagaattttcagactagtcatgtttatcaagagctc 
NN Rev ScADH6-ADH2t  gagctcttgataaacatgactagtctgaaaattctttg 
Used to clone adh6 from 
Saccharomyces cerevisiae 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-ScADH6 ttctcaggataagacatatccgtcgaaactaagttc 
NN Fwd GPDp-ScADH6 gaacttagtttcgacggatatgtcttatcctgagaa 
NN Rev ScADH6-C-HisTag-
stop  ttagtgatgatgatgatgatggtctgaaaattctttgtc 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone adh6 from 
Saccharomyces cerevisiae 
w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-CaCrt atgcatcatcatcatcatcacatggaactaaacaatg 
NN Fwd CaCrt-ADH2t  cttcaaaaatagatagtcatgtttatcaagagctc 
NN Rev CaCrt-ADH2t  gagctcttgataaacatgactatctatttttgaag 
Used to clone crt from 
Clostridium acetobutylicum 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-CaCrt cattgtttagttccatatccgtcgaaactaagttc 
NN Fwd GPDp-CaCrt gaacttagtttcgacggatatggaactaaacaatg 
NN Rev CaCrt-C-HisTag-stop  ttagtgatgatgatgatgatgtctatttttgaagccttc 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone crt from 
Clostridium acetobutylicum 
w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-BfCrt atgcatcatcatcatcatcacatgagttttgttttatatg 
NN Fwd BfCrt-ADH2t  gatttcaagaatgcttaatcatgtttatcaagagctc 
NN Rev BfCrt-ADH2t  gagctcttgataaacatgattaagcattcttgaaatc 
Used to clone crt from 
Butyrivibrio fibrisolvens 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-BfCrt catataaaacaaaactcatatccgtcgaaactaagttc 
NN Fwd GPDp-BfCrt gaacttagtttcgacggatatgagttttgttttatatg 
NN Rev BfCrt-C-HisTag-stop  ttagtgatgatgatgatgatgagcattcttgaaatctac 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone crt from 
Butyrivibrio fibrisolvens 
w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Used to clone crt from Fwd pRS425-GPDp see above 
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NN Fwd st-HisTag-BcCrt atgcatcatcatcatcatcacatgctacaattacaaaat 
NN Fwd BcCrt-ADH2t  gtataagggggagtaatcatgtttatcaagagctc 
NN Rev BcCrt-ADH2t  gagctcttgataaacatgattactcccccttatac 
Bacillus cereus w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-BcCrt attttgtaattgtagcatatccgtcgaaactaagttc 
NN Fwd GPDp-BcCrt gaacttagtttcgacggatatgctacaattacaaaat 
NN Rev BcCrt-C-HisTag-stop  ttagtgatgatgatgatgatgctcccccttatacattg 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone crt from 
Bacillus cereus w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-caPtb atgcatcatcatcatcatcacatgattaagagttttaatg 
NN Fwd caPtb-ADH2t  gttgcaggcaataaataatcatgtttatcaagagctc 
NN Rev caPtb-ADH2t  (rcofabove) 
Used to clone ptb from 
Clostridium acetobutylicum 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-caPtb gagctcttgataaacatgattatttattgcctgcaac 
NN Fwd GPDp-caPtb gaacttagtttcgacggatatgattaagagttttaatg 
NN Rev caPtb-C-HisTag-stop  ttagtgatgatgatgatgatgtttattgcctgcaactaaag 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone ptb from 
Clostridium acetobutylicum 
w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-caBuk atgcatcatcatcatcatcacatgtatagattactaataatc 
NN Fwd caBuk-ADH2t  ctaaggaatacaaataatcatgtttatcaagagctc 
NN Rev caBuk-ADH2t  gagctcttgataaacatgattatttgtattccttag 
Used to clone buk from 
Clostridium acetobutylicum 
w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-caBuk gaacttagtttcgacggatatgtatagattactaataatc 
NN Fwd GPDp-caBuk gaacttagtttcgacggatatgtatagattactaataatc 
NN Rev caBuk-C-HisTag-stop  ttagtgatgatgatgatgatgtttgtattccttagctttttc 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone buk from 
Clostridium acetobutylicum 
w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-scAld4 ctttaagcagagcgtagacatatccgtcgaaactaagttc 
NN Fwd GPDp-scAld4 gaacttagtttcgacggatatgtctacgctctgcttaaag 
NN Rev scAld4-C-HisTag-stop  ttagtgatgatgatgatgatgctcgtccaatttggcacg 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone ald4 (N-
truncated) from 
Saccharomyces cerevisiae 
w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Fwd st-HisTag-teAad atgcatcatcatcatcatcacatgcctaccttattacaag 
NN Fwd teAad-ADH2t  gaaaagcctatggagaataatcatgtttatcaagagctc 
NN Rev teAad-ADH2t  gagctcttgataaacatgattattctccataggcttttc 
Used to clone aad from 
Thermoanaerobacter 
ethanolicus w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN Rev GPDp-teAad cttgtaataaggtaggcatatccgtcgaaactaagttc 
NN Fwd GPDp-teAad gaacttagtttcgacggatatgcctaccttattacaag 
NN Rev teAad-C-HisTag-stop  ttagtgatgatgatgatgatgttctccataggcttttc 
NN Fwd HisTag-stop-ADH2t  see above 
Used to clone aad from 
Thermoanaerobacter 
ethanolicus w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
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Fwd pRS423-GPDp see above 
NN Rev GPDp-CbBad 
gtaggtattagtgtgtctttattcatatccgtcgaaactaagttctg
gtg 
NN Fwd GPDp-CbBad 
caccagaacttagtttcgacggatatgaataaagacacactaata
cctac 
NN Fwd CbBad-ADH2t  
caaagaagatgtgtacttgccggctaa 
tcatgtttatcaagagctctagaattc  
NN Rev CbBad-ADH2t  
gaattctagagctcttgataaacatgattagccggcaagtacaca
tcttctttg 
Used to clone bad from 
Clostridium beijerinckii 
Rev ADH2t–pRS423 see above 
NN R GPDp-SacI-CbBad see above 
NN F GPDp-SacI-CbBad see above 
Used to clone bad from 
Clostridium beijerinckii 
w/N-HisTag 
NN R cbBad-His KpnI 
ttacatgatggtaccttagtgatgatgatgatgatggccggcaag
tacacatcttctttg 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
NN F st-His6-ns-caAdhE2-coSc atgcatcatcatcatcatcacaaggttactaaccaaaag 
NN F caAdhE2-coSc-ADH2t  see above 
NN R caAdhE2-coSc-ADH2t  see above 
Used to clone adhE2-coSc 
from Clostridium 
acetobutylicum w/N-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
NN F GPDp-caAdhE2-coSc see above  
NN R GPDp-caAdhE2-coSc see above 
NN R caAdhE2-coSc-ns-His6 ttagtgatgatgatgatgatggaaagacttgatgtagatgtc 
NN R caAdhE2-coSc-ns-ADH2t  see above 
Used to clone adhE2-coSc 
from Clostridium 
acetobutylicum w/C-HisTag 
Rev ADH2t–pRS425 (crt) see above 
Fwd pRS425-GPDp see above 
Rev GPDp-start-HisTag see above 
Fwd start-HisTag-nostartCbCrt atgcatcatcatcatcatcac  gaaaatattaaggtaaaggaag  
Used to clone crt from 
Clostridium beijerinckii 
w/N-HisTag 
Rev ADH2t–pRS425 see above 
Fwd pRS425-GPDp see above 
Rev CbCrt-nostop-Histag-stop ctagtgatgatgatgatgatgacatcctttaaatagagcctttc 
Fwd Histag-stop-ADH2t catcatcatcatcatcactagtcatgtttatcaagagctctaga 
Used to clone crt from 
Clostridium beijerinckii 
w/C-HisTag 
Rev ADH2t-pRS425 see above 
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Appendix G. A list of all the primers used. Capitals indicate restriction sites, italics indicate the direct repeat 
sequence, bold indicates the point mutations to be introduced into the chromosome, and underline indicates 
sequences annealing to template (pRS406 or pDIRe3).  
 
Purpose Name Sequence (5’ to 3’) 
NN F del GAL7p-URA3 gagcatcaacatgataaaaaaaaacagttgaatattccctcaaaa 
ctaagaaaccattattatc 
Primers for single 
ura3-based method 
NN R del URA3-GAL7p,t 
aggagcctgatggatacccattgagtatgggaaactcgtttcaaa 
ttttgagggaatattcaactgtttt cctgatgcggtattttc 
NN R/F ura3-IR EcoRI 3 atc GAATTC ttttttattcttttttttgatttcggtttctttg Primers used for all 
ura3-IR based 
mutagenesis 
NN F/R ura3-IR MfeI 3 atc CAATTG ttttttattcttttttttgatttcggtttctttg 
NN F delGAL7 ura3-IR LN25 gagcatcaacatgataaaaaaaaacagttgaatattccctcaaaa 
tttgaaacgagtttcccatactcaa cctgatgcggtattttctcc 
Primers used to 
delete gal7 
NN R delGAL7 ura3-IR LN aggagcctgatggataccca ttgagtatgggaaactcgtttcaaa 
cctgatgcggtattttctccttacg 
NN F trp1p ura3-IR LN25 ccgctcacccgcacggcagagaccaatcagtaaaaatcaacggtt 
taaaagactcgtatttccaaaagac cctgatgcggtattttctcc 
Primers used to 
delete trp1 
NN R trp1t ura3-IR LN gcactgagtagtatgttgca gtcttttggaaatacgagtctttta 
cctgatgcggtattttctccttacg 
NN F trp1-1 ura3-IR LN25 ggcactccgaaatacttggttggcgtgtttcgtaatcaacctaag gag 
gatgttttggctctggtcaatgatt cctgatgcggtattttctcc 
Primers used for 
trp1-1 to trp1wt 
mutagenesis NN R trp1-1 ura3-IR LN ttggacgatatcaatgccgt aatcattgaccagagccaaaacatc 
cctgatgcggtattttctccttacg 
NN F adh4 T451 ura3-IRLN25 cacgccatgcatgatgcctgccatttgactaacccagttcaattc act 
aaagaacaagtggttgccattatca cctgatgcggtattttctcc 
Primers used for 
adh4 T451 point 
mutations NN R adh4t ura3-IR LN ttaatattcataggctttct tgataatggcaaccacttgttcttt 
cctgatgcggtattttctccttacg 
NN F adh7 Q149 ura3-IRLN25 aggctttgcctcccacgtgaggcttcatgaacactttgctattca gat 
accagaaaatattccaagtccgcta cctgatgcggtattttctcc 
Primers used for 
adh7 Q149 point 
mutations NN R2 adh7t ura3-IR LN ccacacaataatggagcggc tagcggacttggaatattttctggt 
cctgatgcggtattttctccttacg 
NN F gpd1 D391insC ura3 LN25 atgaagaacctgccggacatgattgaagaattagatctacatgaa c 
tagatttattggagaaagataacat cctgatgcggtattttctcc 
Primers used for 
gpd1 D391 
frameshift mutation NN R gpd1t ura3-IR LN aaagtgggggaaagtatgat atgttatctttctccaataaatcta 
cctgatgcggtattttctccttacg 
NN R/F his3-IR EcoRI atc CAATTG ctgagagtgcaccataaattcccg Primers used for 
his3-ura3-IR based 
mutagenesis 
NN F/R his3-IR MfeI atc GAATTC ctgagagtgcaccataaattcccg 
NN F delGAL7 ura3-IR p gagcatcaacatgataaaaaaaaac agttgaatattccctcaaaa 
cctgatgcggtattttctcc 
NN R delGAL7 ura3-IR p,t,3 aggagcctgatggatacccattgagtatgggaaactcgtttc 
aaattttgagggaatattcaact cctgatgcggtattttctccttac 
NN R delGAL7 ura3-IR p,t,25 aggagcctgatggatacccattgagtatgggaaactcgtttc 
aaattttgagggaatattcaactgtttt cctgatgcggtattttctccttac 
NN R delGAL7 ura3-IR p,t,30 aggagcctgatggatacccattgagtatgggaaactcgtttc 
aaattttgagggaatattcaactgttttttttt cctgatgcggtattttctccttac 
DR optimization 
primers 
NN R delGAL7 ura3-IR p,t,35 aggagcctgatggatacccattgagtatgggaaactcgtttc 
aaattttgagggaatattcaactgtttttttttatcat cctgatgcggtattttctccttac 
Verification primers NN R ura3t IRchk  agatgcgtaaggagaaaataccgcatcagg  
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NN F del conf GAL7p tccttttggaaagctatacttcggagcactg 
NN R del conf GAL7t tacagtctttgtagataatgaatctgaccatc 
NN F trp1 mid atataatataggaagcatttaatagaacagcatcg 
NN R trp1 mid atgcagttggacgatatcaatgccgtaatcattg 
NN F adh7 mid tcagggcatcggtatttccaacgcaaagg 
NN R ADH7t aaaacttactgctctgcactgttgtcgaga 
NN F adh4 mid acgtatgccgttaactctacaaagcaattg 
NN R ADH4t caaacgtaccggtctcggctcattaataga 
NN F gpd1 mid ctacccgacaatttggttgctaatc 
NN R GPD1t gaggtgtacagctaatattataatg 
NN F TRP1p tttcctgctttgaattagtcgcgctgggag 
NN R TRP1t cttttacaccatttgtctccacacctccgc 
NN F DIRe3 EcoRI HIS3p atcgat GAATTC ctgagagtgcaccataaattcccgttttaag 
NN R DIRe3 HIS3t agaaaccgaaatcaaaaaaaagaataaaaaatgacacgtatagaatgatgcattacc 
NN F DIRe3 URA3p ggtaatgcatcattctatacgtgtcattttttattcttttttttgatttcggtttctttg 
Primers used to 
construct pDIRE3 
NN R DIRe BamHI URA3t atcgat GGATCC cctgatgcggtattttctccttacg  
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Appendix H. A list of all the primers used. Capitals/bold indicate terminal repeats (TR), italics indicate homology 
to the chromosome, and underline indicates sequences annealing to template.  
 
Purpose Name Sequence (5’ to 3’) 
NN F D(xylA)cat 
2chi75 
ctagtaatgatc GCTGGTGG GCTGGTGG 
taccgataaccgggccaacggactgcacagttagccgttatttgtcgaacagataatggtttaccagattttcca 
gtgtaggctggagctgcttc 
NN R D(xylA)cat 
2chi75 
ctagtaatgatc CCACCAGC CCACCAGC 
atattacgacatcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
NN F D(xylA)cat 
2chi75inv2 
ctagtaatgatc CCACCAGC CCACCAGC 
taccgataaccgggccaacggactgcacagttagccgttatttgtcgaacagataatggtttaccagattttcca 
gtgtaggctggagctgcttc 
NN F D(xylA)cat 1-
0chi75 
ctagtaatgatc GCTGGTGG GCTAATGG 
taccgataaccgggccaacggactgcacagttagccgttatttgtcgaacagataatggtttaccagattttcca 
gtgtaggctggagctgcttc 
NN R D(xylA)cat 1-
0chi75 
ctagtaatgatc CCACCAGC CCATTAGC 
atattacgacatcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
NN F D(xylA)cat 0-
1chi75 
ctagtaatgatc GCTAATGG GCTGGTGG 
taccgataaccgggccaacggactgcacagttagccgttatttgtcg 
aacagataatggtttaccagattttcca gtgtaggctggagctgcttc 
NN R D(xylA)cat 0-
1chi75 
ctagtaatgatc CCATTAGC CCACCAGC 
atattacgacatcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
NN F D(xylA)cat 0-
0chi75 
ctagtaatgatc GCTAATGG GCTAATGG 
taccgataaccgggccaacggactgcacagttagccgttatttgtcg 
aacagataatggtttaccagattttcca gtgtaggctggagctgcttc 
NN R D(xylA)cat 0-
0chi75 
ctagtaatgatc CCATTAGC CCATTAGC 
atattacgacatcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
NN F D(xylA)cat Y-
Z75 
ctagtaatgatc ATGAACTA CGTATAAG 
taccgataaccgggccaacggactgcacagttagccgttatttgtcgaacagataatggtttaccagattttcca 
gtgtaggctggagctgcttc 
NN R D(xylA)cat 
Y-Z75 
ctagtaatgatc TAGTTCAT CTTATACG 
atattacgacatcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
NN F D(xylA)cat Y-
Y75 
ctagtaatgatc ATGAACTA ATGAACTA 
taccgataaccgggccaacggactgcacagttagccgttatttgtcg 
aacagataatggtttaccagattttcca gtgtaggctggagctgcttc 
NN R D(xylA)cat 
Y-Y75 
ctagtaatgatc TAGTTCAT TAGTTCAT 
atattacgacatcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
NN F D(xylA)cat 
ZZ75 
ctagtaatgatc CGTATAAG CGTATAAG 
taccgataaccgggccaacggactgcacagttagccgttatttgtcgaacagataatggtttaccagattttcca 
gtgtaggctggagctgcttc 
Initial attempts 
w/chi & non-chi 
sequences 
NN R D(xylA)cat 
ZZ75 
ctagtaatgatc CTTATACG CTTATACG 
atattacgacatcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
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NN F D(xylA)cat 
2chi65 
ctagtaatgatc GCTGGTGG GCTGGTGG 
cgggccaacggactgcacagttagccgttatttgtcgaacagataatggtttaccagattttcca 
gtgtaggctggagctgcttc 
NN R D(xylA)cat 
2chi65 
ctagtaatgatc CCACCAGC CCACCAGC 
atcatccatcacccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct 
catatgaatatcctccttag 
NN F D(xylA)cat 
2chi55 ctagtaatgatc GCTGGTGG GCTGGTGG 
gactgcacagttagccgttatttgtcgaacagataatggtttaccagattttcca gtgtaggctggagctgcttc 
NN R D(xylA)cat 
2chi55 ctagtaatgatc CCACCAGC CCACCAGC 
acccgcggcattacctgattatggagttcaatatgcaagcctattttgaccagct catatgaatatcctccttag 
NN F D(xylA)cat 
2chi45 ctagtaatgatc GCTGGTGG GCTGGTGG 
ttagccgttatttgtcgaacagataatggtttaccagattttcca gtgtaggctggagctgcttc 
Changing length 
of homology  
NN R D(xylA)cat 
2chi45 ctagtaatgatc CCACCAGC CCACCAGC 
ttacctgattatggagttcaatatgcaagcctattttgaccagct catatgaatatcctccttag 
NN F xylA start ggtttaccagattttccagttgttcctggc 
NN R xylA end cactggcgttggcgaagcgtaaagcagatg 
NN R xylF chk atccgcatcgttaatcatacggtcgtaagc 
NN F xylB chk ggcaccgtcgccataccccacgctttc   
NN F cat start catcgcagtactgttgtattcattaagc 
NN R cat end ggagaaaaaaatcactggatataccaccg 
NN R pTH18k kan 
chk ctcgatgagtttttctaatcagaattgg 
NN F araB chk atggcgattgcaattggcctcg 
NN R araB chk tgaacagcggggaaggcaaatg 
NN F lacZ chk cctttcggcggtgaaattatcgatg 
NN R lacZ chk cgactgatccacccagtcccagac 
NN F recC chk ccgttatccagacgtatagcctg 
NN R recC chk aatcaacaaggctttagcctgc 
NN F recE chk acgttctttttaccgctcttttcg 
NN R recE chk gcgcattggctacgtaattaaaacag 
NN F xthA chk gaatacgtttgcgatgtgggtg 
NN R xthA chk ggtggcaatgatgaataacagaatatagag 
NN F recJ chk ccagcccctgtttcatttgg 
Chromosome 
verification 
primers 
NN R recJ chk ggggatcaccgtgcgttatc 
NN F ZZ75 pACYC 
ctagtaatgatc CGTATAAG CGTATAAG tgaaacctcaggcatttgagaagcacacgg 
NN R ZZ75 pACYC 
ctagtaatgatc CTTATACG CTTATACG gcgcaacgcaattaatgtaagttagctcac 
Used to test OR 
frequencies 
NN F YY pACYC 
ctagtaatgatc ATGAACTA ATGAACTA tgaaacctcaggcatttgagaagcacacgg 
NN F ZZ-noOH 
pACYC 
CGTATAAG CGTATAAG tgaaacctcaggcatttgagaagcacacgg Used to test 
melting 
temperature of 
TR 
NN R ZZ-noOH 
pACYC CTTATACG CTTATACG gcgcaacgcaattaatgtaagttagctcac 
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NN F Z’Z’49 ACYC 
CGTCGAAG CGTCGAAG tgaaacctcaggcatttgagaagcacacgg 
NN R Z’Z’49 
ACYC CTTCGACGCTTCGACG gcgcaacgcaattaatgtaagttagctcac 
NN F Z’Z’59 ACYC 
CGCGGGAG CGCGGGAG tgaaacctcaggcatttgagaagcacacgg 
NN R Z’Z’59 
ACYC CTCCCGCGCTCCCGCG gcgcaacgcaattaatgtaagttagctcac 
NN F ZZ-noOH 
pACYC 
CGTATAAG CGTATAAG tgaaacctcaggcatttgagaagcacacgg 
NN R ZZ-noOH 
pACYC CTTATACG CTTATACG gcgcaacgcaattaatgtaagttagctcac 
NN R ZZ-noOH 
pACYCco+anti CTTATACG CTTATACG tggcgctgggcgcaatgcg 
NN F ZZ-noOH 
pACYCanti CGTATAAG CGTATAAG gggccaacttttggcgaaaatgagac 
NN R YY 
pACYCco+anti 
gagcatgtctac TAGTTCAT TAGTTCAT tggcgctgggcgcaatgcg 
NN F YY 
pACYCanti 
ctagtaatgatc ATGAACTA ATGAACTA gggccaacttttggcgaaaatgagac 
NN F ZZ ACYC 
open 
CGTATAAG CGTATAAG gctagttattgctcagcggtg 
NN R ZZ ACYC 
open CTTATACG CTTATACG ggtaaaccagcaatagacataagc 
NN F ZZ ACYC 
closed2 CGTATAAG CGTATAAG cgggatctcgacgctctccc 
Used to test 
cat/p15A 
orientation 
NN R ZZ ACYC 
closed2 
ctagtaatgatc ATGAACTA ATGAACTA cgggatctcgacgctctccc 
NN F ACYCp15 
SEQout 
cagagcaagagattacgcgcaga Junction 
sequencing 
primers NN R ACYCcat 
SEQout atgagtggcagggcggggcg 
NN F pTH18k 
D(xylA) AATCAGGTAATGCCGC gggtgatggatgatgtcgtaatattgggcactccctttcagttgctcaattatgttatt 
taaccaattctgattagaaaaactcatcgag 
NN R pTH18 
D(xylA) GCGGCATTACCTGATT 
taacggctaactgtgcagtccgttggcccggttatcggtagcgataccgggcatttttttaaggaacgatcgata 
ccataagaacctcagatccttccg 
NN F pTH18k 60 
D(xylA) AATCAGGTAATGCCGC gggtgatggatgatgtcgtaatattgggcactccctttcagttg 
taaccaattctgattagaaaaactcatcgag 
NN R pTH18k 60 
D(xylA) GCGGCATTACCTGATT taacggctaactgtgcagtccgttggcccggttatcggtagcgataccgggcattttttt 
ccataagaacctcagatccttccg 
Primers used to 
introduce 
mutagenesis 
cassettes 
NN F pTH18k 50 
D(xylA) AATCAGGTAATGCCGC gggtgatggatgatgtcgtaatattgggcactcc 
taaccaattctgattagaaaaactcatcgag 
173 
NN R pTH18k 50 
D(xylA) GCGGCATTACCTGATT taacggctaactgtgcagtccgttggcccggttatcggtagcgataccgg 
ccataagaacctcagatccttccg 
NN F pTH18k 
lacZSacII CCGCGG TGGCTACCGG 
tggctaccggcgatgagcgaacgcgtaacgcgaatggtgcagcgcgatcgtaatcacccgagtgt 
taaccaattctgattagaaaaactcatcgag 
NN R pTH18k 
lacZSacII 
CCGGTAGCCA CCGCGG 
atcatcggtcagacgattcattggcaccatgccgtgggtttcaatattggcttcatccaccacatacagg 
ccataagaacctcagatccttccg 
NN F pTH18k 
araBstop 
TAGCGCGCAGCTGTGG 
tcgggattggcgttgacagtaccggctcgacgcccgcaccgattgatgccgacggaaacg 
taaccaattctgattagaaaaactcatcgag 
NN R pTH18k 
araBstop CCACAGCTGCGCGCTA 
ttcgacgctaagctctgcaagcacggttttcagtgccgcttccattgactcaatgtagtcacgcggatgatgacg 
ccataagaacctcagatccttccg 
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Appendix I. List of all strains used. 
 
Name Genotype Source 
MG1655 F- λ- ilvG- rfb-50 rph-1 ATCC 700926 
DH5α F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG 
Φ80dlacZ∆M15 ∆(lacZYA-argF)U169, hsdR17(rK- mK+), λ– Stratagene  
BW25113 ∆(araD-araB)567 ∆lacZ4787(::rrnB-3) λ- rph-1 ∆(rhaD-
rhaB)568 hsdR514 CGSC, Yale University 
JW2669-1 BW25113 recA774∆::kan CGSC, Yale University 
JW2788-1 BW25113 recB745∆::kan CGSC, Yale University 
JW2787-1 BW25113 recD744∆::kan CGSC, Yale University 
JW1850-2 BW25113 ruvA786∆::kan CGSC, Yale University 
JW1852-1 BW25113 ruvC789∆::kan CGSC, Yale University 
JW3677-1 BW25113 recF735∆::kan CGSC, Yale University 
JW3627-1 BW25113 recG756∆::kan CGSC, Yale University 
JW5855-2 BW25113 recQ767∆::kan CGSC, Yale University 
JW1738-1  BW25113 xthA747∆::kan  CGSC, Yale University 
JW3786-5  BW25113 uvrD769∆::kan  CGSC, Yale University 
JW2790-1  BW25113 recC747∆::kan CGSC, Yale University 
JW2860-1  BW25113 recJ743∆::kan CGSC, Yale University 
JW2493-1 BW25113 xseA758∆::kan CGSC, Yale University 
JW1833-1 BW25113 exoX769∆::kan CGSC, Yale University 
JW0387-1 BW25113 sbcC761∆::kan CGSC, Yale University 
JW1993-1 BW25113 sbcB780∆::kan CGSC, Yale University 
JW1344-1 BW25113 recE787∆::kan CGSC, Yale University 
JW5446-1 BW25113 xni-725∆::kan CGSC, Yale University 
JW0388-1 BW25113 sbcD762∆::kan CGSC, Yale University 
JW0412-3 BW25113 xseB779∆::kan CGSC, Yale University 
JW1343-2 BW25113 recT786∆::kan CGSC, Yale University 
JW2549-1 BW25113 recO737∆::kan CGSC, Yale University 
JW0461-2 BW25113 recR776∆::kan CGSC, Yale University 
JW0762-2 BW25113 uvrB751∆::kan CGSC, Yale University 
JW1898-1 BW25113 uvrC759∆::kan CGSC, Yale University 
JW5931-1 BW25113 tatD782∆::kan CGSC, Yale University 
JW0784-1 BW25113 dinG771∆::kan CGSC, Yale University 
JW0945-1 BW25113 helD777∆::kan CGSC, Yale University 
JW5604-1 BW25113 rep-729∆::kan CGSC, Yale University 
JW4019-2 BW25113 uvrA753∆::kan CGSC, Yale University 
JW2146-1 BW25113 nfo-786∆::kan CGSC, Yale University 
JW1625-1 BW25113 nth-782∆::kan CGSC, Yale University 
JW5547-1 BW25113 nfi-769∆::kan CGSC, Yale University 
JW2912-1 BW25113 endA720∆::kan CGSC, Yale University 
JW1172-1  BW25113 umuD772∆::kan CGSC, Yale University 
JW1173-1 BW25113 umuC773∆::kan CGSC, Yale University 
JW0059-1 BW25113 polB770∆::kan CGSC, Yale University 
JW3835-1 BW25113 polA726∆::kan CGSC, Yale University 
JW0205-1 BW25113 dnaQ744∆::kan CGSC, Yale University 
HZ2162 BW25113 recE∆::FRT recJ∆::FRT recC∆::kan This work 
HZ2222 BW25113 recE∆::FRT xthA∆::FRT recJ∆::FRT recC∆::kan This work 
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Appendix J. List of all plasmids used. 
 
Name Relevant characteristics Source 
pACYCDuet Cm, p15A-derived plasmid, divergent Novagen 
pACYCco Cm, p15A-derived plasmid, co-directional This work 
pACYCconv Cm, p15A-derived plasmid, convergent This work 
pKD4 FRT::cat::FRT, oriR6Kγ [17] 
pKD46 λred genes under AraBAD promoter, ts ori [17] 
pCP20 Flp under heat inducible promoter, ts ori [17] 
pTH18ks1 Kn, pSC101, temperature sensitive [39] 
pWM91 Amp, sacB, oriR6Kγ [45] 
 
